Medications for human use with 2-4 active ingredients.

Médicaments à usage humain contenant 2-4 ingrédients actifs.

Last Update: 2021-05-03
Product Name;
DIN;
Active ingredient(s) and concentration;
Number of active ingredients: Number of active ingredients;
Original market date;
Route(s) of administration;
Dosage form(s);
AHFS;
Schedule;
Company
Monograph
KIVEXA;
02269341;
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
2005-08-17;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75473
APO-ABACAVIR-LAMIVUDINE;
02399539;
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
2016-03-15;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88441
TEVA-ABACAVIR/LAMIVUDINE;
02416662;
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
2016-03-14;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90124
MYLAN-ABACAVIR/LAMIVUDINE;
02450682;
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
2016-03-29;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93683
AURO-ABACAVIR/LAMIVUDINE;
02454513;
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
2016-08-31;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94109
PMS-ABACAVIR-LAMIVUDINE;
02458381;
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
2016-10-31;
Oral;
Tablet;
08:18.20 – INTERFERONS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94550
NEOCITRAN ULTRA STRENGTH TOTAL FLU;
02404966;
acetaminophen 1000 mg / sachet , dextromethorphan hydrobromide 30 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet;
2014-10-06;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88979
NEOCITRAN ULTRA STRENGTH TOTAL FLU NIGHT;
02217147;
acetaminophen 1000 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , chlorpheniramine maleate 4 mg / sachet , dextromethorphan hydrobromide 30 mg / sachet;
1998-08-28;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37105
CHILDREN’S TYLENOL COLD;
02039982;
acetaminophen 160 mg / 5 ml , chlorpheniramine maleate 1 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
1997-08-11;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26863
CHILDREN’S TYLENOL COLD AND COUGH NIGHTTIME;
02279150;
acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
2006-08-31;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76469
BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER NIGHTIME;
02305666;
acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
2008-09-01;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79122
CHILDREN’S TYLENOL COMPLETE COLD, COUGH & FEVER NIGHTTIME;
02416050;
acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
2014-06-15;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90063
CHILDREN’S TYLENOL COLD & STUFFY NOSE;
02229538;
acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
1997-10-08;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47448
COLD AND SINUS COMPLETE LIQUID GELS;
02349523;
acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
2016-06-01;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83481
TEVA-LENOLTEC NO. 2;
00653241;
acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 15 mg;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6764
TEVA-LENOLTEC NO. 1;
00653233;
acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 8 mg;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6763
ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS;
02154234;
acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 8 mg;
1996-10-11;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33917
TEVA-EMTEC-30;
00608882;
acetaminophen 300 mg , codeine phosphate 30 mg;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5780
TRIATEC-30;
00789828;
acetaminophen 300 mg , codeine phosphate 30 mg;
1989-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9626
TEVA-LENOLTEC NO. 4;
00621463;
acetaminophen 300 mg , codeine phosphate 60 mg;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6824
ACETAMINOPHEN WITH CODEINE – CAPLET;
02143933;
acetaminophen 300 mg , codeine phosphate 8 mg , caffeine 15 mg;
1997-10-28;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31568
MERSYNDOL WITH CODEINE;
02047667;
acetaminophen 325 mg , codeine phosphate 8 mg , doxylamine succinate 5 mg;
1982-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15805
VICKS NYQUIL COMPLETE COLD & FLU CAPLETS;
02410737;
acetaminophen 325 mg , dextromethorphan hydrobromide 10 mg , doxylamine succinate 6.25 mg , phenylephrine hydrochloride 5 mg;
2015-07-08;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89539
VICKS DAYQUIL COMPLETE COLD & FLU CAPLETS;
02409526;
acetaminophen 325 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg;
2014-08-15;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89421
VICKS DAYQUIL COLD & FLU MULTI-SYMPTOM RELIEF LIQUICAPS;
02272784;
acetaminophen 325 mg , dextromethorphan hydrobromide 10 mg , phenylephrine hydrochloride 5 mg;
2006-06-26;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75828
MUCINEX MULTI-ACTION COLD & SINUS CAPLETS;
02433451;
acetaminophen 325 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg;
2020-08-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91782
MUCINEX MULTI-ACTION COLD, FLU & SORE THROAT CAPLETS;
02433435;
acetaminophen 325 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg;
2020-08-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91781
COMBOGESIC;
02488280;
acetaminophen 325 mg , ibuprofen 97.5 mg;
2020-12-14;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BIOSYENT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97838
ROBAXACET;
02026805;
acetaminophen 325 mg , methocarbamol 400 mg;
1993-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14509
DILOTAB II;
02266148;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg;
2006-04-17;
Oral;
Tablet;
12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
ZEE MEDICAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75158
DAYQUIL SINUS LIQUICAPS;
02273829;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg;
2006-06-11;
Oral;
Capsule;
12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75930
COLTALIN COLD & ALLERGY TABLETS;
02244263;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
2002-01-09;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FORTUNE PHARMACAL CO. LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68230
VICKS NYQUIL COMPLETE COLD & FLU LIQUICAPS;
02483351;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , doxylamine succinate 6.25 mg;
2019-07-08;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97379
DAYQUIL COMPLETE + VICKS VAPOCOOL;
02481936;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg;
2020-07-20;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97240
VICKS DAYQUIL COMPLETE COLD & FLU LIQUICAPS;
02483378;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg;
2019-07-08;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97380
HISTENOL II;
02276119;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 200 mg;
2007-03-06;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
ZEE MEDICAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76178
NYQUIL SINUS LIQUICAPS;
02273810;
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , doxylamine succinate 6.25 mg;
2006-06-11;
Oral;
Capsule;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75929
MEDICAMENT POUR LES SINUS, REGULIER;
02240562;
acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg;
2000-04-19;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64134
APO-TRAMADOL/ACET;
02336790;
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
2009-11-09;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82241
TEVA-TRAMADOL/ACETAMINOPHEN;
02347180;
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
2012-09-04;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83257
TARO-TRAMADOL/ACET;
02388197;
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
2012-10-01;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87374
JAMP-ACET-TRAMADOL;
02388308;
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
2012-09-05;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87385
MAR-TRAMADOL/ACET;
02388324;
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
2012-09-04;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87386
MINT-TRAMADOL/ACET;
02389800;
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
2012-09-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87528
AURO-TRAMADOL/ACETAMINOPHEN;
02439050;
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
2015-04-08;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92342
COLD STIX;
02377861;
acetaminophen 325 mg / sachet , pheniramine maleate 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
2013-10-10;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86367
HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU REGULAR STRENGTH;
02047349;
acetaminophen 325 mg / sachet , pheniramine maleate 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , ascorbic acid 50 mg / sachet;
1999-01-06;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=32780
BUCKLEY’S COMPLETE PLUS EXTRA STRENGTH MUCUS RELIEF;
02357232;
acetaminophen 325 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 20 mg / 5 ml;
2012-10-04;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84236
BUCKLEY’S COMPLETE;
02279703;
acetaminophen 325 mg / 5 ml , menthol 20 mg / 5 ml;
2006-08-09;
Oral;
Liquid;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76530
MENSTRUAL MIDOL COMPLETE;
02275201;
acetaminophen 500 mg , caffeine 60 mg , pyrilamine maleate 15 mg;
2006-06-22;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76086
MENSTRUAL COMPLETE;
02397420;
acetaminophen 500 mg , caffeine 60 mg , pyrilamine maleate 15 mg;
2013-07-09;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.08 – ETHYLENEDIAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88238
TYLENOL ULTRA RELIEF;
02254468;
acetaminophen 500 mg , caffeine 65 mg;
2005-01-05;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73935
ULTRA HEADACHE RELIEF;
02264870;
acetaminophen 500 mg , caffeine 65 mg;
2005-06-17;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75038
ACETAMINOPHEN 500MG AND CAFFEINE 65MG;
02269988;
acetaminophen 500 mg , caffeine 65 mg;
2007-06-21;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75534
COLDASIDE COLD & FLU EXTRA STRENGTH;
02305216;
acetaminophen 500 mg , chlorpheniramine maleate 2 mg , dextromethorphan hydrobromide 15 mg;
2009-01-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79071
EXTRA STRENGTH ALLERGY SINUS MEDICATION;
02159546;
acetaminophen 500 mg , chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg;
1996-10-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34150
EXTRA STRENGTH TYLENOL COLD NIGHTTIME;
02276259;
acetaminophen 500 mg , dextromethorphan hydrobromide 10 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76192
FLU, COUGH & COLD COMPLETE;
02380447;
acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg , pseudoephedrine hydrochloride 30 mg;
2012-05-05;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86625
EXTRA STRENGTH TYLENOL NIGHTTIME;
02385619;
acetaminophen 500 mg , diphenhydramine hydrochloride 25 mg;
2012-10-02;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87122
EXTRA STRENGTH TYLENOL BACK PAIN;
02290510;
acetaminophen 500 mg , methocarbamol 400 mg;
2009-07-10;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77584
PAINAID PMF PREMENSTRUAL FORMULA;
02246308;
acetaminophen 500 mg , pamabrom 25 mg;
2004-12-20;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
ZEE MEDICAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70470
PMS MIDOL COMPLETE;
02275228;
acetaminophen 500 mg , pamabrom 25 mg , pyrilamine maleate 15 mg;
2006-07-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76087
BENYLIN EXTRA STRENGTH COLD & SINUS DAY;
02273462;
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg;
2006-08-16;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75895
EXTRA STRENGTH TYLENOL SINUS DAYTIME;
02276003;
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg;
2006-07-24;
Oral;
Tablet;
12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76168
BENYLIN EXTRA STRENGTH COLD & SINUS NIGHT;
02306409;
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
2008-09-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79195
EXTRA STRENGTH TYLENOL FLU NIGHTTIME;
02276046;
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg , dextromethorphan hydrobromide 10 mg;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76171
EXTRA STRENGTH TYLENOL FLU DAYTIME;
02275996;
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76167
EXTRA STRENGTH SINUTAB SINUS DAYTIME;
01938371;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
1992-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13120
MEDICAMENT POUR LES SINUS, EXTRA-FORT;
02240563;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
2000-04-19;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64135
EXTRA STRENGTH TYLENOL COLD & SINUS DAYTIME;
02348071;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
2010-08-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83343
SINUS MEDICATION DAYTIME RELIEF;
02368854;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
2012-01-13;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85382
COLD AND SINUS DAYTIME RELIEF;
02385252;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
2014-07-15;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87089
EXTRA STRENGTH SINUTAB SINUS & ALLERGY;
01986988;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
1986-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17113
EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME;
02348098;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
2010-08-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83344
BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT;
02256576;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
2005-09-23;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74181
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU NIGHTTIME;
02365766;
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
2011-08-08;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85064
COUGH & COLD RELIEF;
02487004;
acetaminophen 500 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
2020-01-14;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97715
NEOCITRAN TOTAL COLD NIGHT;
02413280;
acetaminophen 500 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
2017-08-01;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89795
ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH;
02291371;
acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , chlorpheniramine maleate 2 mg / 15 ml;
2008-08-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77675
NIGHT TIME TOTAL EXTRA STRENGTH;
02344548;
acetaminophen 650 mg / sachet , chlorpheniramine maleate 4 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
2010-12-08;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83004
EXTRA STRENGTH TOTAL SYMPTOM RELIEF SUGAR-FREE;
02420937;
acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
2014-12-04;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90552
COLD AND FLU RELIEF;
02432498;
acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
2015-10-02;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91694
COLD STIX SUPER STRENGTH;
02377888;
acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
2013-10-10;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86368
NEOCITRAN EXTRA STRENGTH TOTAL COLD;
02293994;
acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
2008-07-21;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77936
HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU EXTRA STRENGTH;
02238890;
acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , pheniramine maleate 20 mg / sachet , ascorbic acid 50 mg / sachet;
2001-09-01;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62330
HOT LEMON RELIEF FOR SYMPTOMS OF COUGH, COLD AND FLU EXTRA STRENGTH;
02246848;
acetaminophen 650 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet , chlorpheniramine maleate 4 mg / sachet;
2004-02-13;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71050
VICKS NYQUIL COMPLETE COLD & FLU;
02409542;
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
2014-08-15;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89423
VICKS DAYQUIL COMPLETE COLD & FLU LIQUID;
02409534;
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
2014-08-15;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89422
DAYTIME COMPLETE;
02458470;
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
2020-01-14;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94560
DAYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID;
02482428;
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
2020-07-20;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97287
DAYQUIL COLD & FLU;
02300842;
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
2009-08-23;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78620
VICKS NYQUIL COLD & FLU NIGHTTIME RELIEF;
02374277;
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 30 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
2012-07-09;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85947
DAYTIME COLD/FLU MEDICINE;
02290863;
acetaminophen 650 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml;
2007-08-20;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77628
NYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID;
02482401;
acetaminophen 650 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
2020-07-20;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97286
ANACIN;
02332450;
acetylsalicylic acid 325 mg , caffeine 32 mg;
2011-01-05;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 28:20.32 – Respiratory and CNS Stimulants;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81810
TEVA-OXYCODAN;
00608157;
acetylsalicylic acid 325 mg , oxycodone hydrochloride 5 mg;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5777
ALKA-SELTZER FLAVOURED;
02245367;
acetylsalicylic acid 325 mg , sodium bicarbonate 1700 mg , citric acid 1000 mg;
2002-09-10;
Oral;
Tablet (Effervescent);
56:04.00 – ANTACIDS AND ADSORBENTS , 28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69406
ALKA-SELTZER;
02152746;
acetylsalicylic acid 325 mg / evt , citric acid 1000 mg / evt , sodium bicarbonate 1916 mg / evt;
1995-12-31;
Oral;
Tablet (Effervescent);
28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42652
FIORINAL-C 1/4;
00176192;
acetylsalicylic acid 330 mg , caffeine 40 mg , butalbital 50 mg , codeine phosphate 15 mg;
1970-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:24.04 – BARBITURATES;
Narcotic (Cdsa I);
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=872
FIORINAL-C 1/2;
00176206;
acetylsalicylic acid 330 mg , caffeine 40 mg , codeine phosphate 30 mg , butalbital 50 mg;
1970-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:24.04 – BARBITURATES;
Narcotic (Cdsa I);
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=873
METHOXISAL EXTRA STRENGTH;
02242978;
acetylsalicylic acid 500 mg , methocarbamol 400 mg;
2002-11-15;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66818
DUAKLIR GENUAIR;
02439530;
aclidinium bromide 400 mcg / act , formoterol fumarate dihydrate 12 mcg / act;
2015-07-09;
Inhalation;
Powder (Metered Dose);
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92396
XERESE;
02404044;
acyclovir 5 % / w/w , hydrocortisone 1 % / w/w;
2013-07-26;
Topical;
Cream;
84:04.06 – ANTIVIRALS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88879
TACTUPUMP;
02365871;
adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
2011-05-13;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85075
TARO-ADAPALENE/BENZOYL PEROXIDE;
02456923;
adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
2019-10-01;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94404
SANDOZ ADAPALENE/BENZOYL PEROXIDE;
02489007;
adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
2019-09-27;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97906
TACTUPUMP FORTE;
02446235;
adapalene 0.3 % / w/w , benzoyl peroxide 2.5 % / w/w;
2016-01-04;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93152
FOSAVANCE;
02276429;
alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 2800 unit;
2006-03-13;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76210
FOSAVANCE;
02314940;
alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
2008-09-17;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80047
SANDOZ ALENDRONATE/CHOLECALCIFEROL;
02429160;
alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
2014-08-29;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91361
APO-ALENDRONATE/VITAMIN D3;
02454467;
alendronic acid (alendronate sodium) 70 mg , vitamin d3 (cholecalciferol) 2800 unit;
2016-07-21;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94104
APO-ALENDRONATE/VITAMIN D3;
02454475;
alendronic acid (alendronate sodium) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
2016-07-21;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94105
KAZANO;
02417235;
alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 1000 mg;
2014-04-30;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90187
KAZANO;
02417219;
alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 500 mg;
2014-04-30;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90185
KAZANO;
02417227;
alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 850 mg;
2014-04-30;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90186
PIQRAY;
02497085;
alpelisib 50 mg , alpelisib 200 mg;
2020-06-29;
Oral;
Kit , Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98694
ACTIVASE RT-PA;
02147440;
alteplase 100 mg / kit , water 100 ml / kit;
1996-12-31;
Intravenous;
Liquid , Powder For Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20105
ACTIVASE RT-PA;
02225689;
alteplase 50 mg / kit , water 50 ml / kit;
1998-04-12;
Intravenous;
Liquid , Powder For Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43443
DIOVOL PLUS SUSPENSION;
00116815;
aluminum hydroxide (dried aluminum hydroxide gel) 165 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , simethicone 25 mg / 5 ml;
1963-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=187
ALMAGEL PLUS SUS;
00815527;
aluminum hydroxide 200 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , dimethicone 25 mg / 5 ml;
1997-04-09;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44552
DIOVOL PLUS TABLETS;
00116882;
aluminum hydroxide-magnesium carbonate-co dried gel 300 mg , magnesium hydroxide 100 mg , simethicone 25 mg;
1963-12-31;
Oral;
Tablet;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=188
NOVAMILOR;
01937219;
amiloride hydrochloride 5 mg , hydrochlorothiazide 50 mg;
1992-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12430
APO-AMLODIPINE-ATORVASTATIN;
02411318;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89592
APO-AMLODIPINE-ATORVASTATIN;
02411326;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89593
APO-AMLODIPINE-ATORVASTATIN;
02411334;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89594
APO-AMLODIPINE-ATORVASTATIN;
02411342;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89595
CADUET;
02273284;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 10 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75877
GD-AMLODIPINE/ATORVASTATIN;
02362791;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 10 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84779
CADUET;
02273292;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 20 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75878
GD-AMLODIPINE/ATORVASTATIN;
02362805;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 20 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84780
CADUET;
02273306;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 40 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75879
GD-AMLODIPINE/ATORVASTATIN;
02362813;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 40 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84781
CADUET;
02273314;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 80 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75880
GD-AMLODIPINE/ATORVASTATIN;
02362821;
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 80 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84782
APO-PERINDOPRIL/AMLODIPINE;
02468565;
amlodipine (amlodipine besylate) 2.5 mg , perindopril arginine 3.5 mg;
2019-06-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95699
APO-AMLODIPINE-ATORVASTATIN;
02411253;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89588
APO-AMLODIPINE-ATORVASTATIN;
02411261;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89589
APO-AMLODIPINE-ATORVASTATIN;
02411288;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89590
APO-AMLODIPINE-ATORVASTATIN;
02411296;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89591
CADUET;
02273233;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 10 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75873
GD-AMLODIPINE/ATORVASTATIN;
02362759;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 10 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84775
CADUET;
02273241;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 20 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75874
CADUET;
02273268;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 40 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75875
GD-AMLODIPINE/ATORVASTATIN;
02362775;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 40 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84777
CADUET;
02273276;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 80 mg;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75876
GD-AMLODIPINE/ATORVASTATIN;
02362783;
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 80 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84778
VIACORAM;
02451549;
amlodipine (amlodipine besylate) 5 mg , perindopril arginine 7 mg;
2016-04-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93783
BALMINIL NIGHT-TIME;
02242999;
ammonium chloride 125 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml;
2001-03-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66839
CLAVULIN 200;
02238831;
amoxicillin (amoxicillin trihydrate) 200 mg / 5 ml , clavulanic acid (clavulanate potassium) 28.5 mg / 5 ml;
1998-10-29;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62269
APO-AMOXI CLAV;
02243350;
amoxicillin (amoxicillin trihydrate) 250 mg , clavulanic acid (clavulanate potassium) 125 mg;
2001-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67257
CLAVULIN 250 F ORAL SUS;
01916874;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml , clavulanic acid (clavulanate potassium) 62.5 mg / 5 ml;
1992-12-31;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15209
CLAVULIN 500 F TAB;
01916858;
amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
1992-12-31;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15903
APO-AMOXI CLAV;
02243351;
amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
2001-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67258
SANDOZ AMOXI-CLAV TABLET;
02482576;
amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
2019-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97300
CLAVULIN 875;
02238829;
amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
1998-10-29;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62267
APO-AMOXI CLAV;
02245623;
amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
2002-10-24;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69723
SANDOZ AMOXI-CLAV TABLET;
02482584;
amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
2019-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97301
CREON MINIMICROSPHERES 10;
02200104;
amylase 11200 unit , protease 730 unit , lipase 10000 unit;
1996-10-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36179
PANCREASE MT 10;
00789437;
amylase 43750 unit , protease 25000 unit , lipase 10500 unit;
1988-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
VIVUS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9513
CEPACOL SENSATIONS;
02382938;
amylmetacresol 0.6 mg , dichlorobenzyl alcohol 1.2 mg;
2012-07-19;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86872
REFRESH EYE ALLERGY RELIEF;
02315890;
antazoline phosphate 0.51 % , naphazoline hydrochloride 0.051 %;
2009-02-09;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80140
WILATE;
02286769;
antihemophilic factor (human) 1000 unit / 10 ml , von willebrand factor (human) 1000 unit / 10 ml , human plasma proteins 15 mg / 10 ml;
2008-04-29;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77222
HUMATE-P;
02261235;
antihemophilic factor (human) 1200 unit / 15 ml , von willebrand factor (human) 3360 unit / 15 ml;
2004-12-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74663
HUMATE-P;
02261219;
antihemophilic factor (human) 300 unit / 5 ml , von willebrand factor (human) 840 unit / 5 ml;
2004-12-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74661
WILATE;
02286750;
antihemophilic factor (human) 500 unit / 5 ml , von willebrand factor (human) 500 unit / 5 ml , human plasma proteins 7.5 mg / 5 ml;
2008-04-29;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77219
OTEZLA;
02434318;
apremilast 10 mg , apremilast 20 mg , apremilast 30 mg;
2014-11-27;
Oral;
Kit , Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91864
EMEND TRI-PACK;
02298813;
aprepitant 125 mg , aprepitant 80 mg;
2007-09-24;
Oral;
Kit , Capsule;
56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78412
TISSEEL;
02326175;
aprotinin (synthetic) 3000 kiu / ml , thrombin (human) 500 unit / ml , calcium chloride 40 mcmol / ml , sealer protein (human) 125 mg / ml;
2011-06-20;
Topical;
Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81151
SEPTANEST N;
02123371;
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
1994-12-31;
Block/Infiltration;
Liquid;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16851
4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML);
02248489;
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
2004-01-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72841
POSICAINE N;
02381311;
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
2012-04-13;
Block/Infiltration;
Solution;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86711
4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML);
02248488;
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
2004-01-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72840
POSICAINE SP;
02381338;
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
2012-04-13;
Block/Infiltration;
Solution;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86712
ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION;
02339536;
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.009 mg / ml;
2010-04-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82513
ORABLOC 1:200,000;
02361906;
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.009 mg / ml;
2012-06-14;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84694
ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION;
02339544;
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.018 mg / ml;
2010-04-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82514
ORABLOC 1:100,000;
02361914;
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.018 mg / ml;
2012-06-14;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84695
AA-ATENIDONE;
02248764;
atenolol 100 mg , chlorthalidone 25 mg;
2004-08-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73132
AA-ATENIDONE;
02248763;
atenolol 50 mg , chlorthalidone 25 mg;
2004-08-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73131
GD-AMLODIPINE/ATORVASTATIN;
02362767;
atorvastatin (atorvastatin calcium) 20 mg , amlodipine (amlodipine besylate) 5 mg;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84776
MALARONE;
02238151;
atovaquone 250 mg , proguanil hydrochloride 100 mg;
1998-08-07;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61542
TEVA-ATOVAQUONE PROGUANIL;
02380927;
atovaquone 250 mg , proguanil hydrochloride 100 mg;
2012-03-01;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86668
MYLAN-ATOVAQUONE/PROGUANIL;
02402165;
atovaquone 250 mg , proguanil hydrochloride 100 mg;
2013-10-16;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88703
ATOVAQUONE PROGUANIL;
02421429;
atovaquone 250 mg , proguanil hydrochloride 100 mg;
2014-05-22;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90605
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS;
02466783;
atovaquone 250 mg , proguanil hydrochloride 100 mg;
2017-10-30;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95514
MALARONE PEDIATRIC;
02264935;
atovaquone 62.5 mg , proguanil hydrochloride 25.0 mg;
2005-05-17;
Oral;
Tablet;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75044
INSTANT BRONZER INSTANTANÉ 4 SPRAY GEL SUNSCREEN;
02502062;
avobenzone 1 % / w/w , octocrylene 1 % / w/w;
2020-10-30;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99166
SHEER DAILY MOISTURIZER;
02462133;
avobenzone 1.5 % / w/w , octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w;
2018-01-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94987
REVERSA UV CREME VISAGE ET COU FPS 15;
02244858;
avobenzone 1.8 % , octinoxate 7.5 % , oxybenzone 4 %;
2002-09-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68850
PREVENTAGE FIRMING DEFENSE CRÈME NORMAL/DRY BROAD SPECTRUM SPF 15;
02403552;
avobenzone 1.9 % / w/w , octocrylene 9.4 % / w/w;
2013-06-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88834
PREVENTAGE FIRMING DEFENSE CRÈME NORMAL/OILY BROAD SPECTRUM SPF 15;
02403560;
avobenzone 1.9 % / w/w , octocrylene 9.4 % / w/w;
2013-06-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88835
SUNSCREEN CONTINUOUS SPRAY NO PUMPING NEEDED;
02447525;
avobenzone 2 % , homosalate 15 % , octisalate 5 % , oxybenzone 4 %;
2016-03-08;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93311
SPORT SUNSCREEN CONTINUOUS SPRAY SPF 15;
02491044;
avobenzone 2 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w;
2020-03-17;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98106
SUNSCREEN CONTINUOUS SPRAY SPF/FPS 30;
02359995;
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
2011-03-02;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84496
30 SPF;
02391155;
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
2017-02-28;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87652
SUNSCREEN SPORT SPF 30;
02393727;
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
2014-03-05;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87892
PHARMASAVE SPORT SUNSCREEN CONTINUOUS SPRAY SPF FPS 30;
02465698;
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
2017-08-21;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95393
RODAN + FIELDS REDEFINE TRIPLE DEFENSE LOTION;
02492830;
avobenzone 2 % / w/w , homosalate 6.8 % / w/w , octisalate 3.4 % / w/w , octocrylene 4.4 % / w/w;
2020-09-16;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98283
HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 30;
02454602;
avobenzone 2 % / w/w , homosalate 7 % / w/w , octocrylene 5 % / w/w;
2017-01-03;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94131
CLÉ DE PEAU BEAUTÉ CRÈME FORTIFIANTE PROTECTRICE;
02440806;
avobenzone 2 % / w/w , octinoxate 4.9 % / w/w , octocrylene 5 % / w/w , oxybenzone 2 % / w/w;
2016-03-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92516
SPRAYGEL WITH INSTANT BRONZE TINT SPF/FPS 15;
02447754;
avobenzone 2 % / w/w , octisalate 5 % / w/w , octocrylene 2.75 % / w/w , oxybenzone 0.5 % / w/w;
2016-03-23;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93333
VITAMIN E MOISTURE-PROTECT LIP CARE;
02423952;
avobenzone 2 % / w/w , octisalate 5 % / w/w , octocrylene 3 % / w/w;
2016-08-17;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90868
SUNSCREEN CONTINUOUS SPRAY;
02447649;
avobenzone 2 % / w/w , octisalate 5 % / w/w , oxybenzone 3 % / w/w , homosalate 10 % / w/w;
2016-03-07;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93322
LIFE BRAND SPORT SUNSCREEN BROAD SPECTRUM SPRAY;
02447509;
avobenzone 2 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w , homosalate 15 % / w/w;
2016-03-17;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93309
DRY BALANCE SUNSCREEN SPRAY SPF 30;
02456060;
avobenzone 2 % / w/w , octocrylene 1.5 % / w/w , homosalate 7 % / w/w , oxybenzone 3 % / w/w;
2017-01-03;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94291
INSTANT BRONZER INSTANTANÉ 15;
02497344;
avobenzone 2 % / w/w , octocrylene 2 % / w/w , octisalate 5 % / w/w;
2020-10-30;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98717
INSTANT BRONZER INSTANTANÉ 15 CONTINUOUS SPRAY SUNSCREEN;
02501066;
avobenzone 2 % / w/w , octocrylene 2 % / w/w , octisalate 5 % / w/w;
2020-10-30;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99071
COOLA PINA COLADA SCENT SUNSCREEN SPRAY;
02458918;
avobenzone 2 % / w/w , octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 4 % / w/w;
2017-07-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94608
COOLA CITRUS MIMOSA SCENT SUNSCREEN SPRAY;
02458950;
avobenzone 2 % / w/w , octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 4 % / w/w;
2017-07-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94610
ABSOLUE HAND SPF 15;
02248071;
avobenzone 2.0 % , octisalate 5.0 % , octocrylene 10.0 %;
2004-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72392
COOLA MAKEUP SETTING SPRAY GREEN TEA SCENT;
02458942;
avobenzone 2.1 % / w/w , homosalate 3.5 % / w/w , octinoxate 3.5 % / w/w , octisalate 2.8 % / w/w;
2017-07-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94609
DRY BALANCE SUNSCREEN LOTION SPF 30;
02456052;
avobenzone 2.2 % / w/w , homosalate 7 % / w/w , octocrylene 4.2 % / w/w;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94290
SPF 30 SPRAY-ON ALCOHOL-FREE SUNSCREEN;
02375788;
avobenzone 2.5 % , octinoxate 7.5 % , octocrylene 7.5 % , octisalate 5 %;
2012-01-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
WILC HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86119
RODAN+FIELDS ESSENTIALS LIP SHIELD;
02407051;
avobenzone 2.5 % / w/w , homosalate 8.0 % / w/w , octisalate 5.0 % / w/w , octocrylene 2.2 % / w/w;
2016-04-19;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89171
MOISTURE SUN PROTECTOR;
02462931;
avobenzone 2.5 % / w/w , homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w;
2018-07-12;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95082
CLÉ DE PEAU BEAUTÉ ÉMULSION FORTIFIANTE PROTECTRICE;
02440814;
avobenzone 2.5 % / w/w , octinoxate 7.4 % / w/w , octocrylene 2 % / w/w , oxybenzone 1 % / w/w;
2016-04-22;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92517
CLE DE PEAU BEAUTE 30 SOIN PROTECTEUR UV POUR LES LEVRES;
02450224;
avobenzone 2.5 % / w/w , oxybenzone 2 % / w/w , octocrylene 3 % / w/w , octinoxate 4.9 % / w/w;
2017-02-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93627
ADAPTASUN CRÈME DE SOIN SOLAIRE MER ET TROPIQUES VISAGE FPS/SPF 25;
02445581;
avobenzone 2.54 % / w/w , octinoxate 6 % / w/w;
2016-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93087
HAWAIIAN TROPIC OIL SPRAY MOISTURIZING SUNSCREEN SPF 4;
02446898;
avobenzone 2.8 % , octocrylene 2.2 % , oxybenzone 2 %;
2017-06-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93246
RODAN + FIELDS REVERSE BRIGHTENING DEFENSE FLUID LOTION;
02498081;
avobenzone 2.8 % / w/w , homosalate 9.3 % / w/w , octisalate 4.67 % / w/w , octocrylene 6.1 % / w/w;
2021-03-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98788
RODAN + FIELDS ESSENTIALS FACE + BODY SUNSCREEN;
02491001;
avobenzone 2.8 % / w/w , homosalate 9.6 % / w/w , octisalate 4.8 % / w/w , octocrylene 9.6 % / w/w;
2020-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98103
SUNSCREEN OIL;
02448564;
avobenzone 2.8 g / 100 g , octocrylene 2.2 g / 100 g , oxybenzone 2 g / 100 g;
2016-04-15;
Topical;
Oil;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93426
ANEW REVERSALIST COMPLETE RENEWAL DAY LOTION;
02414023;
avobenzone 2.85 % / w/w , homosalate 8.0 % / w/w , octinoxate 5.0 % / w/w , oxybenzone 4.0 % / w/w;
2014-03-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89870
SUN LOGIC 20 FPS UVA UVB SPF MOYENNE MEDIUM PROTECTION LARGE SPECTRE BROAD SPECTRUM LAIT SOLAIRE CORPS SUNSCREEN LOTION BODY;
02480484;
avobenzone 2.9 % , homosalate 12 % , octocrylene 2.7 %;
2019-04-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUINOT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97100
TANNING OIL HUILE BRONZANTE 15;
02471795;
avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 10 %;
2018-03-07;
Topical;
Oil;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96099
SMART TONE BROAD-SPECTRUM SUNSCREEN SPF 50;
02475294;
avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 10 %;
2018-12-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ZO SKIN HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96566
PREMIUM SUNSCREEN SPRAY SUN BUM 30;
02483335;
avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 3.75 %;
2019-04-08;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97377
PREMIUM SUNSCREEN SPRAY SUN BUM 50;
02483726;
avobenzone 3 % , homosalate 15 % , octisalate 5 % , octocrylene 7 %;
2019-04-08;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97407
EXTRA-FIRMING JOUR FPS/SPF 15;
02481294;
avobenzone 3 % , homosalate 9 % , octocrylene 6.5 %;
2018-12-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97178
BEAUTY BOOSTER CREAM SPF 30;
02461854;
avobenzone 3 % , octinoxate 7.5 % , oxybenzone 6 %;
2017-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TRISH MCEVOY LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94959
CETAPHIL DAILY FACIAL MOISTURIZER SPF 15;
02243329;
avobenzone 3 % , octocrylene 10 %;
2001-06-19;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67232
OMBRELLE-LOTION SPF 15;
02246798;
avobenzone 3 % , octocrylene 10 % , ensulizole 1.5 % , terephthalylidene dicamphor sulfonic acid 1 %;
2003-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70998
SPORT SUNSCREEN LOTION SPF 50+;
02491036;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , octocrylene 8 % / w/w;
2020-02-19;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98105
SPORT SUNSCREEN;
02447630;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
2016-02-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93321
PREMIUM SUNSCREEN FACE LOTION SUN BUM FACE 50;
02478986;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
2020-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96970
PREMIUM SUNSCREEN LOTION SUN BUM 50;
02479001;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
2019-04-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96972
SPORT SUNSCREEN LOTION SPF 30;
02488485;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
2019-11-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97857
RODAN + FIELDS UNBLEMISH INVISIBLE MATTE DEFENSE;
02491761;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
2020-03-10;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98178
SENSITIVE SKIN SUNSCREEN CONTINUOUS SPRAY SPF 30;
02488469;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2 % / w/w;
2020-09-21;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97855
SPORT SUNSCREEN CONTINUOUS SPRAY SPF 30;
02490862;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2 % / w/w;
2019-11-04;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98090
BROAD SPECTRUM SPF 50+ SUNSCREEN;
02407078;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2.6 % / w/w;
2015-02-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89172
RODAN+FIELDS REVERSE;
02415135;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2.6 % / w/w;
2015-02-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89976
KIDS SUNSCREEN CONTINUOUS SPRAY SPF 50+;
02488663;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
2020-02-27;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97876
SPORT SUNSCREEN CONTINUOUS SPRAY SPF 50+;
02491052;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
2020-03-21;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98108
SUNSCREEN CONTINUOUS SPRAY SPF 50 KIDS;
02494094;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
2020-02-27;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98412
KIDS SUNSCREEN LOTION 50+;
02494833;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
2020-02-27;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98481
SUNSCREEN FACE STICK / ÉCRAN SOLAIRE BÂTON;
02500612;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w;
2021-03-11;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99028
SCALP MIST;
02506068;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 4 % / w/w , octisalate 5 % / w/w;
2020-12-11;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99541
COPPERTONE LOTION SUNSCREEN SPF 50 SUN GUARD;
02478277;
avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96903
KIDS SUNSCREEN LOTION SPF 50+;
02490382;
avobenzone 3 % / w/w , homosalate 13 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
2020-06-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98043
SENSITIVE SKIN SUNSCREEN LOTION SPF 50+;
02491028;
avobenzone 3 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
2020-01-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98104
OLAY UV MOISTURIZING CREAM;
02442779;
avobenzone 3 % / w/w , homosalate 4 % / w/w , octisalate 4.5 % / w/w , octocrylene 2.6 % / w/w;
2016-01-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92717
OLAY AGE DEFYING ANTI WRINKLE DAY LOTION WITH SPF 15;
02444208;
avobenzone 3 % / w/w , homosalate 4 % / w/w , octisalate 4.5 % / w/w , octocrylene 2.6 % / w/w;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92910
PREMIUM SUNSCREEN LOTION SUN BUM 30;
02478994;
avobenzone 3 % / w/w , homosalate 5 % / w/w , octisalate 3 % / w/w , octocrylene 10 % / w/w;
2019-04-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96971
LIFTACTIV SPECIALIST FPS/SPF 30;
02498642;
avobenzone 3 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
2021-03-24;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98839
SPORT 30 CONTINUOUS SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR;
02492261;
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
2019-11-01;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98230
SUNSCREEN CONTINUOUS SPRAY SPF 30;
02494108;
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
2020-02-27;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98413
SUNSCREEN LOTION 30 SPF/FPS SPORT;
02494825;
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
2020-02-27;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98480
INSTANT BRONZER INSTANTANÉ 30 CONTINUOUS SPRAY SUNSCREEN;
02501058;
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w;
2020-10-30;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99070
INSTANT BRONZER INSTANTANÉ 30 SPRAY GEL SUNSCREEN;
02502054;
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w;
2020-10-30;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99165
OLAY LUMINOUS WHIP;
02463911;
avobenzone 3 % / w/w , homosalate 8 % / w/w , octisalate 4 % / w/w , octocrylene 5 % / w/w;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95201
COPPERTONE LOTION SUNSCREEN SPF 30 SPORT;
02452804;
avobenzone 3 % / w/w , homosalate 8 % / w/w , octisalate 4.5 % / w/w , octocrylene 6 % / w/w;
2016-10-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93921
OLAY REGENERIST MICRO-SCULPTING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 30;
02436450;
avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
2016-07-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92079
RE9 ADVANCED EXTRA MOISTURE RESTORATIVE CREAM WITH SPF 20;
02378256;
avobenzone 3 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 2.79 % / w/w;
2012-04-02;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ARBONNE INTERNATIONAL LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86407
CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER COMBINATION OILY TO OILY;
02440083;
avobenzone 3 % / w/w , octisalate 5 % / w/w;
2016-01-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92447
ARTISTRY SKIN NUTRITION BALANCING MATTE DAY LOTION;
02502968;
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
2021-04-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99248
RODAN + FIELDS REDEFINE TRIPLE DEFENSE CREAM;
02492849;
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
2020-09-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98284
ARTISTRY SKIN NUTRITION HYDRATING DAY LOTION;
02502976;
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
2021-04-16;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99249
NO7 LIFT & LUMINATE TRIPLE ACTION DAY CREAM;
02460300;
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7.5 % / w/w;
2018-03-21;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94759
ORIGINS VITAZING SPF 15 ENERGY-BOOSTING MOISTURIZER;
02351455;
avobenzone 3 % / 50 ml , octisalate 3 % / 50 ml , octocrylene 2.7 % / 50 ml;
2010-10-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ORIGINS NATURAL RESOURCES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83672
SPF FPS 50 KIDS SUNSCREEN;
02448556;
avobenzone 3 g / 100 g , homosalate 15 g / 100 g , octisalate 5 g / 100 g , oxybenzone 6 g / 100 g;
2016-03-09;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93424
POSITIVELY RADIANT DAILY MOISTURIZER SPF 15;
02250942;
avobenzone 3.0 % , octinoxate 7.5 % , octisalate 2.0 %;
2004-12-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73587
EDARBYCLOR;
02397749;
azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg , chlorthalidone 12.5 mg;
2013-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88267
EDARBYCLOR;
02397765;
azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg , chlorthalidone 25 mg;
2013-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88269
OZONOL ANTIBIOTICS PLUS;
02236917;
bacitracin 500 unit / g , lidocaine hydrochloride 40 mg / g , polymyxin b (polymyxin b sulfate) 10000 unit / g;
1998-05-27;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
EXZELL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60209
JAMPOLYCIN;
02357569;
bacitracin 500 unit / g , polymyxin b sulfate 10000 unit / g;
2013-12-09;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84267
POLY ANTIBIOTIC OINTMENT;
02510383;
bacitracin 500 unit / g , polymyxin b sulfate 10000 unit / g;
2021-03-03;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99961
POLYDERM OINTMENT USP;
02181908;
bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
1996-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20134
ANTIBIOTIC OINTMENT USP;
02230251;
bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
2002-06-10;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48982
STERISPORIN;
02359928;
bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
2017-05-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS;
Otc;
LABORATOIRES STERIGEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84489
VIONEXUS NO-RINSE SPRAY;
02248463;
benzalkonium chloride 0.10 % , alcohol anhydrous 65.87 %;
2004-11-20;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
METREX RESEARCH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72815
FOOTWORKS HEALTHY CRACKED HEEL CREAM;
02397587;
benzalkonium chloride 0.13 % / w/w , lidocaine 4 % / w/w;
2013-05-27;
Topical;
Cream;
72:00.00 – LOCAL ANESTHETICS , 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88252
CETACAINE LIQUID;
02028867;
benzocaine 14 % , butamben 2 % , tetracaine hydrochloride 2 %;
1996-09-19;
Topical;
Liquid;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
CETYLITE INDUSTRIES INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26564
AURALGAN;
02332477;
benzocaine 14 mg / ml , antipyrine 54 mg / ml;
2011-02-28;
Otic;
Solution;
52:16.00 – LOCAL ANESTHETICS;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81814
ZAP TOPICAL ANESTHETIC GEL;
01930699;
benzocaine 18 % , tetracaine hydrochloride 2 %;
1992-12-31;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13347
ONE TOUCH TOPICAL ANESTHETIC GEL;
02230958;
benzocaine 18 % , tetracaine hydrochloride 2 %;
1998-04-21;
Buccal;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ABJ CUSTOM PACKAGING
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50238
FRIAR’S BALSAM BENZOIN TINCTURE;
00545279;
benzoin 10 g / 100 ml , aloe 2 g / 100 ml , storax 8 g / 100 ml , myroxylon balsamum 4 g / 100 ml;
1982-12-31;
Inhalation , Topical;
Tincture;
92:01.00* – HERBS AND NATURAL PRODUCTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41578
PROACTIV 3-STEP CONVENIENCE PAK;
02406179;
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
2013-08-08;
Topical;
Gel , Kit;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89090
PROACTIV 3 PIECE SET;
02414422;
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
2014-06-20;
Topical;
Gel , Kit;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89901
ACTIVE ANTI-ACNE TREATMENT KIT;
02444054;
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
2015-12-10;
Topical;
Kit , Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92884
ADVANTAGE ACNE CONTROL KIT;
02452782;
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 5 % / w/w;
2017-01-30;
Topical;
Gel , Kit , Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93919
CLINDOXYL ADV GEL;
02382822;
benzoyl peroxide 3 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
2013-08-20;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86863
STUBBORN ACNE SOLUTION;
02457938;
benzoyl peroxide 3.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
2017-01-30;
Topical;
Gel , Kit , Paste;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94496
RODAN+FIELDS SPOTLESS;
02469707;
benzoyl peroxide 5 % , benzoyl peroxide 2.5 %;
2019-04-09;
Topical;
Kit , Lotion , Cream;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95852
CLINDOXYL GEL;
02243158;
benzoyl peroxide 5 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
2001-09-04;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67033
TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL;
02440180;
benzoyl peroxide 5 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
2015-08-05;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92456
ACNE TREATMENT SYSTEM;
02402149;
benzoyl peroxide 5 % / w/w , salicylic acid 2 % / w/w;
2013-11-15;
Topical;
Kit , Liquid , Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
VIVIER CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88701
LOTRIDERM;
00611174;
betamethasone (betamethasone dipropionate) 0.05 % , clotrimazole 1 %;
1990-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.08 – AZOLES;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10748
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE;
02496410;
betamethasone (betamethasone dipropionate) 0.05 % / w/w , clotrimazole 1 % / w/w;
2020-04-06;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.08 – AZOLES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98629
ENSTILAR;
02457393;
betamethasone (betamethasone dipropionate) 0.5 mg / g , calcipotriol (calcipotriol monohydrate) 50 mcg / g;
2016-11-11;
Topical;
Aerosol, Foam;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94445
TEVA-BETAMETHASONE/ CALCIPOTRIOL;
02427419;
betamethasone (betamethasone dipropionate) 0.5 mg / g , calcipotriol 50 mcg / g;
2020-08-07;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91194
RATIO-TOPISALIC;
02245688;
betamethasone (betamethasone dipropionate) 0.5 mg / g , salicylic acid 20 mg / g;
2002-05-03;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69789
DIPROSALIC;
00578436;
betamethasone (betamethasone dipropionate) 0.5 mg / g , salicylic acid 30 mg / g;
1983-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5287
VALISONE-G;
00232351;
betamethasone (betamethasone valerate) 0.1 % / w/w , gentamicin (gentamicin sulfate) 0.1 % / w/w;
1972-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1285
CELESTONE SOLUSPAN;
00028096;
betamethasone acetate 3 mg / ml , betamethasone (betamethasone sodium phosphate) 3 mg / ml;
1965-12-31;
Intra-Articular , Intrabursal , Intradermal , Intramuscular;
Suspension;
68:04.00 – ADRENALS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=354
BIKTARVY;
02478579;
bictegravir (bictegravir sodium) 50 mg , emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
2018-08-08;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96935
STOMACH RELIEF CHEWABLE TABLETS;
02389215;
bismuth subsalicylate 262 mg , calcium carbonate 350 mg;
2013-11-20;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
GUARDIAN DRUG COMPANY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87472
PHOTODERM SPF/FPS 50+ CRÈME;
02354489;
bisoctrizole 6 % , octocrylene 10 % , bemotrizinol 2.5 % , avobenzone 5 %;
2012-02-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83965
PHOTODERM SPF/FPS 50+ LAIT;
02354497;
bisoctrizole 6 % , octocrylene 10 % , bemotrizinol 2.5 % , avobenzone 5 %;
2012-02-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83966
PHOTODERM SPF/FPS 40 SPRAY;
02354500;
bisoctrizole 6 % , octocrylene 8 % , avobenzone 4.5 %;
2012-02-08;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83967
REXULTI;
02485923;
brexpiprazole 0.5 mg , brexpiprazole 1 mg;
2019-06-08;
Oral;
Kit , Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97617
ALUNBRIG;
02479230;
brigatinib 90 mg , brigatinib 180 mg;
2018-08-31;
Oral;
Kit , Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96985
COMBIGAN;
02248347;
brimonidine tartrate 0.2 % , timolol (timolol maleate) 0.5 %;
2003-12-11;
Ophthalmic;
Solution;
52:40.04 – ALPHA-ADRENERGIC AGONISTS , 52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72692
SIMBRINZA;
02435411;
brinzolamide 1 % / w/v , brimonidine tartrate 0.2 % / w/v;
2015-02-17;
Ophthalmic;
Suspension;
52:40.04 – ALPHA-ADRENERGIC AGONISTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91973
ROBITUSSIN CHILDREN’S COUGH & COLD BEDTIME;
02394707;
brompheniramine maleate 2 mg / 5 ml , phenylephrine hydrochloride 5 mg / 5 ml , dextromethorphan hydrobromide 10 mg / 5 ml;
2013-07-17;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87985
SYMBICORT 100 TURBUHALER;
02245385;
budesonide 100 mcg / act , formoterol fumarate dihydrate 6 mcg / act;
2002-02-08;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69428
ENTOCORT ENEMA;
02052431;
budesonide 2.3 mg , sodium chloride 115 ml;
1994-12-31;
Rectal;
Enema , Kit , Tablet;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TILLOTTS PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16264
SYMBICORT 200 TURBUHALER;
02245386;
budesonide 200 mcg / act , formoterol fumarate dihydrate 6 mcg / act;
2002-02-08;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69429
MARCAINE E;
02241916;
bupivacaine hydrochloride 100 mg / 20 ml , epinephrine bitartrate 0.182 mg / 20 ml;
2001-07-15;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65586
SENSORCAINE WITH EPINEPHRINE;
01976206;
bupivacaine hydrochloride 5 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
1994-12-31;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16163
VIVACAINE;
02305135;
bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
2008-04-11;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79063
BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION;
02381850;
bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
2012-05-07;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86769
MARCAINE;
02474247;
bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
2019-04-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96430
MARCAINE E;
02241915;
bupivacaine hydrochloride 50 mg / 20 ml , epinephrine bitartrate 0.182 mg / 20 ml;
2001-07-15;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65585
SUBOXONE;
02468085;
buprenorphine (buprenorphine hydrochloride) 12 mg , naloxone (naloxone hydrochloride dihydrate) 3 mg;
2018-02-14;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95646
SUBOXONE;
02502356;
buprenorphine (buprenorphine hydrochloride) 12 mg , naloxone (naloxone hydrochloride) 3 mg;
2021-01-20;
Buccal , Sublingual;
Film, Soluble;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99192
SUBOXONE;
02468093;
buprenorphine (buprenorphine hydrochloride) 16 mg , naloxone (naloxone hydrochloride dihydrate) 4 mg;
2018-02-14;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95647
SUBOXONE;
02295695;
buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride dihydrate) 0.5 mg;
2007-11-26;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78104
PMS-BUPRENORPHINE-NALOXONE;
02424851;
buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride dihydrate) 0.5 mg;
2014-12-10;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90952
SUBOXONE;
02502313;
buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride) 0.5 mg;
2021-01-20;
Buccal , Sublingual;
Film, Soluble;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99189
SUBOXONE;
02295709;
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
2007-11-26;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78105
PMS-BUPRENORPHINE-NALOXONE;
02424878;
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
2014-12-10;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90953
TEVA-BUPRENORPHINE/NALOXONE;
02453916;
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
2017-09-28;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94044
SUBOXONE;
02502348;
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride) 2 mg;
2021-01-20;
Buccal , Sublingual;
Film, Soluble;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99191
FIORINAL;
00226327;
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
1971-12-31;
Oral;
Capsule;
28:24.04 – BARBITURATES , 28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1233
TEVA-TECNAL;
00608211;
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
1984-12-31;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5779
TEVA-TECNAL;
00608238;
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
1985-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS , 28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6480
TRIANAL TABLET;
01971409;
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
1997-02-07;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23671
TEVA-TECNAL C 1/2;
00608181;
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg , codeine phosphate 30 mg;
1984-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6419
CABENUVA;
02497220;
cabotegravir 200 mg / ml , rilpivirine 300 mg / ml;
2020-09-21;
Intramuscular;
Suspension (Extended-Release) , Kit;
08:18.08 – ANTIRETROVIRALS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98706
TEVA-LENOLTEC NO. 3;
00653276;
caffeine 15 mg , codeine phosphate 30 mg , acetaminophen 300 mg;
1985-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6346
TEVA-TECNAL C 1/4;
00608203;
caffeine 40 mg , acetylsalicylic acid 330 mg , codeine phosphate 15 mg , butalbital 50 mg;
1984-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6479
AVEENO ANTI-ITCH LOTION;
02240105;
calamine 3.0 % , pramoxine hydrochloride 1.0 %;
2000-05-01;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63620
CALAMINE LOTION WITH ANTIHISTAMINE;
00538493;
calamine 8 % , diphenhydramine hydrochloride 1 %;
1981-12-31;
Topical;
Suspension;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41558
LOTION CALAMINE AVEC ANTIHISTAMINIQUE;
02241462;
calamine 8 % , diphenhydramine hydrochloride 1 %;
2000-10-13;
Topical;
Suspension;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65100
DOVOBET GEL;
02319012;
calcipotriol (calcipotriol monohydrate) 50 mcg / g , betamethasone (betamethasone dipropionate) 0.5 mg / g;
2009-01-28;
Topical;
Gel;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80450
DOVOBET OINTMENT;
02244126;
calcipotriol 50 mcg / g , betamethasone (betamethasone dipropionate) 0.5 mg / g;
2001-11-29;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68084
DIOVOL PLUS ALUMINUM FREE SUSPENSION;
02157616;
calcium carbonate 200 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , simethicone 25 mg / 5 ml;
1995-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19082
PEPTO-BISMOL CHEWABLES;
02237315;
calcium carbonate 350 mg , bismuth subsalicylate 262 mg;
2000-02-18;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60637
INVOKAMET;
02455455;
canagliflozin 150 mg , metformin hydrochloride 1000 mg;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94226
INVOKAMET;
02455439;
canagliflozin 150 mg , metformin hydrochloride 500 mg;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94224
INVOKAMET;
02455420;
canagliflozin 50 mg , metformin hydrochloride 1000 mg;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94223
INVOKAMET;
02455404;
canagliflozin 50 mg , metformin hydrochloride 500 mg;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94221
ATACAND PLUS;
02244021;
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
2001-06-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67964
SANDOZ CANDESARTAN PLUS;
02327902;
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
2012-09-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81340
CANDESARTAN/HCTZ;
02394804;
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
2012-11-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87995
CANDESARTAN HCT;
02394812;
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
2012-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87997
TEVA-CANDESARTAN/HCTZ;
02395541;
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
2013-09-23;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88063
AURO-CANDESARTAN HCT;
02421038;
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
2015-03-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90562
JAMP CANDESARTAN-HCT;
02473240;
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
2020-02-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96264
PMS-CANDESARTAN HCTZ;
02391295;
candesartan cilexetil 16.0 mg , hydrochlorothiazide 12.5 mg;
2012-09-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87664
CANDESARTAN-HCTZ;
02392275;
candesartan cilexetil 16.0 mg , hydrochlorothiazide 12.5 mg;
2012-10-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87755
ATACAND PLUS;
02332922;
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
2009-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81858
TEVA-CANDESARTAN/HCTZ;
02395568;
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88064
SANDOZ CANDESARTAN PLUS;
02420732;
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
2014-02-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90530
AURO-CANDESARTAN HCT;
02421046;
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
2015-03-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90563
JAMP CANDESARTAN-HCT;
02473259;
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
2020-02-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96265
ATACAND PLUS;
02332957;
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
2009-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81859
SANDOZ CANDESARTAN PLUS;
02420740;
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
2014-02-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90531
AURO-CANDESARTAN HCT;
02421054;
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
2015-03-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90564
JAMP CANDESARTAN-HCT;
02473267;
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
2020-02-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96266
DUODOPA;
02292165;
carbidopa (carbidopa monohydrate) 5 mg / ml , levodopa 20 mg / ml;
2008-11-10;
Intraintestinal (Upper);
Gel;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77753
APO-LEVOCARB – TAB 10MG/100MG;
02195933;
carbidopa 10 mg , levodopa 100 mg;
1995-12-31;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20189
TEVA-LEVOCARBIDOPA;
02244494;
carbidopa 10 mg , levodopa 100 mg;
2002-07-05;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68470
APO-LEVOCARB-TAB 25MG/100MG;
02195941;
carbidopa 25 mg , levodopa 100 mg;
1995-12-31;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20239
TEVA-LEVOCARBIDOPA;
02244495;
carbidopa 25 mg , levodopa 100 mg;
2002-07-05;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68471
PRO-LEVOCARB – 100/25;
02311178;
carbidopa 25 mg , levodopa 100 mg;
2008-07-04;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79676
APO-LEVOCARB – TAB 25MG/250MG;
02195968;
carbidopa 25 mg , levodopa 250 mg;
1995-12-31;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20190
TEVA-LEVOCARBIDOPA;
02244496;
carbidopa 25 mg , levodopa 250 mg;
2002-07-05;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68472
CARBON DIOXIDE 7.1% W OXYGEN;
00882755;
carbon dioxide 12 % , oxygen 88 %;
1990-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11058
CARBON DIOXIDE, COMPRESSED AIR MEDICAL G.MIX.;
02014343;
carbon dioxide 15 % , air 85 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13896
CARBOGEN;
02154749;
carbon dioxide 50 % , oxygen 50 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19293
CARBON DIOXIDE USP, OXYGEN USP MEDICAL G.M.;
02014432;
carbon dioxide 7 % , oxygen 93 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13910
CO-HE-O2-N2 MIXTURE;
02154773;
carbon monoxide 0.3 % , helium 10.0 % , oxygen 21.0 % , nitrogen 68.7 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19101
CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.;
02014424;
carbon monoxide 0.3 % , helium 10.5 % , oxygen 21.5 % , nitrogen 67.7 %;
1993-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13920
LUNG DIFFUSION TEST MIX NO NE CO;
00588075;
carbon monoxide 0.3 % , neon 0.5 % , oxygen 21 % , nitrogen 78.2 %;
1968-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8185
CO-NE-O2-N2 MIXTURE;
02182238;
carbon monoxide 0.3 % / v/v , neon 0.5 % / v/v , oxygen 21 % / v/v , nitrogen 78.2 % / v/v;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19100
REFRESH OPTIVE FUSION;
02435578;
carboxymethylcellulose sodium 0.5 % , glycerine 0.9 %;
2015-05-15;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91991
REFRESH OPTIVE ADVANCED;
02399148;
carboxymethylcellulose sodium 0.5 % , glycerine 1.0 % , polysorbate 80 0.5 %;
2013-03-06;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88404
REFRESH OPTIVE FUSION SENSITIVE;
02450534;
carboxymethylcellulose sodium 0.5 % / w/v , glycerine 1 % / w/v;
2016-04-26;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93669
REFRESH OPTIVE ADVANCED SENSITIVE;
02425815;
carboxymethylcellulose sodium 0.5 % / w/v , glycerine 1.0 % / w/v , polysorbate 80 0.5 % / w/v;
2014-10-14;
Ophthalmic;
Emulsion;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91045
REFRESH OPTIVE GEL DROPS;
02463652;
carboxymethylcellulose sodium 1 % / w/v , glycerine 0.9 % / w/v;
2017-07-28;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95175
ORABASE PASTE;
02035286;
carboxymethylcellulose sodium 13.3 % , gelatin 13.3 % , pectin 13.3 %;
1995-12-31;
Oral , Topical;
Paste;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
CONVATEC CANADA LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42486
ZERBAXA;
02446901;
ceftolozane (ceftolozane sulfate) 1 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
2016-01-12;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93248
REACTINE COMPLETE;
02246162;
cetirizine hydrochloride 5 mg , pseudoephedrine hydrochloride 120 mg;
2003-03-07;
Oral;
Tablet (Extended-Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70312
LIBRAX;
00115630;
chlordiazepoxide hydrochloride 5 mg , clidinium bromide 2.5 mg;
1961-12-31;
Oral;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=728
CHLORAX;
00618454;
chlordiazepoxide hydrochloride 5 mg , clidinium bromide 2.5 mg;
1984-12-31;
Oral;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6283
STERIGEL PLUS;
02240800;
chlorhexidine gluconate 0.5 % , alcohol anhydrous 70 %;
1999-11-05;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64391
SOLUPREP QD WIPE;
02060019;
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
1994-12-31;
Topical (Hospital/Hc Facilities);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16494
SOLUPREP QD SWAB;
02119803;
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
1996-09-09;
Topical (Hospital/Hc Facilities);
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=30398
CHLORHEXIDINE AND ISOPROPYL ALCOHOL SWABSTICKS;
02243002;
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
2001-06-14;
Topical;
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROFESSIONAL DISPOSABLES INTERNATIONAL INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66842
CHLORHEXIDINE AND ISOPROPYL ALCOHOL PREP PADS;
02243003;
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
2001-06-14;
Topical;
Pad;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROFESSIONAL DISPOSABLES INTERNATIONAL INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66843
DEXIDIN 0.5 SOLUTION;
02240680;
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70.0 %;
2000-02-02;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64263
SOLUPREP QD SOLUTION;
02116472;
chlorhexidine gluconate 0.5 % / w/v , isopropyl alcohol 70 % / v/v;
1995-12-31;
Topical (Hospital/Hc Facilities);
Solution , Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19626
AVAGARD CHG;
02246888;
chlorhexidine gluconate 1 % , alcohol anhydrous 61 %;
2003-07-02;
Topical (Hospital/Hc Facilities);
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71113
STANHEXIDINE 2% WITH ISOPROPYL ALCOHOL 4%;
01938991;
chlorhexidine gluconate 2 % , isopropyl alcohol 4 %;
1992-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13289
STANHEXIDINE AQUEOUS 2% WITH 4% ISOPROPYL ALCOHOL;
02246950;
chlorhexidine gluconate 2 % , isopropyl alcohol 4 %;
2002-12-04;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71177
BAXEDIN 2% – 70%;
02251477;
chlorhexidine gluconate 2 % , isopropyl alcohol 70 %;
2004-07-07;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73640
CHLORAPREP ONE-STEP;
02160757;
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
1998-08-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CAREFUSION CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34222
SOLUPREP SWAB;
02382040;
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
2012-12-05;
Topical (Hospital/Hc Facilities);
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86791
SOLUPREP WIPE;
02385708;
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
2013-01-16;
Topical (Hospital/Hc Facilities);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87132
3M SOLUPREP SPONGE;
02404125;
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
2013-09-11;
Topical (Hospital/Hc Facilities);
Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88890
CHLORAPREP;
02484374;
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
2019-11-18;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BECTON DICKINSON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97469
LORIS – I.V.;
02297442;
chlorhexidine gluconate 2.0 % , isopropyl alcohol 70 %;
2009-02-24;
Topical;
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LERNAPHARM (LORIS) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78280
SOLUPREP;
02240356;
chlorhexidine gluconate 2.0 % / w/v , isopropyl alcohol 70 % / v/v;
2002-08-02;
Topical (Hospital/Hc Facilities);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63898
SOLUPREP APPLICATOR;
02382113;
chlorhexidine gluconate 2.0 % / w/v , isopropyl alcohol 70.0 % / v/v;
2013-01-17;
Topical (Hospital/Hc Facilities);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86799
STANHEXIDINE 4% WITH ISOPROPYL ALCOHOL 4%;
01938983;
chlorhexidine gluconate 4 % , isopropyl alcohol 4 %;
1992-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13290
CHILDREN’S TYLENOL COLD AND COUGH;
02039990;
chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
1997-08-12;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26864
BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER;
02305496;
chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
2008-09-01;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79105
CHILDREN’S TYLENOL COMPLETE COLD, COUGH & FEVER;
02376474;
chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
2012-08-31;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86193
EXTRA STRENGTH COLD MEDICATION NIGHTTIME RELIEF;
02039842;
chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
1995-12-31;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17887
BUCKLEY’S COMPLETE EXTRA STRENGTH COUGH, COLD AND FLU NIGHT;
02241592;
chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
2000-08-08;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65249
VICKS CHILDREN’S NYQUIL COLD & COUGH MULTI-SYMPTOM RELIEF;
02273330;
chlorpheniramine maleate 2 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml;
2006-07-21;
Oral;
Solution;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75882
COLDASIDE COUGH & COLD;
02309440;
chlorpheniramine maleate 4 mg , dextromethorphan hydrobromide 30 mg;
2009-01-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79504
ACETAZONE FORTE;
00834300;
chlorzoxazone 250 mg , acetaminophen 300 mg;
1991-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11427
ACETAZONE FORTE C8;
00834319;
chlorzoxazone 250 mg , acetaminophen 300 mg , codeine phosphate 8 mg;
1991-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11339
MICRO PLUS 4 REGULAR STRENGTH;
02091135;
chromium (chromic chloride) 4 mcg / ml , zinc (zinc sulfate) 1 mg / ml , copper (cupric sulfate) .4 mg / ml , manganese (manganese sulfate) .1 mg / ml;
1996-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19923
INHIBACE PLUS;
02181479;
cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
1999-04-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44252
APO-CILAZAPRIL/HCTZ;
02284987;
cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
2006-08-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77051
TEVA-CILAZAPRIL/HCTZ;
02313731;
cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
2009-03-30;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79924
CIPRODEX;
02252716;
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
2004-05-13;
Otic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73758
TARO-CIPROFLOXACIN/DEXAMETHASONE;
02481901;
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
2020-11-23;
Otic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97239
SANDOZ CIPROFLOXACIN / DEXAMETHASONE;
02506882;
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
2021-01-26;
Otic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99623
OTIXAL;
02459655;
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , fluocinolone acetonide 0.025 % / w/v;
2017-05-08;
Otic;
Solution;
52:04.04 – ANTIBACTERIALS , 08:12.18 – QUINOLONES , 52:08.08 – CORTICOSTEROIDS;
Prescription;
MEDEXUS PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94696
PICO-SALAX;
02254794;
citric acid 12 g / sachet , magnesium oxide 3.5 g / sachet , sodium picosulfate 10 mg / sachet;
2004-11-25;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Ethical;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73995
PURG-ODAN;
02317966;
citric acid 12 g / sachet , magnesium oxide 3.5 g / sachet , sodium picosulfate 10 mg / sachet;
2009-02-16;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Ethical;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80347
ANTICOAGULANT SOLUTION CITRATE PHOSPHATE DEXTROSE (CPD);
02444100;
citric acid 3.27 g / l , sodium citrate dihydrate 26.3 g / l , sodium phosphate monobasic 2.51 g / l , dextrose 25.5 g / l;
2016-08-22;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
MACO PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92893
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A;
02469731;
citric acid monohydrate 0.8 g / 100 ml , dextrose 2.45 g / 100 ml , sodium citrate dihydrate 2.2 g / 100 ml;
2018-06-20;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
TERUMO BCT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95858
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION;
02495910;
clavulanic acid (clavulanate potassium) 100 mg / vial , amoxicillin (amoxicillin sodium) 500 mg / vial;
2020-07-03;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98581
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION;
02495929;
clavulanic acid (clavulanate potassium) 200 mg / vial , amoxicillin (amoxicillin sodium) 1000 mg / vial;
2020-07-03;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98582
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION;
02495937;
clavulanic acid (clavulanate potassium) 200 mg / vial , amoxicillin (amoxicillin sodium) 2000 mg / vial;
2020-07-03;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98583
CLAVULIN 125 F ORAL SUS;
01916882;
clavulanic acid (clavulanate potassium) 31.25 mg / 5 ml , amoxicillin (amoxicillin trihydrate) 125 mg / 5 ml;
1992-12-31;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15208
CLAVULIN 400;
02238830;
clavulanic acid (clavulanate potassium) 57 mg / 5 ml , amoxicillin (amoxicillin trihydrate) 400 mg / 5 ml;
1998-10-29;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62268
BENZACLIN;
02248472;
clindamycin (clindamycin phosphate) 1 % / w/w , benzoyl peroxide 5 % / w/w;
2004-05-04;
Topical;
Gel;
84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72824
TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT;
02464519;
clindamycin (clindamycin phosphate) 1 % / w/w , benzoyl peroxide 5 % / w/w;
2017-07-24;
Topical;
Gel;
84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95265
BIACNA TOPICAL GEL;
02359685;
clindamycin phosphate 1.2 % / w/w , tretinoin 0.025 % / w/w;
2011-05-16;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84468
LOCACORTEN VIOFORM;
00074462;
clioquinol 3 % , flumethasone pivalate 0.02 %;
1968-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.92 – MISCELLANEOUS ANTIFUNGALS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=631
VIOFORM HYDROCORTISONE;
00074500;
clioquinol 3 % / w/w , hydrocortisone 1 % / w/w;
1957-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.92 – MISCELLANEOUS ANTIFUNGALS;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=810
CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS;
02230509;
clotrimazole 1 % / w/w , clotrimazole 10 % / w/w;
1997-06-11;
Topical , Vaginal;
Kit , Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49563
CANESTEN COMBI 3 DAY COMFORTAB + EXTERNAL CREAM;
02264099;
clotrimazole 200 mg / vtab , clotrimazole 1 % / w/w;
2006-06-02;
Topical , Vaginal;
Vaginal Tablet , Kit , Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74951
CANESTEN COMBI 1 DAY COMFORTAB + EXTERNAL CREAM;
02264102;
clotrimazole 500 mg / vtab , clotrimazole 1 % / w/w;
2006-05-12;
Topical , Vaginal;
Vaginal Tablet , Kit , Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74952
TARGEL SA;
00510335;
coal tar 10 % , salicylic acid 3 %;
1980-12-31;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4037
DENOREX EXTRA STRENGTH MEDICATED SHAMPOO;
02285703;
coal tar 2.4 % / w/w , menthol 1.5 % / w/w , chloroxylenol 0.5 % / w/w;
2007-04-20;
Topical;
Shampoo;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
NEOTERIC COSMETICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77120
DENOREX EXTRA STRENGTH MEDICATED SHAMPOO WITH CONDITIONERS;
02285711;
coal tar 2.4 % / w/w , menthol 1.5 % / w/w , chloroxylenol 0.5 % / w/w;
2007-04-20;
Topical;
Shampoo;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
NEOTERIC COSMETICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77121
DAMYLIN WITH CODEINE SYRUP;
02245592;
codeine phosphate 3.3 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
2002-09-13;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69689
COUGH AND ALLERGY SYRUP WITH CODEINE;
02486903;
codeine phosphate 3.3 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
2019-10-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97706
COUGH SYRUP WITH CODEINE;
02099748;
codeine phosphate 3.3 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
1995-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19625
CALMYLIN PSE WITH CODEINE;
02172917;
codeine phosphate 3.3 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
1996-08-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34650
CALMYLIN;
00535230;
codeine phosphate 3.33 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
1981-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4469
COUGH SYRUP;
00690074;
codeine phosphate 3.33 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
1986-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6844
PMS-ACETAMINOPHEN WITH CODEINE ELIXIR;
00816027;
codeine phosphate 8 mg / 5 ml , acetaminophen 160 mg / 5 ml;
1991-12-31;
Oral;
Elixir;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11384
DUAVIVE;
02432854;
conjugated estrogens 0.45 mg , bazedoxifene (bazedoxifene acetate) 20 mg;
2016-12-20;
Oral;
Tablet (Immediate And Extended Release);
68:16.12 – ESTROGEN AGONIST-ANTAGONISTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91723
CYESTRA-35;
02290308;
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
2007-04-03;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77558
TEVA-CYPROTERONE / ETHINYL ESTRADIOL;
02309556;
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
2008-09-26;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79517
TARO-CYPROTERONE/ETHINYL ESTRADIOL;
02425017;
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
2015-03-26;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90968
CLÉO -35;
02436736;
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
2015-10-30;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ALTIUS HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92104
DIANE-35;
02233542;
cyproterone acetate 2 mg , ethinyl estradiol 35 mcg;
1998-04-08;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=53444
XIGDUO;
02449943;
dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg , metformin hydrochloride 1000 mg;
2016-02-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93581
XIGDUO;
02449935;
dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg , metformin hydrochloride 850 mg;
2016-02-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93580
PREZCOBIX;
02426501;
darunavir (darunavir ethanolate) 800 mg , cobicistat 150 mg;
2014-08-28;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS , 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91108
SYMTUZA;
02473720;
darunavir (darunavir ethanolate) 800 mg , cobicistat 150 mg , emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg;
2018-04-25;
Oral;
Tablet;
08:18.08 – ANTIRETROVIRALS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96312
INQOVI;
02501600;
decitabine 35 mg , cedazuridine 100 mg;
2020-11-11;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99121
SATIVEX;
02266121;
delta-9-tetrahydrocannabinol (cannabis sativa extract) 2.7 mg / act , cannabidiol (cannabis sativa extract) 2.5 mg / act;
2005-06-22;
Buccal;
Spray;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
GW PHARMA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75157
ALLERGENIC EXTRACT, STANDARDIZED MITE MIXED;
02270919;
dermatophagoides farinae 5000 unit / ml , dermatophagoides pteronyssinus 5000 unit / ml;
2006-02-28;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75630
ALLERGENIC EXTRACT – STANDARDIZED MITE MIX;
02231325;
dermatophagoides pteronyssinus 5000 unit / ml , dermatophagoides farinae 5000 unit / ml;
2002-08-20;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50632
ACARIZAX;
02463644;
dermatophagoides pteronyssinus 6 unit , dermatophagoides farinae 6 unit;
2017-11-06;
Sublingual;
Tablet;
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95174
AERIUS DOUBLE ACTION 12 HOUR;
02309300;
desloratadine 2.5 mg , pseudoephedrine sulfate 120 mg;
2010-02-01;
Oral;
Tablet (Extended-Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79491
MARVELON 21;
02042487;
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
1993-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14354
APRI 21;
02317192;
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2008-09-29;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80270
APRI 28;
02317206;
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2008-09-29;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80272
FREYA 21;
02396491;
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2012-11-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88154
MIRVALA 21;
02410249;
desogestrel 0.1500 mg / tab , ethinyl estradiol 0.0300 mg / tab;
2014-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89490
MIRVALA 28;
02410257;
desogestrel 0.1500 mg / tab , ethinyl estradiol 0.0300 mg / tab;
2014-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89491
MAXITROL;
00042676;
dexamethasone 0.1 % / w/v , neomycin (neomycin sulfate) 3.5 mg / ml , polymyxin b sulfate 6000 unit / ml;
1963-12-31;
Ophthalmic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=259
MAXITROL;
00358177;
dexamethasone 0.1 % / w/w , neomycin (neomycin sulfate) 3.5 mg / g , polymyxin b sulfate 6000 unit / g;
1970-12-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2423
LMD 10% IN DEXTROSE 5%;
00224235;
dextran 10 % , dextrose 5 %;
1968-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1744
LMD 10% IN 0.9% SODIUM CHLORIDE;
00224227;
dextran 10 % , sodium chloride 0.9 %;
1968-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1743
TEARS NATURALE FORTE;
02246397;
dextran 70 0.1 % , glycerine 0.2 % , hypromellose 0.3 %;
2003-01-02;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70567
TEARS NATURALE II;
00743445;
dextran 70 0.1 % / w/v , hypromellose 0.3 % / w/v;
1989-12-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10032
VISINE FOR RED EYE TRIPLE ACTION;
02248657;
dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
2005-03-08;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73019
ADVANCED RELIEF EYE DROPS;
02344319;
dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
2010-08-30;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82979
VISINE FOR RED EYE WORKPLACE;
02436086;
dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
2016-06-03;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92041
COLD & SINUS LIQUID FASTGELS;
02305356;
dextromethorphan hydrobromide 10 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg;
2009-01-22;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79088
NYQUIL COMPLETE + VICKS VAPOCOOL;
02481928;
dextromethorphan hydrobromide 10 mg , doxylamine succinate 6.25 mg , phenylephrine hydrochloride 5 mg , acetaminophen 325 mg;
2020-07-20;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97241
TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF;
02295326;
dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg;
2009-08-18;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78062
BENYLIN ALL-IN-ONE COLD, FLU & COUGH LIQUID GELS;
02345110;
dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg;
2010-08-11;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83056
ROBITUSSIN SUGAR FREE COUGH CONTROL;
02248568;
dextromethorphan hydrobromide 10 mg / 5 ml , guaifenesin 100 mg / 5 ml;
2006-08-07;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72923
DAYTIME COLD & FLU LIQUID CAPSULES;
02258919;
dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg;
2005-01-10;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74414
VICKS NYQUIL LIQUICAPS COLD & FLU MULTI-SYMPTOM RELIEF;
02272792;
dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg;
2006-06-26;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75829
BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH;
02218186;
dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
1997-08-06;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37150
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF;
02347652;
dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
2010-08-11;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83303
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU;
02347660;
dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
2010-08-11;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83304
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU DAYTIME;
02365731;
dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
2011-08-08;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85062
VICKS NYQUIL COUGH;
02244662;
dextromethorphan hydrobromide 15 mg / 15 ml , doxylamine succinate 6.25 mg / 15 ml;
2010-08-19;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68650
BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU;
02245710;
dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
2003-07-03;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69814
BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU WITH WARMING SENSATION;
02321432;
dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
2009-08-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80682
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF;
02365774;
dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
2011-08-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85065
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF;
02366207;
dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
2011-08-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85106
BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF;
01944762;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12449
BALMINIL DM + EXPECTORANT;
02201712;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
1997-02-04;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36293
DM-EXPECTORANT SYRUP;
02241491;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
2000-02-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65131
COUGH & CHEST CONGESTION;
02405938;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
2013-07-26;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89068
BALMINIL DM + EXPECTORANT EXTRA STRENGTH;
02233027;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
1998-03-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52514
DM EXPECTORANT (EXTRA STRENGTH) SYRUP;
02243010;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
2001-01-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66851
MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH;
02405857;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
2013-09-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89062
COUGH & CHEST CONGESTION EXTRA STRENGTH;
02405911;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
2013-08-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89067
BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION;
02265419;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
2005-03-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75088
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL;
02320959;
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
2009-07-21;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80637
BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES;
02436485;
dextromethorphan hydrobromide 15 mg / 5 ml , menthol 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
2015-07-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92082
BALMINIL DM + DECONGESTANT + EXPECTORANT;
02236915;
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
1998-05-22;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60207
BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION;
02003317;
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13440
ROBITUSSIN EXTRA STRENGTH COUGH & COLD;
02172380;
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml;
1995-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19060
BALMINIL DM + DECONGESTANT + EXPECTORANT EXTRA STRENGTH;
02233026;
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml;
1998-04-22;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52513
BENYLIN EXTRA STRENGTH COUGH COMPLETE;
02265400;
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
2005-09-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75087
ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION;
02485524;
dextromethorphan hydrobromide 20 mg / 20 ml , guaifenesin 400 mg / 20 ml;
2019-08-01;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97576
NIGHTTIME COMPLETE;
02458462;
dextromethorphan hydrobromide 20 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
2018-12-20;
Oral;
Solution;
48:08.00 – ANTITUSSIVES , 52:24.00 – MYDRIATICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94559
DIMETAPP EXTRA STRENGTH DM COUGH & COLD;
02245076;
dextromethorphan hydrobromide 20 mg / 5 ml , brompheniramine maleate 4 mg / 5 ml , phenylephrine hydrochloride 10 mg / 5 ml;
2002-08-01;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69080
ROBITUSSIN HONEY COUGH & COLD NIGHTTIME;
02485443;
dextromethorphan hydrobromide 30 mg / 20 ml , doxylamine succinate 12.5 mg / 20 ml;
2019-08-01;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97569
NIGHTTIME COLD AND FLU RELIEF;
02378655;
dextromethorphan hydrobromide 30 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
2013-02-06;
Oral;
Solution;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86446
COLD FLU RELIEF;
02218836;
dextromethorphan hydrobromide 30 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , pseudoephedrine hydrochloride 60 mg / 30 ml , acetaminophen 1 g / 30 ml;
1997-01-09;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37183
ROBITUSSIN TOTAL COUGH, COLD & FLU;
02291363;
dextromethorphan hydrobromide 30 mg / 30 ml , pseudoephedrine hydrochloride 30 mg / 30 ml , acetaminophen 650 mg / 30 ml;
2008-08-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77674
TOTAL COLD AND FLU EXTRA STRENGTH;
02289385;
dextromethorphan hydrobromide 30 mg / 30 ml , pseudoephedrine hydrochloride 60 mg / 30 ml , guaifenesin 200 mg / 30 ml , acetaminophen 1000 mg / 30 ml;
2007-07-11;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77475
JACK & JILL COUGH & COLD;
02412357;
dextromethorphan hydrobromide 5.0 mg / 5 ml , phenylephrine hydrochloride 2.5 mg / 5 ml;
2014-08-05;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89697
BENYLIN FOR CHILDREN COUGH & COLD;
01944746;
dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12504
DM-DECONGESTANT CHILDREN’S SYRUP;
02241492;
dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
2000-03-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65132
CHILDREN’S COUGH & COLD RELIEF;
02405903;
dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
2013-08-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89066
DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ;
00060755;
dextrose 10 g / 100 ml , sodium chloride 900 mg / 100 ml;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10441
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A;
00788139;
dextrose 2.45 g / 100 ml , sodium citrate 2.2 g / 100 ml , citric acid 730 mg / 100 ml;
1991-12-31;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
FRESENIUS KABI AG
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11376
DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION;
00783641;
dextrose 200 mg / 100 ml , sodium chloride 900 mg / 100 ml;
1991-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12171
SCLERODEX;
02020939;
dextrose 250 mg / ml , sodium chloride 100 mg / ml;
1977-12-31;
Intravenous;
Liquid;
24:16.00 – SCLEROSING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14183
POTASSIUM CHLORIDE 20 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE;
00472085;
dextrose 3.3 g / 100 ml , sodium chloride 0.3 g / 100 ml , potassium chloride 0.149 g / 100 ml;
1979-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3538
POTASSIUM CHLORIDE 40 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE;
00472077;
dextrose 3.3 g / 100 ml , sodium chloride 0.3 g / 100 ml , potassium chloride 0.298 g / 100 ml;
1979-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3537
DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ;
00060712;
dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10515
(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP;
00438014;
dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml , potassium chloride 150 mg / 100 ml;
1978-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3132
(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP;
00438022;
dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml , potassium chloride 300 mg / 100 ml;
1978-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3133
3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE;
00038881;
dextrose 33.3 mg / ml , sodium chloride 3 mg / ml;
1976-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2575
HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ;
02209713;
dextrose 5 g / 100 ml , heparin sodium 4000 unit / 100 ml;
1996-09-10;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36794
POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE;
00466697;
dextrose 5 g / 100 ml , potassium chloride 0.149 g / 100 ml;
1979-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3536
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE;
00606820;
dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml;
1983-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6400
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE;
02299135;
dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml , sodium chloride 0.9 g / 100 ml;
2008-04-07;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78453
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP;
00438049;
dextrose 5 g / 100 ml , potassium chloride 150 mg / 100 ml;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10041
(40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP;
00438030;
dextrose 5 g / 100 ml , potassium chloride 300 mg / 100 ml;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10042
POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE;
00466670;
dextrose 5 g / 100 ml , sodium chloride 0.45 g / 100 ml , potassium chloride 0.149 g / 100 ml;
1979-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3534
DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ;
00060704;
dextrose 5 g / 100 ml , sodium chloride 200 mg / 100 ml;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10438
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP;
01931598;
dextrose 5 g / 100 ml , sodium chloride 200 mg / 100 ml , potassium chloride 150 mg / 100 ml;
1998-09-03;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=21753
DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ;
00060739;
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10439
5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP;
01927531;
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13033
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP;
00437999;
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml , potassium chloride 150 mg / 100 ml;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10044
(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP;
00438006;
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml , potassium chloride 300 mg / 100 ml;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10045
DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ;
00060747;
dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10440
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP;
00786292;
dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml , potassium chloride 150 mg / 100 ml;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10866
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR;
00786306;
dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml , potassium chloride 300 mg / 100 ml;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10867
HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML;
01935941;
dextrose 5 g / 100 ml , sodium phosphate dibasic 410 mg / 100 ml , citric acid 93 mg / 100 ml , heparin sodium 5000 unit / 100 ml;
1993-12-31;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16794
5% DEXTROSE AND 0.225% SODIUM CHLORIDE;
00038873;
dextrose 50 mg / ml , sodium chloride 2.25 mg / ml;
1955-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1751
5% DEXTROSE AND 0.45% SODIUM CHLORIDE;
00038903;
dextrose 50 mg / ml , sodium chloride 4.5 mg / ml;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1750
5% DEXTROSE AND 0.9% SODIUM CHLORIDE;
00038946;
dextrose 50 mg / ml , sodium chloride 9 mg / ml;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1747
5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP;
01924435;
dextrose 50 mg / ml , sodium chloride 9 mg / ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13288
GASTROGRAFIN – LIQ ORL;
02228564;
diatrizoate meglumine 66 % , diatrizoate sodium 10 %;
1978-12-30;
Oral;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BRACCO IMAGING CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37570
SANDOZ PROCTOMYXIN HC SUPPOSITORIES;
02242528;
dibucaine hydrochloride 5 mg , esculin 10 mg , hydrocortisone 5 mg , framycetin sulfate 10 mg;
2001-01-05;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66276
TEVA-PROCTOSONE;
02226391;
dibucaine hydrochloride 5 mg , framycetin sulfate 10 mg , hydrocortisone (hydrocortisone acetate) 5 mg , esculin 10 mg;
1996-12-30;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37455
CERUMOL;
00221570;
dichlorobenzene 2 % , oil of turpentine 10 % , peanut oil 57 % , chlorobutanol 5 %;
1971-12-31;
Otic;
Drops;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
THORNTON & ROSS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1103
ANTIBACTERIAL THROAT LOZENGES;
02375567;
dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg;
2013-03-07;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
QUIMICA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86098
CEPACOL CHILDREN’S FRUITY STRAWBERRY;
02404982;
dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg;
2013-08-15;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88981
CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE;
02382881;
dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg , levomenthol 8 mg;
2012-07-19;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86869
CEPACOL SENSATIONS SORE THROAT & COUGH;
02388642;
dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg , menthol 8 mg;
2012-09-04;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87415
ARTHROTEC 50;
01917056;
diclofenac sodium 50 mg , misoprostol 200 mcg;
1993-12-31;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13636
GD-DICLOFENAC/MISOPROSTOL 50;
02341689;
diclofenac sodium 50 mg , misoprostol 200 mcg;
2014-07-22;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
GENMED A DIVISION OF PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82718
PMS-DICLOFENAC-MISOPROSTOL;
02413469;
diclofenac sodium 50 mg , misoprostol 200 mcg;
2018-12-11;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89812
ARTHROTEC 75;
02229837;
diclofenac sodium 75 mg , misoprostol 200 mcg;
1996-11-11;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48191
GD-DICLOFENAC/MISOPROSTOL 75;
02341697;
diclofenac sodium 75 mg , misoprostol 200 mcg;
2014-07-22;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
GENMED A DIVISION OF PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82719
PMS-DICLOFENAC-MISOPROSTOL;
02413477;
diclofenac sodium 75 mg , misoprostol 200 mcg;
2018-12-11;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89813
HUMATROPE;
02243078;
diluent 3.15 ml , somatropin 12 mg;
2001-08-28;
Intramuscular , Subcutaneous;
Liquid , Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66944
HUMATROPE;
02243079;
diluent 3.15 ml , somatropin 24 mg;
2003-12-08;
Intramuscular , Subcutaneous;
Liquid , Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66945
HUMATROPE;
02243077;
diluent 3.15 ml , somatropin 6 mg;
2001-09-25;
Intramuscular , Subcutaneous;
Liquid , Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66943
BAZA PROTECT II;
02315793;
dimethicone 1 % / w/w , zinc oxide 12 % / w/w;
2009-05-20;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
COLOPLAST A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80131
ABC ARBONNE BABY CARE DIAPER RASH CREAM;
02417693;
dimethicone 1 % / w/w , zinc oxide 12 % / w/w;
2014-09-25;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ARBONNE INTERNATIONAL LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90232
ADVIL COLD & FLU;
02362643;
diphenhydramine citrate 38 mg , ibuprofen 200 mg;
2011-10-27;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84765
BENADRYL ITCH STOPPING CREAM;
02484838;
diphenhydramine hydrochloride 2 % , zinc acetate 0.1 %;
2020-01-13;
Topical;
Cream;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97511
BENADRYL BUG BITE RELIEF;
02280868;
diphenhydramine hydrochloride 2 % / w/v , zinc acetate 0.1 % / w/v;
2007-03-09;
Topical;
Liquid;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76653
BENADRYL SPRAY;
02280876;
diphenhydramine hydrochloride 2.0 % , zinc acetate 0.1 %;
2007-03-09;
Topical;
Spray;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76655
ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME;
02238183;
diphenhydramine hydrochloride 25 mg , acetaminophen 500 mg;
2018-02-23;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61574
ADVIL NIGHTTIME;
02355841;
diphenhydramine hydrochloride 25 mg , ibuprofen 200 mg;
2011-01-03;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84104
EXTRA STRENGTH FLU RELIEF NIGHTIME;
02248700;
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
2004-01-07;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73064
BENADRYL ALLERGY, SINUS & PAIN TOTAL;
02250993;
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
2004-10-15;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73592
EXTRA STRENGTH ALLERGY TOTAL;
02303833;
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
2008-03-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78913
NIGHTTIME TOTAL COLD AND FLU;
02305305;
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
2009-03-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79084
NIGHTTIME FLU, COUGH & COLD COMPLETE RELIEF EXTRA STRENGTH;
02404974;
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
2014-07-16;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88980
NEOCITRAN EXTRA STRENGTH TOTAL COLD NIGHT;
02409178;
diphenhydramine hydrochloride 25 mg / sachet , acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
2015-08-04;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89389
JACK & JILL BEDTIME COUGH & COLD;
02412349;
diphenhydramine hydrochloride 6.25 mg / 5 ml , phenylephrine hydrochloride 2.5 mg / 5 ml;
2014-08-05;
Oral;
Syrup;
04:04.04 – ETHANOLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89696
LOMOTIL;
00036323;
diphenoxylate hydrochloride 2.5 mg , atropine sulfate .025 mg;
1960-12-31;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Narcotic (Cdsa I);
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=937
TD ADSORBED;
00514462;
diphtheria toxoid adsorbed 2 lf / 0.5 ml , tetanus toxoid adsorbed 5 lf / 0.5 ml;
1980-12-31;
Intramuscular;
Suspension;
80:08.00 – TOXOIDS;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4109
TARO-DIPYRIDAMOLE/ ASA;
02471051;
dipyridamole 200 mg , acetylsalicylic acid 25 mg;
2018-11-27;
Oral;
Capsule (Immediate And Extended Release);
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS , 28:08.04.24 – SALICYLATES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96015
TRIUMEQ;
02430932;
dolutegravir (dolutegravir sodium) 50 mg , abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
2014-10-22;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91536
DOVATO;
02491753;
dolutegravir (dolutegravir sodium) 50 mg , lamivudine 300 mg;
2019-09-09;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98173
JULUCA;
02475774;
dolutegravir (dolutegravir sodium) 50 mg , rilpivirine (rilpivirine hydrochloride) 25 mg;
2018-06-04;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96645
DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP;
00761850;
dopamine hydrochloride .8 mg / ml , dextrose 50 mg / ml;
1992-12-31;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12256
DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP;
00761826;
dopamine hydrochloride 1.6 mg / ml , dextrose 50 mg / ml;
1990-12-31;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11625
DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP;
00761834;
dopamine hydrochloride 3.2 mg / ml , dextrose 50 mg / ml;
1990-12-31;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11624
DELSTRIGO;
02482592;
doravirine 100 mg , lamivudine 300 mg , tenofovir disoproxil fumarate 300 mg;
2018-12-10;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97302
COSOPT;
02258692;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2005-11-02;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74388
APO-DORZO-TIMOP;
02299615;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2010-12-15;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78499
SANDOZ DORZOLAMIDE/TIMOLOL;
02344351;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2010-10-25;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82984
ACT DORZOTIMOLOL;
02404389;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2013-05-01;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88915
MED-DORZOLAMIDE-TIMOLOL;
02437686;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2016-05-17;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92207
RIVA-DORZOLAMIDE/TIMOLOL;
02441659;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2015-07-22;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92604
JAMP DORZOLAMIDE-TIMOLOL;
02457539;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2019-12-13;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94459
DORZOLAMIDE AND TIMOLOL EYE DROPS BP;
02489635;
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
2020-05-01;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
TELIGENT CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97971
DICLECTIN;
00609129;
doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
1983-12-31;
Oral;
Tablet (Delayed-Release);
56:22.08 – ANTIHISTAMINES;
Prescription;
DUCHESNAY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5509
PMS-DOXYLAMINE-PYRIDOXINE;
02406187;
doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
2017-07-10;
Oral;
Tablet (Delayed-Release);
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89091
APO-DOXYLAMINE/B6;
02413248;
doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
2017-08-11;
Oral;
Tablet (Delayed-Release);
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89791
COMPLETE LIQUID CAPSULES NIGHTTIME RELIEF;
02427923;
doxylamine succinate 6.25 mg , acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg;
2017-05-25;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91242
SINUS MEDICATION;
02245016;
doxylamine succinate 6.25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
2003-03-07;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69017
ANGELIQ;
02268825;
drospirenone 1.0 mg , estradiol 1.0 mg;
2008-10-20;
Oral;
Tablet;
68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75422
YAZ;
02321157;
drospirenone 3 mg , ethinyl estradiol 0.02 mg;
2009-01-06;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80656
YASMIN 21;
02261723;
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
2004-12-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74710
YASMIN 28;
02261731;
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
2004-12-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74711
ZAMINE 21;
02410788;
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
2014-01-30;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89544
ZAMINE 28;
02410796;
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
2014-01-30;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89545
MYA;
02415380;
drospirenone 3.00 mg , ethinyl estradiol 0.02 mg;
2014-05-20;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89999
YAZ PLUS;
02387433;
drospirenone 3.00 mg , ethinyl estradiol 0.02 mg , levomefolate calcium 0.451 mg , levomefolate calcium 0.451 mg;
2013-03-01;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87302
JALYN;
02372010;
dutasteride 0.5 mg , tamsulosin hydrochloride 0.4 mg;
2011-11-17;
Oral;
Capsule (Immediate And Extended Release);
92:08.00 – 5 ALFA REDUCTASE INHIBITORS , 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85714
ATRIPLA;
02300699;
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2007-10-23;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78602
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR;
02393549;
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87876
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE;
02461412;
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2017-07-31;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94902
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR;
02468247;
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2018-09-04;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95665
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR;
02478404;
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2020-03-18;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96916
SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR;
02484676;
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2019-09-30;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97496
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR;
02487284;
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2019-10-29;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97744
ZEPATIER;
02451131;
elbasvir 50 mg , grazoprevir 100 mg;
2016-01-25;
Oral;
Tablet;
08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93740
GLYXAMBI;
02459752;
empagliflozin 10 mg , linagliptin 5 mg;
2016-12-21;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94707
SYNJARDY;
02456621;
empagliflozin 12.5 mg , metformin hydrochloride 1000 mg;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94362
SYNJARDY;
02456605;
empagliflozin 12.5 mg , metformin hydrochloride 500 mg;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94360
SYNJARDY;
02456613;
empagliflozin 12.5 mg , metformin hydrochloride 850 mg;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94361
GLYXAMBI;
02459760;
empagliflozin 25 mg , linagliptin 5 mg;
2016-12-21;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94709
SYNJARDY;
02456591;
empagliflozin 5 mg , metformin hydrochloride 1000 mg;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94359
SYNJARDY;
02456575;
empagliflozin 5 mg , metformin hydrochloride 500 mg;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94357
SYNJARDY;
02456583;
empagliflozin 5 mg , metformin hydrochloride 850 mg;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94358
GENVOYA;
02449498;
emtricitabine 200 mg , elvitegravir 150 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg , cobicistat 150 mg;
2016-02-03;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93532
STRIBILD;
02397137;
emtricitabine 200 mg , elvitegravir 150 mg , tenofovir disoproxil fumarate 300 mg , cobicistat 150 mg;
2012-12-20;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS , 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88208
ODEFSEY;
02461463;
emtricitabine 200 mg , rilpivirine (rilpivirine hydrochloride) 25 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
2017-03-20;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94909
COMPLERA;
02374129;
emtricitabine 200 mg , rilpivirine (rilpivirine hydrochloride) 25 mg , tenofovir disoproxil fumarate 300 mg;
2011-10-20;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85932
DESCOVY;
02454416;
emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg;
2016-06-03;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94099
DESCOVY;
02454424;
emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
2016-06-03;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94100
TEVA-EMTRICITABINE/TENOFOVIR;
02399059;
emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88396
ENALAPRIL MALEATE/HCTZ;
02352931;
enalapril maleate 10 mg , hydrochlorothiazide 25 mg;
2011-02-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83817
ENALAPRIL MALEATE/HCTZ;
02352923;
enalapril maleate 5 mg , hydrochlorothiazide 12.5 mg;
2011-02-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83816
VASERETIC;
00657298;
enalapril sodium (enalapril maleate) 8 mg , hydrochlorothiazide 25 mg;
1990-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10913
REFRESHING DAY CREAM;
02466589;
ensulizole 2 % / w/w , avobenzone 2 % / w/w , octocrylene 3 % / w/w;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95492
ARTISTRY EXACT FIT BEAUTY BALM PERFECTING PRIMER;
02434865;
ensulizole 2 % / w/w , octinoxate 5 % / w/w , zinc oxide 5.49 % / w/w;
2015-09-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91916
SOOTHING DAY CREAM;
02466600;
ensulizole 2.25 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95494
ZORCAINE;
02474239;
epinephrine (epinephrine bitartrate) 0.01 mg / ml , articaine hydrochloride 40 mg / ml;
2019-07-24;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96424
SEPTANEST SP;
02123398;
epinephrine (epinephrine bitartrate) 0.01 mg / ml , articaine hydrochloride 40.0 mg / ml;
1994-12-31;
Block/Infiltration;
Solution;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16850
LIDOCAINE 2% AND EPINEPHRINE 1:100,000;
02473518;
epinephrine (epinephrine bitartrate) 0.01 mg / ml , lidocaine hydrochloride 20 mg / ml;
2019-04-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96290
LIDOCAINE 2% AND EPINEPHRINE 1:50,000;
02473526;
epinephrine (epinephrine bitartrate) 0.02 mg / ml , lidocaine hydrochloride 20 mg / ml;
2019-05-10;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96291
SENSORCAINE WITH EPINEPHRINE;
01976184;
epinephrine (epinephrine bitartrate) 5 mcg / ml , bupivacaine hydrochloride 2.5 mg / ml;
1994-12-31;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16162
ULTRACAINE D-S FORTE INJECTION;
01988557;
epinephrine 0.01 mg / ml , articaine hydrochloride 40 mg / ml;
1993-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
HANSAMED LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16511
ULTRACAINE D-S INJECTION;
01988530;
epinephrine 5 mcg / ml , articaine hydrochloride 40 mg / ml;
1994-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
HANSAMED LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16508
TEVETEN PLUS;
02253631;
eprosartan (eprosartan mesylate) 600 mg , hydrochlorothiazide 12.5 mg;
2004-07-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73859
BENZAMYCIN;
02225271;
erythromycin 3 % / w/w , benzoyl peroxide 5 % / w/w;
1996-11-05;
Topical;
Gel;
84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43428
PROCTOSEDYL;
02223252;
esculin 1 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , hydrocortisone 0.5 %;
2003-04-01;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37334
ACTIVELLE LD;
02309009;
estradiol 0.5 mg , norethindrone acetate 0.1 mg;
2008-05-16;
Oral;
Tablet;
68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
Prescription;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79461
ACTIVELLE;
02249405;
estradiol 1.0 mg , norethindrone acetate 0.5 mg;
2008-05-16;
Oral;
Tablet;
68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
Prescription;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73420
ESTALIS 140/50 MCG;
02241835;
estradiol 50 mcg / 24 hour , norethindrone acetate 140 mcg / 24 hour;
2000-05-25;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65502
ESTALIS 250/50 MCG;
02241837;
estradiol 50 mcg / 24 hour , norethindrone acetate 250 mcg / 24 hour;
2000-05-25;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65503
ENBREL;
02242903;
etanercept 25 mg / kit , water 1 ml / kit;
2001-03-14;
Subcutaneous;
Kit , Liquid , Powder For Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
IMMUNEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66735
BREVICON 0.5/35 TABLETS (28-DAY PACK);
02187094;
ethinyl estradiol .035 mg , norethindrone .5 mg;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42888
SEASONIQUE;
02346176;
ethinyl estradiol 0.01 mg , levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2011-04-18;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83160
MARVELON 28;
02042479;
ethinyl estradiol 0.03 mg , desogestrel 0.15 mg;
1993-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14355
FREYA 28;
02396610;
ethinyl estradiol 0.03 mg , desogestrel 0.15 mg;
2012-11-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88165
BREVICON 0.5/35 TABLETS (21-DAY PACK);
02187086;
ethinyl estradiol 0.035 mg , norethindrone 0.5 mg;
1976-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20162
SYNPHASIC 28 TABLETS;
02187116;
ethinyl estradiol 0.035 mg , norethindrone 0.5 mg , ethinyl estradiol 0.035 mg , norethindrone 1.0 mg;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42890
SELECT 1/35 (28-DAY);
02199297;
ethinyl estradiol 0.035 mg , norethindrone 1.0 mg;
1997-05-08;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42960
NUVARING;
02253186;
etonogestrel 11.4 mg , ethinyl estradiol 2.6 mg;
2004-12-02;
Vaginal;
Ring (Slow-Release);
68:12.00 – CONTRACEPTIVES;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73815
DEMO-CINEOL ENFANTS/CHILDREN;
00319724;
eucalyptol 185 mg , guaiacol 90 mg , camphor 20 mg , guaiacol carbonate 100 mg;
1977-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2787
DEMO-CINEOL ADULTES/ADULTS;
00319716;
eucalyptol 370 mg , guaiacol 180 mg , camphor 40 mg , guaiacol carbonate 200 mg;
1986-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6645
PEPCID COMPLETE;
02243053;
famotidine 10 mg , calcium carbonate 800 mg , magnesium hydroxide 165 mg;
2001-05-14;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS , 56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66915
ALLEGRA-D;
02239853;
fexofenadine hydrochloride 60 mg , pseudoephedrine hydrochloride 120 mg;
1999-04-29;
Oral;
Tablet (Immediate And Extended Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63341
EVICEL;
02348497;
fibrinogen (human) 90 mg / ml , thrombin (human) 1200 unit / ml;
2011-03-01;
Topical;
Solution , Kit;
20:28.16 – HEMOSTATICS;
Schedule D;
OMRIX BIOPHARMACEUTICALS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83385
CANESORAL COMBI 1 DAY;
02490935;
fluconazole 150 mg , clotrimazole 2 % / w/w;
2020-02-14;
Oral , Topical;
Capsule , Cream;
#N/A;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98097
MONICURE COMBO;
02382628;
fluconazole 150 mg , miconazole nitrate 2 %;
2012-10-25;
Oral , Topical;
Kit , Capsule , Cream;
84:04.08.08 – AZOLES , 08:14.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86844
CANESORAL COMBI;
02311739;
fluconazole 150 mg / cap , clotrimazole 1 %;
2010-03-10;
Oral , Topical , Vaginal;
Capsule , Cream;
08:14.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79728
CLOTRIMADERM-FLUCONAZOLE COMBI-PACK;
02445131;
fluconazole 150 mg / cap , clotrimazole 1 % / w/w;
2017-02-14;
Oral , Topical;
Kit , Capsule , Cream;
08:14.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93036
CLOTRIMAZOLE-FLUCONAZOLE COMBI;
02451727;
fluconazole 150 mg / cap , clotrimazole 1 % / w/w;
2017-02-03;
Oral , Topical;
Kit , Capsule , Cream;
08:14.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93803
LOCACORTEN VIOFORM EARDROPS;
00074454;
flumethasone pivalate 0.02 % , clioquinol 1 %;
1969-12-31;
Otic;
Drops;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=868
ACTIKERALL;
02428946;
fluorouracil 0.5 % / w/w , salicylic acid 10 % / w/w;
2016-02-19;
Topical;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
CIPHER PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91338
TRELEGY ELLIPTA;
02474522;
fluticasone furoate 100 mcg / act , umeclidinium (umeclidinium bromide) 62.5 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
2018-05-30;
Inhalation;
Powder;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96469
BREO ELLIPTA;
02444186;
fluticasone furoate 200 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
2015-10-02;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92906
PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI;
02494507;
fluticasone propionate 100 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
2020-03-05;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98451
WIXELA INHUB;
02495597;
fluticasone propionate 100 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
2020-02-13;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98549
PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI;
02494515;
fluticasone propionate 250 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
2020-03-05;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98452
WIXELA INHUB;
02495600;
fluticasone propionate 250 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
2020-02-13;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98550
DYMISTA;
02432889;
fluticasone propionate 50 mcg / act , azelastine hydrochloride 137 mcg / act;
2015-03-31;
Nasal;
Spray, Metered Dose;
52:02.00 – ANTIALLERGIC AGENTS , 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91729
PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI;
02494523;
fluticasone propionate 500 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
2020-03-05;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98453
WIXELA INHUB;
02495619;
fluticasone propionate 500 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
2020-02-13;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98551
SOFRAMYCIN NASAL SPRAY;
02224860;
framycetin sulfate 12.5 mg / ml , gramicidin 0.05 mg / ml , phenylephrine hydrochloride 2.5 mg / ml;
2001-05-04;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37384
SOFRACORT;
02224623;
framycetin sulfate 5 mg / ml , dexamethasone (dexamethasone sodium metasulphobenzoate) 0.5 mg / ml , gramicidin 0.05 mg / ml;
2002-07-26;
Ophthalmic , Otic;
Drops;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37363
FUCIDIN H;
02238578;
fusidic acid 2 % , hydrocortisone acetate 1 %;
1998-11-11;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62005
FUCIBET;
02474883;
fusidic acid 2 % / w/w , betamethasone (betamethasone valerate) 0.1 % / w/w;
2018-10-03;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96510
VALISONE-G;
00177016;
gentamicin (gentamicin sulfate) 0.1 % / w/w , betamethasone (betamethasone valerate) 0.1 % / w/w;
1970-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=816
ARTIFICIAL TEARS;
02354535;
glycerine 0.2 % / w/v , hypromellose 0.2 % / w/v;
2011-04-19;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83970
DRY EYE TEARS;
02389886;
glycerine 0.2 % / w/v , hypromellose 0.2 % / w/v;
2014-02-12;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87535
LUBRICANT EYE DROPS/ ARTIFICIAL TEARS;
02321696;
glycerine 0.3 % / w/v , propylene glycol 1 % / w/v;
2009-08-25;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80709
SOOTHE DRY EYES;
02242370;
glycerine 0.3 % / w/v , propylene glycol 1.0 % / w/v;
2004-12-01;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66081
PH 12 STERILE DILUENT FOR FLOLAN;
02443651;
glycine 94 mg / vial , sodium chloride 73.3 mg / vial , water 50 ml / vial;
2016-08-04;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92834
ULTIBRO BREEZHALER;
02418282;
glycopyrronium (glycopyrronium bromide) 50 mcg , indacaterol (indacaterol maleate) 110 mcg;
2014-03-05;
Inhalation;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90285
OPTIMYXIN;
00701785;
gramicidin 0.025 mg / ml , polymyxin b (polymyxin b sulfate) 10000 unit / ml;
1989-12-31;
Ophthalmic , Otic;
Drops;
52:04.04 – ANTIBACTERIALS;
Otc;
EURO-PHARM INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10025
VIADERM KC ONT;
00717029;
gramicidin 0.25 mg / g , nystatin 100000 unit / g , triamcinolone acetonide 1 mg / g , neomycin (neomycin sulfate) 2.5 mg / g;
1983-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9449
ANTIBIOTIC CREAM;
02372029;
gramicidin 0.25 mg / g , polymyxin b sulfate 10000 unit / g;
2012-03-22;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85715
CREO-RECTAL ENFANTS/CHILDREN;
00299596;
guaiacol carbonate 200 mg , diphenylpyraline hydrochloride 0.5 mg , camphor 2 mg;
1951-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2150
CREO-RECTAL ADULTES/ADULTS;
00299561;
guaiacol carbonate 600 mg , diphenylpyraline hydrochloride 1.5 mg , camphor 5 mg;
1951-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2148
ROBITUSSIN COUGH CONTROL;
01931024;
guaifenesin 100 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13296
ROBITUSSIN COUGH AND COLD;
02068419;
guaifenesin 100 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml;
1994-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16698
BUCKLEY’S CHEST CONGESTION;
02289164;
guaifenesin 100 mg / 5 ml , menthol 10 mg / 5 ml;
2007-08-07;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77454
BUCKLEY’S MUCUS & PHLEGM;
02346451;
guaifenesin 100 mg / 5 ml , menthol 10 mg / 5 ml;
2010-08-02;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83190
CALMYLIN ACE;
02198630;
guaifenesin 100 mg / 5 ml , pheniramine maleate 7.5 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
1996-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19690
VICKS DAYQUIL COUGH COUGH & CONGESTION;
02323907;
guaifenesin 200 mg / 15 ml , dextromethorphan hydrobromide 10 mg / 15 ml;
2009-09-18;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80938
ROBITUSSIN EXTRA STRENGTH COUGH CONTROL;
02142775;
guaifenesin 200 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml;
1995-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19026
BENYLIN EXTRA STRENGTH CHEST CONGESTION & COLD;
02265427;
guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
2005-09-30;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75089
BENYLIN EXTRA STRENGTH SORE THROAT & COUGH;
02479869;
guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
2019-07-02;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97024
EXTRA STRENGTH MUCOUS RELIEF COUGH;
02353563;
guaifenesin 400 mg , dextromethorphan hydrobromide 20 mg;
2011-05-17;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83878
FLUZONE QUADRIVALENT;
02420643;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
2014-10-15;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90522
FLULAVAL TETRA;
02420783;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
2015-10-14;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
ID BIOMEDICAL CORPORATION OF QUEBEC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90535
AFLURIA TETRA;
02473283;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
2019-10-25;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS PTY LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96268
AFLURIA TETRA;
02473313;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
2020-09-23;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS PTY LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96272
INFLUVAC TETRA;
02484854;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
2019-10-17;
Intramuscular , Subcutaneous;
Suspension;
80:12.00 – VACCINES;
Schedule D;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97512
FLUCELVAX QUAD;
02494248;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
2020-09-21;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98427
FLUAD;
02362384;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b 15 mcg / 0.5 ml;
2011-09-10;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84739
FLUVIRAL;
02420686;
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b 15 mcg / 0.5 ml;
2015-09-23;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
ID BIOMEDICAL CORPORATION OF QUEBEC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90524
FLUZONE QUADRIVALENT;
02432730;
haemagglutinin-strain a (h1n1) 30 mcg / ml , haemagglutinin-strain a (h3n2) 30 mcg / ml , haemagglutinin-strain b (victoria) 30 mcg / ml , haemagglutinin-strain b (yamagata) 30 mcg / ml;
2015-09-14;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91717
FLUAD PEDIATRIC;
02434881;
haemagglutinin-strain a (h1n1) 7.5 mcg / 0.25 ml , haemagglutinin-strain a (h3n2) 7.5 mcg / 0.25 ml , haemagglutinin-strain b 7.5 mcg / 0.25 ml;
2015-11-05;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91919
ACT-HIB;
01959034;
haemophilus influenzae type b-prp 10 mcg / 0.5 ml , tetanus protein 30 mcg / 0.5 ml;
1992-12-31;
Intramuscular;
Kit , Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13140
DUOBRII;
02499967;
halobetasol propionate 0.01 % / w/w , tazarotene 0.045 % / w/w;
2020-08-04;
Topical;
Lotion;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 84:06.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98967
HELIOX 70/30;
02416468;
helium 70 % , oxygen 30 %;
2014-12-22;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
VITALAIRE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90106
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ;
00828750;
heparin (heparin sodium) 2 unit / ml , sodium chloride 9 mg / ml;
1990-12-31;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10521
HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ;
02209721;
heparin sodium 10000 unit / 100 ml , dextrose 5 g / 100 ml;
1996-09-10;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36795
TWINRIX;
02230578;
hepatitis a vaccine – inactivated 720 unit / 1.0 ml , hepatitis b surface antigen (recombinant) 20 mcg / 1.0 ml;
1997-09-23;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49687
TWINRIX JUNIOR;
02237548;
hepatitis b surface antigen (recombinant) 10 mcg / 0.5 ml , hepatitis a vaccine – inactivated 360 unit / 0.5 ml;
1998-11-06;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60885
STREPSILS EXTRA BLACK CHERRY;
02263998;
hexylresorcinol 2.4 mg , levomenthol 4 mg;
2007-03-23;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74940
ULTRA-LIGHT MOISTURIZING LOTION SPF 30;
02481944;
homosalate 10 % , octisalate 5 % , avobenzone 3 % , octocrylene 2.7 %;
2019-08-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CERAVE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97242
OIL AND PORE CONTROL MATTIFIER BROAD SPECTRUM SPF 45;
02483866;
homosalate 10 % , octisalate 5 % , octocrylene 5 % , avobenzone 3 %;
2019-07-28;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97422
BROAD SPECTRUM SPF/FPS 30;
02444232;
homosalate 10 % , octocrylene 10 % , octisalate 5 % , avobenzone 3 %;
2017-06-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92916
ULTRA SHEER BODY MIST SUNSCREEN SPF 45;
02487942;
homosalate 10 % , octocrylene 10 % , octisalate 5 % , avobenzone 3 %;
2020-01-20;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97806
BANANA BOAT KIDS FREE CONTINUOUS SPRAY SUNSCREEN SPF 50+;
02440849;
homosalate 10 % , octocrylene 6 % , octisalate 5 % , avobenzone 3 %;
2016-01-04;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92520
CLEAR SUNSCREEN STICK 50+;
02501384;
homosalate 10 % / w/w , avobenzone 2.5 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w;
2021-04-12;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99101
SENSITIVE SKIN SUNSCREEN LOTION SPF 30;
02490390;
homosalate 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
2020-01-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98044
LOTION SOLAIRE CORPS FPS 30;
02504871;
homosalate 10 % / w/w , bisoctrizole 5 % / w/w , octocrylene 4.5 % / w/w , avobenzone 3 % / w/w;
2020-12-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99426
CLINIQUE SPF 30 SHEER BODY MIST;
02455048;
homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2017-05-15;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94184
LOTION SOLAIRE ANTI-ÂGE;
02425602;
homosalate 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2014-07-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91024
SUNSCREEN LIP BALM;
02501406;
homosalate 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 8 % / w/w;
2020-10-13;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99103
ULTRA SHEER FACE MIST SUNSCREEN;
02486458;
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w;
2020-01-20;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97665
PRISMA PROTECT SPF 30;
02486687;
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w;
2019-07-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMALOGICA, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97685
ÉMULSION HYDRATANTE VISAGE FPS 30;
02494205;
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2.7 % / w/w , avobenzone 3 % / w/w;
2020-12-02;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98424
DREAM URBAN COVER;
02486784;
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
2019-07-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAYBELLINE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97695
ULTRA SUN PROTECTOR LOTION LAIT SOLAIRE ULTRA PROTECTION 50+;
02497050;
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 2.3 % / w/w;
2020-12-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98691
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN SPRAY SPF 50+;
02422360;
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
2014-12-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90705
PLAY EVERYDAY LOTION;
02494949;
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 7.5 % / w/w , avobenzone 3 % / w/w;
2020-06-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98492
NATURE REPUBLIC CALIFORNIA MOISTURIZING ALOE DAILY SUN CREAM SPF 50+;
02493136;
homosalate 10 % / w/w , octisalate 5 % / w/w , titanium dioxide 4.315 % / w/w;
2019-12-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NATURE REPUBLIC CO LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98310
SPF/FPS 30;
02404338;
homosalate 10 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
2014-07-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88910
SPF 30 FPS SUNSCREEN LOTION LOTION ÉCRAN SOLAIRE;
02415321;
homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2014-05-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89994
NEUTROGENA CLEAR FACE SUNSCREEN LOTION;
02496240;
homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98611
SPF 50 FACE CREAM;
02494965;
homosalate 10 % / w/w , octocrylene 10 % / w/w , zinc oxide 7 % / w/w , octisalate 5 % / w/w;
2020-12-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98493
SPF/FPS 15;
02404362;
homosalate 10 % / w/w , octocrylene 5 % / w/w , avobenzone 2 % / w/w , octisalate 5 % / w/w;
2014-07-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88913
COPPERTONE SPRAY SUNSCREEN SPF 50 DEFEND & CARE;
02488892;
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
2020-02-07;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97894
COPPERTONE SPRAY SUNSCREEN SPF 50 KIDS;
02487705;
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2019-12-16;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97785
COPPERTONE SPRAY SUNSCREEN SPF 50 SPORT;
02487934;
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-04-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97805
SPORT 50 CONTINUOUS SPRAY SUNSCREEN ECRAN SOLAIRE EN VAPORISATEUR;
02491567;
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2019-11-01;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98155
BANANA BOAT BABY SUNSCREEN LOTION SPF/FPS 60;
02430207;
homosalate 10 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
2015-03-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91469
BANANA BOAT KIDS SUNSCREEN LOTION SPF/FPS 60;
02430215;
homosalate 10 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
2015-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91470
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN LOTION SPF/FPS 60;
02432455;
homosalate 10 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
2015-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91693
SUN SILK DROPS;
02490854;
homosalate 10 % / w/w , octocrylene 6 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
2020-07-09;
Topical;
Solution;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98089
BANANA BOAT KIDS TEAR-FREE SUNSCREEN SPRAY SPF 50+;
02464977;
homosalate 10 % / w/w , octocrylene 6 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2017-12-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95318
CRÈME SOLAIRE VISAGE TOUCHER SEC FPS 30;
02494450;
homosalate 10 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
2020-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98446
CRÈME SOLAIRE CORPS FPS 30;
02494655;
homosalate 10 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
2020-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98465
COPPERTONE LOTION SUNSCREEN SPF 50 KIDS;
02478269;
homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96902
COPPERTONE LOTION SUNSCREEN SPF 50 DEFEND & CARE;
02489791;
homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97987
OLAY REGENERIST WHIP SUN PROTECTION FACTOR 40;
02493098;
homosalate 10 % / w/w , octocrylene 9 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-05-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98307
SKIN TONE CORRECTING & BEAUTIFYING BB CREAM;
02406195;
homosalate 10.0 % / w/w , octisalate 5.0 % / w/w , octocrylene 5.0 % / w/w , titanium dioxide 4.5 % / w/w;
2013-06-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89092
EQUATE SPORT SUNSCREEN CONTINOUS SPRAY SPF/FPS 15;
02359871;
homosalate 10.0 % / w/w , octisalate 5.0 % / w/w , oxybenzone 3.0 % / w/w , avobenzone 2.0 % / w/w;
2011-03-02;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84486
PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 50;
02496801;
homosalate 13.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 10 % / w/w;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98665
PROTECT + HYDRATE FACE;
02497336;
homosalate 13.5 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98716
SUNTHERA3 KIDS/ENFANTS SPF/FPS 50 CONTINUOUS SPRAY;
02301741;
homosalate 15 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w , oxybenzone 6 % / w/w;
2008-04-03;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78709
HYDRO BOOST WATER GEL LOTION SUNSCREEN;
02496585;
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98644
ULTRA SHEER BODY MIST SUNSCREEN;
02502526;
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-01-18;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99209
ULTRA SHEER DRY-TOUCH SUNSCREEN;
02502534;
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99210
ULTRA SHEER FACE SUNSCREEN;
02502542;
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99211
EQUATE SPORT SUNSCREEN CONTINUOUS SPRAY SPF/FPS30;
02359898;
homosalate 15.0 % / w/w , octisalate 5.0 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.0 % / w/w;
2011-03-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84487
OLAY COMPLETE ALL DAY MOISTURE CREAM;
02314800;
homosalate 3 % / w/w , avobenzone 3 % / w/w , octocrylene 2.6 % / w/w , octisalate 5 % / w/w;
2009-05-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80034
OLAY COMPLETE UV365* DAILY MOISTURIZING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 15 NORMAL;
02461196;
homosalate 4 % , avobenzone 3 % , octisalate 4.5 % , octocrylene 2.6 %;
2017-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94870
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 NORMAL;
02461234;
homosalate 4 % , avobenzone 3 % , octisalate 4.5 % , octocrylene 2.6 %;
2017-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94874
CRÈME HYDRA FINISH CREAM CRÈME HYDRATATION RÉVÉLATRICE DE TEINT FPS 15 LARGE SPECTRE VISAGE MOISTURIZING COMPLEXION ENHACING CREAM SPF 15 BROAD SPECTRUM FACE;
02480441;
homosalate 4 % , octinoxate 6 %;
2019-04-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUINOT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97097
INVISIBLUR PERFECTING SHIELD BROAD SPECTRUM SPF 30 PA+++;
02433710;
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
2015-05-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91807
HYDRO BOOST GEL CREAM SPF 15;
02438240;
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
2016-01-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92261
AGE BALANCING MOISTURE BROAD SPECTRUM SPF 30 | PA+++;
02445743;
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
2017-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93102
HYDRO BOOST GEL CREAM SPF 25;
02484285;
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
2020-01-06;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97460
RAPID WRINKLE REPAIR MOISTURIZER;
02368382;
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
2012-01-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85335
RAPID TONE REPAIR MOISTURIZER;
02384159;
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
2013-01-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86990
TRIPLE AGE REPAIR MOISTURIZER;
02387557;
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
2015-01-12;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87316
DEEP MOISTURE;
02405342;
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
2015-06-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89014
ABSOLUTELY AGELESS DAILY MOISTURIZER;
02440873;
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
2016-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92523
OLAY REGENERIST ENHANCING UV LOTION WITH SPF 15;
02376466;
homosalate 4.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.6 % / w/w , octisalate 4.5 % / w/w;
2014-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86192
ORIGINS PLANTSCRIPTION SPF 25 POWER ANTI-AGING CREAM;
02444216;
homosalate 5 % , octisalate 4.5 % , avobenzone 3 % , octocrylene 2.8 %;
2016-05-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ORIGINS NATURAL RESOURCES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92912
ORIGINS PLANTSCRIPTION SPF 25 POWER ANTI-AGING OIL-FREE CREAM;
02444828;
homosalate 5 % , octisalate 4.5 % , avobenzone 3 % , octocrylene 2.8 %;
2016-05-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ORIGINS NATURAL RESOURCES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93002
BANANA BOAT SUNCOMFORT SUNSCREEN LOTION SPF 30;
02440822;
homosalate 5 % , octocrylene 4 % , avobenzone 3 %;
2017-01-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92518
LAB SERIES DAY RESCUE DEFENSE LOTION SPF 35;
02462648;
homosalate 5 % / w/w , octisalate 4.5 % / w/w , octocrylene 3.3 % / w/w , avobenzone 3 % / w/w;
2018-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LAB SERIES DIST.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95043
SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L’ÂGE VERY DRY TO DRY COMBINATION / TRÈS SÈCHE À MIXTE SPF 25 FPS;
02492083;
homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98208
EVEN TONE DAILY MOISTURIZER;
02448394;
homosalate 5 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w , avobenzone 3 % / w/w;
2016-02-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93408
KIDS SUNSCREEN STICK SPF 50+;
02488825;
homosalate 5 % / w/w , octocrylene 10 % / w/w , zinc oxide 15 % / w/w;
2019-11-11;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97890
COPPERTONE LOTION SUNSCREEN SPF 15 SUN GUARD;
02478730;
homosalate 5 % / w/w , octocrylene 3 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96948
HAWAIIAN TROPIC PROTECTIVE ARGAN DRY OIL SUNSCREEN SPRAY SPF 15;
02477874;
homosalate 5 % / w/w , octocrylene 3.5 % / w/w , avobenzone 1.5 % / w/w;
2019-02-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96872
HAWAIIAN TROPIC SILK HYDRATION WEGHTLESS FACE;
02458160;
homosalate 5.5 % , octisalate 4.5 % , octocrylene 4 % , avobenzone 2 %;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94521
SILK HYDRATION WEIGHTLESS CLEAR SUNSCREEN SPRAY SPF 30;
02455315;
homosalate 5.5 % , octocrylene 4 % , avobenzone 2 % , octisalate 4.5 %;
2017-01-03;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94213
SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 30;
02409488;
homosalate 5.5 % / w/w , octisalate 4.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
2014-02-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89418
HAWAIIAN TROPIC SHEER TOUCH CLEAR SUNSCREEN SPRAY SPF 30 ULTRA RADIANCE;
02425831;
homosalate 5.5 % / w/w , octisalate 4.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
2015-02-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91047
BB CREAM SUNSCREEN SPF 30;
02456281;
homosalate 5.9 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.4 % / w/w , avobenzone 2.2 % / w/w;
2017-01-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94317
DUO DEFENCE SUNSCREEN LOTION SPF 30;
02464934;
homosalate 6 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.5 % / w/w , avobenzone 3 % / w/w;
2017-12-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95314
BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 30;
02505304;
homosalate 6 % / w/w , octocrylene 4.5 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
2021-01-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99467
BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 30;
02505959;
homosalate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 2 % / w/w;
2021-01-25;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99531
HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS DAILY USE SUNSCREEN MIST SPRAY SPF 30;
02490919;
homosalate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 2.7 % / w/w;
2019-12-02;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98095
COPPERTONE LOTION SUNSCREEN SPF 15 GLOW;
02487969;
homosalate 6 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97808
HAWAIIAN TROPIC MATTE EFFECT MINERAL ENRICHED SUNSCREEN LOTION SPF 30;
02488310;
homosalate 6 % / w/w , zinc oxide 5.6 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.5 % / w/w;
2019-12-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97841
ULTRA FACIAL MOISTURIZER SPF 30;
02401908;
homosalate 7 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
2013-07-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88678
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN SPRAY SPF 30;
02422352;
homosalate 7 % / w/w , octocrylene 5 % / w/w , avobenzone 2 % / w/w;
2014-12-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90704
BANANA BOAT SUNCOMFORT SUNSCREEN SPRAY SPF 30;
02426722;
homosalate 7 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w , octocrylene 1.5 % / w/w;
2015-02-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91129
ANEW REVERSALIST COMPLETE RENEWAL DAY CREAM;
02414031;
homosalate 7.0 % / w/w , octinoxate 7.0 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.85 % / w/w;
2014-03-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89871
SPORT 30 LOTION SUNSCREEN LOTION ÉCRAN SOLAIRE;
02502070;
homosalate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w;
2020-10-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99167
ANEW ULTIMATE DAY MULTI-PERFORMANCE CREAM;
02431432;
homosalate 8 % / w/w , avobenzone 2.9 % / w/w , octinoxate 5 % / w/w , oxybenzone 4 % / w/w;
2015-05-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91585
COPPERTONE SPRAY SUNSCREEN SPF 30 SUN GUARD;
02478285;
homosalate 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w , octocrylene 7 % / w/w;
2020-02-05;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96904
DAILYSCREEN;
02494957;
homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
2020-05-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98488
ANTI-AGING MOISTURIZER BROAD SPECTRUM SPF 30 | PA+++;
02445751;
homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
2016-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93103
UNSEEN SUNSCREEN;
02495481;
homosalate 8 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w , avobenzone 3 % / w/w;
2020-05-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98540
MATTE DEFENSE SPF 30;
02490455;
homosalate 8 % / w/w , octisalate 5 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w;
2020-11-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMALOGICA, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98050
SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 45 ULTRA RADIANCE/ULTRA-RADIEUX;
02409496;
homosalate 8 % / w/w , octocrylene 5 % / w/w , avobenzone 2.7 % / w/w , octisalate 4.5 % / w/w;
2014-02-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89419
COPPERTONE LOTION SUNSCREEN SPF 30 SUN GUARD;
02478749;
homosalate 8 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96949
COPPERTONE SPRAY SUNSCREEN SPF 30 SPORT;
02478250;
homosalate 8 % / w/w , octocrylene 7 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
2019-12-16;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96901
ULTRA SHEER BODY MIST SUNSCREEN SPF 30;
02486474;
homosalate 8 % / w/w , octocrylene 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-01-20;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97667
HAWAIIAN TROPIC MATTE EFFECT MINERAL ENRICHED SUNSCREEN LOTION SPF 50;
02488329;
homosalate 8 % / w/w , zinc oxide 7.3 % / w/w , octocrylene 5.7 % / w/w , octisalate 4.5 % / w/w;
2019-12-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97842
ANEW VITALE DAY LOTION;
02424363;
homosalate 8.0 % / w/w , octinoxate 5.0 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.85 % / w/w;
2015-06-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90907
COMPLETE DRY MIST SPRAY HYPOALLERGENIC UVA + UVB SPF 30;
02415313;
homosalate 8.78 % / w/w , octocrylene 5.92 % / w/w , octisalate 4.88 % / w/w , avobenzone 2.96 % / w/w;
2014-03-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89993
HAUTE EXIGENCE JOUR SPF 20 MULTI-INTENSIVE;
02425289;
homosalate 9 % , avobenzone 3 % , octocrylene 2.7 %;
2015-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90992
DENTEC LOTION;
02440792;
homosalate 9 % , octinoxate 7.5 % , octisalate 5 % , oxybenzone 4 %;
2019-06-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DENTEC SAFETY SPECIALISTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92515
BANANA BOAT SUNCOMFORT SUNSCREEN LOTION SPF 50+;
02440830;
homosalate 9 % , octocrylene 5 % , avobenzone 3 %;
2017-01-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92519
HYDRA-ESSENTIEL FLUIDE FONDANT DÉSALTÉRANT PEAUX NORMALES À MIXTES FPS/SPF 15;
02471043;
homosalate 9 % , octocrylene 5 % , avobenzone 3 %;
2018-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96014
DUO DEFENCE SUNSCREEN LOTION SPF 50+;
02464926;
homosalate 9 % / w/w , octisalate 4 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
2017-12-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95312
INTO REPAIR DRY SKIN / PEAUX SÈCHES;
02489104;
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
2020-06-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97916
SUN ULTIMATE FACE CREAM / CRÈME VISAGE;
02489112;
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
2020-05-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97917
HYDRA VIZOR;
02496577;
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-12-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KENDO HOLDINGS, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98643
SUNSCREEN OIL SPRAY;
02388154;
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.4 % / w/w;
2013-01-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87370
BANANA BOAT SIMPLY PROTECT SPORT SUNSCREEN SPRAY SPF 50+;
02465051;
homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 7 % / w/w , avobenzone 3 % / w/w;
2017-12-10;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95329
BANANA BOAT SPORT FOR KIDS SUNSCREEN STICK SPF 50+;
02464861;
homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w , avobenzone 2.7 % / w/w;
2017-12-10;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95306
BANANA BOAT ULTRA SPORT SUNSCREEN STICK SPF 50+;
02464969;
homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w , avobenzone 2.7 % / w/w;
2017-12-10;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95317
MARY KAY FOUNDATION PRIMER SPF 15;
02353695;
homosalate 9 % / w/w , octisalate 5 % / w/w , octocrylene 3 % / w/w , avobenzone 2.5 % / w/w;
2012-03-16;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MARY KAY COSMETICS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83890
BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 50+;
02505967;
homosalate 9 % / w/w , octocrylene 6 % / w/w , avobenzone 2.7 % / w/w , octisalate 4.5 % / w/w;
2021-01-25;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99532
HAWAIIAN TROPIC SHEER TOUCH CLEAR SUNSCREEN SPRAY SPF 50+ ULTRA RADIANCE;
02425998;
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
2015-02-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91061
BANANA BOAT SIMPLY PROTECT KIDS SUNSCREEN LOTION SPRAY SPF 50+;
02466627;
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2017-12-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95496
OLAY REGENERIST MICRO-SCULPTING CREAM WITH SUNSCREEN;
02482177;
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2019-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97264
BANANA BOAT SIMPLY PROTECT SENSITIVE FACES VISAGES SUNCREEN LOTION SPF 50 PLUS;
02478056;
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , zinc oxide 7.3 % / w/w;
2019-01-24;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96878
BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 50+;
02505290;
homosalate 9 % / w/w , octocrylene 6.5 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
2021-01-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99466
HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 50;
02495031;
homosalate 9 % / w/w , octocrylene 7 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
2021-01-31;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98499
BANANA BOAT SIMPLY PROTECT SPORT SUNSCREEN LOTION SPF 50+;
02467445;
homosalate 9 % / w/w , octocrylene 7.5 % / w/w , avobenzone 3 % / w/w;
2017-12-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95582
COPPERTONE LOTION SUNSCREEN SPF 30 GLOW;
02488124;
homosalate 9 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97823
COPPERTONE LOTION SUNSCREEN SPF 50 WATERBABIES;
02487799;
homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97795
COPPERTONE LOTION SUNSCREEN SPF 50 GLOW;
02487950;
homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97807
COPPERTONE CLEAR SUNSCREEN SPF 50 SPORT;
02489538;
homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-02-07;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97961
BANANA BOAT SIMPLY PROTECT SENSITIVE SUNSCREEN LOTION SPF 50 PLUS;
02478064;
homosalate 9 % / w/w , zinc oxide 7.3 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w;
2019-01-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96879
FIVE STAR LIP PROTECTION;
02353822;
homosalate 9.6 % / w/w , octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 5.0 % / w/w;
2010-09-29;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83903
IRBESARTAN-HCTZ;
02365162;
hydrochlorothiazide 12.5 mg , irbesartan 150 mg;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85001
TEVA-IRBESARTAN HCTZ;
02330520;
hydrochlorothiazide 12.5 mg , irbesartan 300 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81625
ZESTORETIC;
02103729;
hydrochlorothiazide 12.5 mg , lisinopril 10 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16636
ACH-OLMESARTAN HCTZ;
02468948;
hydrochlorothiazide 12.5 mg , olmesartan medoxomil 20 mg;
2019-06-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95759
ACH-OLMESARTAN HCTZ;
02468956;
hydrochlorothiazide 12.5 mg , olmesartan medoxomil 40 mg;
2019-06-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95760
TEVA-IRBESARTAN HCTZ;
02330539;
hydrochlorothiazide 25 mg , irbesartan 300 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81626
ACH-OLMESARTAN HCTZ;
02468964;
hydrochlorothiazide 25 mg , olmesartan medoxomil 40 mg;
2019-06-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95761
AA-AMILZIDE;
00784400;
hydrochlorothiazide 50 mg , amiloride hydrochloride 5 mg;
1989-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10494
TEVA-PROCTOSONE;
02226383;
hydrocortisone (hydrocortisone acetate) 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
1997-02-03;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37454
PRAMOX HC CREAM;
00770957;
hydrocortisone (hydrocortisone acetate) 1 % , pramoxine hydrochloride 1 %;
1989-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10052
PRAMOX HC LOTION;
01954210;
hydrocortisone (hydrocortisone acetate) 1 % , pramoxine hydrochloride 1 %;
1994-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15948
SANDOZ PROCTOMYXIN HC;
02242527;
hydrocortisone 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
2001-03-09;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66275
PROCTOL OINTMENT;
02247322;
hydrocortisone 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
2003-08-06;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71565
PROCTOL SUPPOSITORIES;
02247882;
hydrocortisone 5 mg , dibucaine hydrochloride 5 mg , framycetin sulfate 10 mg , esculin 10 mg;
2004-03-15;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72190
ANUSOL-HC OINTMENT;
00505773;
hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
1981-12-31;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4389
ANODAN-HC OINTMENT;
02128446;
hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
1995-12-31;
Rectal , Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18240
JAMPZINC-HC;
02387239;
hydrocortisone acetate 0.5 % / w/w , zinc sulfate monohydrate 0.5 % / w/w;
2012-07-23;
Rectal , Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87281
PROCTOFOAM HC;
00363014;
hydrocortisone acetate 1 % , pramoxine hydrochloride 1 %;
1979-12-31;
Rectal;
Aerosol;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
DUCHESNAY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3492
ANUSOL-HC SUPPOSITORIES;
00476285;
hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
1975-12-31;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4630
ANODAN-HC 10MG SUPPOSITORIES;
02236399;
hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
1998-08-13;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59873
VISINE FOR DRY EYE EYE REVIVAL;
02436132;
hypromellose 0.2 % / w/v , glycerine 0.2 % / v/v;
2016-05-19;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92046
VISINE FOR DRY EYE TIRED EYE RELIEF;
02438585;
hypromellose 0.2 % / w/v , glycerine 0.2 % / w/v;
2016-06-07;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92296
TEARS NATURALE FREE;
01943308;
hypromellose 0.3 % / w/v , dextran 70 0.1 % / w/v;
1992-12-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13167
NIGHTTIME PAIN RELIEF;
02424630;
ibuprofen (ibuprofen – ibuprofen potassium) 200 mg , diphenhydramine hydrochloride 25 mg;
2017-10-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90931
CHILDREN’S ADVIL COLD;
02248435;
ibuprofen 100 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
2004-08-09;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72786
CHILDREN’S ADVIL COLD & FLU MULTI-SYMPTOM;
02268701;
ibuprofen 100 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml , chlorpheniramine maleate 1 mg / 5 ml;
2010-01-26;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75412
ADVIL COLD, COUGH & FLU NIGHTTIME;
02401193;
ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
2013-08-06;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88592
ADVIL DAY/NIGHT CONVENIENCE PACK;
02410583;
ibuprofen 200 mg , ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
2014-06-02;
Oral;
Kit , Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89525
ROBAX PLATINUM;
02247147;
ibuprofen 200 mg , methocarbamol 500 mg;
2003-07-02;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71388
MOTRIN PLATINUM MUSCLE & BODY;
02418967;
ibuprofen 200 mg , methocarbamol 500 mg;
2014-06-18;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90351
ADVIL COLD AND SINUS;
02036312;
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
1993-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14492
ADVIL COLD & SINUS LIQUI-GELS;
02250705;
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
2005-07-09;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73565
ADVIL COLD AND SINUS DAYTIME;
02267616;
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
2006-08-07;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75302
COLD + SINUS;
02352281;
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
2010-10-12;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83757
COLD & SINUS RELIEF CAPSULES;
02407779;
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
2014-03-20;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89248
ADVIL COLD & SINUS PLUS;
02248645;
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
2004-08-02;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73002
ADVIL COLD AND SINUS NIGHTTIME;
02267632;
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
2006-08-04;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75304
ADVIL COLD, SINUS & FLU EXTRA STRENGTH;
02471604;
ibuprofen 400 mg , pseudoephedrine hydrochloride 60 mg , chlorpheniramine maleate 4 mg;
2018-08-17;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96076
TARO-IMIPENEM-CILASTATIN;
02351692;
imipenem 250 mg / vial , cilastatin (cilastatin sodium) 250 mg / vial;
2010-08-25;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83695
IMIPENEM AND CILASTATIN FOR INJECTION USP;
02358336;
imipenem 250 mg / vial , cilastatin (cilastatin sodium) 250 mg / vial;
2010-12-21;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84339
PRIMAXIN 500;
00717282;
imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
1987-12-31;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8054
TARO-IMIPENEM-CILASTATIN;
02351706;
imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
2010-08-25;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83696
IMIPENEM AND CILASTATIN FOR INJECTION USP;
02358344;
imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
2010-12-21;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84340
IMOVAX POLIO;
01959042;
inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 40 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1 8 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 32 unit / 0.5 ml;
2007-03-22;
Subcutaneous;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44019
ENERZAIR BREEZHALER;
02501244;
indacaterol (indacaterol acetate) 150 mcg , glycopyrronium (glycopyrronium bromide) 50 mcg , mometasone furoate 160 mcg;
2020-11-05;
Inhalation;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99087
ATECTURA BREEZHALER;
02498707;
indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 160 mcg;
2020-08-19;
Inhalation;
Capsule;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98849
ATECTURA BREEZHALER;
02498693;
indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 320 mcg;
2020-08-19;
Inhalation;
Capsule;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98848
ATECTURA BREEZHALER;
02498685;
indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 80 mcg;
2020-08-19;
Inhalation;
Capsule;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98847
APO-PERINDOPRIL-INDAPAMIDE;
02453061;
indapamide 2.5 mg , perindopril erbumine 8 mg;
2021-02-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93947
FLUMIST QUADRIVALENT;
02426544;
influenza virus type a (h1n1) 32000000 ffu / 0.2 ml , influenza virus type a (h3n2) 32000000 ffu / 0.2 ml , influenza virus type b (victoria) 32000000 ffu / 0.2 ml , influenza virus type b (yamagata) 32000000 ffu / 0.2 ml;
2014-10-10;
Nasal;
Spray;
80:12.00 – VACCINES;
Schedule D;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91111
HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ);
00795879;
insulin 30 unit / ml , insulin isophane (nph) 70 unit / ml;
1989-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9788
NOVOMIX 30;
02265435;
insulin aspart 30 unit / ml , insulin aspart protamine 70 unit / ml;
2005-09-12;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75090
XULTOPHY;
02474875;
insulin degludec 100 unit / ml , liraglutide 3.6 mg / ml;
2018-06-06;
Subcutaneous;
Solution;
68:20.08 – INSULINS , 68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96506
SOLIQUA;
02478293;
insulin glargine 100 unit / ml , lixisenatide 33 mcg / ml;
2018-09-12;
Subcutaneous;
Solution;
68:20.08 – INSULINS , 68:20.06 – INCRETIN MIMETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96906
HUMULIN 30/70 CARTRIDGE;
01959212;
insulin injection human biosynthetic 30 unit / ml , insulin isophane human biosynthetic 70 unit / ml;
1992-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12568
NOVOLIN GE 30/70;
02024217;
insulin injection human biosynthetic 30 unit / ml , insulin isophane human biosynthetic 70 unit / ml;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14269
NOVOLIN GE 40/60 PENFILL;
02024314;
insulin injection human biosynthetic 40 unit / ml , insulin isophane human biosynthetic 60 unit / ml;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14262
NOVOLIN GE 50/50 PENFILL;
02024322;
insulin injection human biosynthetic 50 unit / ml , insulin isophane human biosynthetic 50 unit / ml;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14270
NOVOLIN GE 30/70 PENFILL;
02025248;
insulin isophane human biosynthetic 70 unit / ml , insulin injection human biosynthetic 30 unit / ml;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14265
HUMALOG MIX 25 (CARTRIDGE);
02240294;
insulin lispro 25 unit / ml , insulin lispro protamine suspension 75 unit / ml;
1999-07-05;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63832
HUMALOG MIX 25 (KWIKPEN);
02403420;
insulin lispro 25 unit / ml , insulin lispro protamine suspension 75 unit / ml;
2013-09-30;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88823
HUMALOG MIX 50 (CARTRIDGE);
02240297;
insulin lispro 50 unit / ml , insulin lispro protamine suspension 50 unit / ml;
2007-01-12;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63835
HUMALOG MIX 50 (KWIKPEN);
02403439;
insulin lispro 50 unit / ml , insulin lispro protamine suspension 50 unit / ml;
2014-01-23;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88824
INTRON A;
02223406;
interferon alfa-2b 10000000 unit / vial , water 1 ml / vial;
1997-03-12;
Intralesional , Intramuscular , Intravenous , Subcutaneous;
Liquid , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS , 08:18.20 – INTERFERONS;
Prescription , Schedule D;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43361
IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION;
02483394;
ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg / 2.5 ml , salbutamol (salbutamol sulfate) 2.5 mg / 2.5 ml;
2019-08-29;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97384
COMBIVENT RESPIMAT;
02419106;
ipratropium bromide (ipratropium bromide monohydrate) 20 mcg / act , salbutamol (salbutamol sulfate) 100 mcg / act;
2014-09-16;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90364
AVALIDE;
02241818;
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
2000-03-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65483
PMS-IRBESARTAN-HCTZ;
02328518;
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81403
TEVA-IRBESARTAN HCTZ;
02330512;
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81624
SANDOZ IRBESARTAN HCT;
02337428;
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82301
IRBESARTAN/HCTZ;
02372886;
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85799
IRBESARTAN HCT;
02385317;
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87095
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE;
02418223;
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90280
AVALIDE;
02241819;
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
2000-03-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65484
PMS-IRBESARTAN-HCTZ;
02328526;
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81404
SANDOZ IRBESARTAN HCT;
02337436;
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82302
IRBESARTAN-HCTZ;
02365170;
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85002
IRBESARTAN/HCTZ;
02372894;
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85800
IRBESARTAN HCT;
02385325;
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
2012-06-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87096
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE;
02418231;
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90281
PMS-IRBESARTAN-HCTZ;
02328534;
irbesartan 300 mg , hydrochlorothiazide 25 mg;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81405
SANDOZ IRBESARTAN HCT;
02337444;
irbesartan 300 mg , hydrochlorothiazide 25 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82303
IRBESARTAN-HCTZ;
02365189;
irbesartan 300 mg , hydrochlorothiazide 25 mg;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85003
IRBESARTAN/HCTZ;
02372908;
irbesartan 300 mg , hydrochlorothiazide 25 mg;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85801
IRBESARTAN HCT;
02385333;
irbesartan 300 mg , hydrochlorothiazide 25 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87097
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE;
02418258;
irbesartan 300 mg , hydrochlorothiazide 25 mg;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90282
GERMI-STAT PREP GEL;
02241528;
isopropyl alcohol 70 % , chlorhexidine gluconate 0.5 %;
2002-05-17;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65180
ORKAMBI;
02451379;
ivacaftor 125 mg , lumacaftor 200 mg;
2016-01-27;
Oral;
Tablet;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93762
COMBIVIR;
02239213;
lamivudine 150 mg , zidovudine 300 mg;
1998-12-08;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62673
APO-LAMIVUDINE-ZIDOVUDINE;
02375540;
lamivudine 150 mg , zidovudine 300 mg;
2012-06-04;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86096
TEVA-LAMIVUDINE/ZIDOVUDINE;
02387247;
lamivudine 150 mg , zidovudine 300 mg;
2012-06-06;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87285
AURO-LAMIVUDINE/ZIDOVUDINE;
02414414;
lamivudine 150 mg , zidovudine 300 mg;
2014-03-03;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89907
APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN;
02470780;
lansoprazole 30 mg / cap , amoxicillin 500 mg / cap , clarithromycin 500 mg / tab;
2018-08-03;
Oral;
Capsule (Delayed Release) , Kit , Capsule , Tablet;
08:12.12.92 – OTHER MACROLIDES , 08:12.16.08 – AMINOPENICILLINS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95983
ACT LATANOPROST/TIMOLOL;
02436256;
latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
2015-09-29;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92058
MED-LATANOPROST-TIMOLOL;
02454505;
latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
2019-08-22;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94108
LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION;
02489368;
latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
2020-07-03;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
TELIGENT CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97945
PROLOPA CAP 100-25;
00386464;
levodopa 100 mg , benserazide (benserazide hydrochloride) 25 mg;
1977-12-31;
Oral;
Capsule;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2723
AA-LEVOCARB CR;
02272873;
levodopa 100 mg , carbidopa 25 mg;
2009-02-04;
Oral;
Tablet (Extended-Release);
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75839
STALEVO;
02305941;
levodopa 100 mg , carbidopa 25 mg , entacapone 200 mg;
2008-04-28;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79151
STALEVO;
02337835;
levodopa 125 mg , carbidopa 31.25 mg , entacapone 200 mg;
2010-01-20;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82348
STALEVO;
02305968;
levodopa 150 mg , carbidopa 37.5 mg , entacapone 200 mg;
2008-04-28;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79152
PROLOPA CAP 200-50;
00386472;
levodopa 200 mg , benserazide (benserazide hydrochloride) 50 mg;
1977-12-31;
Oral;
Capsule;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2724
AA-LEVOCARB CR;
02245211;
levodopa 200 mg , carbidopa 50 mg;
2003-11-13;
Oral;
Tablet (Extended-Release);
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69226
PROLOPA CAP 50-12.5;
00522597;
levodopa 50 mg , benserazide (benserazide hydrochloride) 12.5 mg;
1981-12-31;
Oral;
Capsule;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4459
STALEVO;
02305933;
levodopa 50 mg , carbidopa 12.5 mg , entacapone 200 mg;
2008-04-28;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79150
STALEVO;
02337827;
levodopa 75 mg , carbidopa 18.75 mg , entacapone 200 mg;
2010-01-20;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82347
PORTIA 21;
02295946;
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2007-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78129
PORTIA 28;
02295954;
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2007-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78130
SEASONALE;
02296659;
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2008-01-03;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78201
INDAYO;
02398869;
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
2016-09-01;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88378
ALESSE 21;
02236974;
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
1998-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60269
ALESSE 28;
02236975;
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
1998-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60270
AVIANE 21;
02298538;
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
2007-11-05;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78383
AVIANE 28;
02298546;
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
2007-11-05;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78384
ALYSENA 21;
02387875;
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
2012-11-19;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87345
ALYSENA 28;
02387883;
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
2012-11-19;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87346
MIN-OVRAL 21;
02042320;
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
1995-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18754
MIN-OVRAL 28;
02042339;
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
1995-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18755
OVIMA 21;
02387085;
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
2013-08-27;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87265
OVIMA 28;
02387093;
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
2013-08-27;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87266
XYLONOR;
02218607;
lidocaine 15 g / 100 g , cetrimide 150 mg / 100 g;
1997-03-26;
Buccal;
Spray, Metered Dose;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37164
EMLA PATCH;
02057794;
lidocaine 2.5 % , prilocaine 2.5 %;
1994-12-31;
Topical;
Patch;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16733
XYLONOR GEL;
00479896;
lidocaine 5 g / 100 g , cetrimonium bromide 150 mg / 100 g;
1981-12-31;
Topical;
Gel;
52:16.00 – LOCAL ANESTHETICS;
Otc;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4410
PLIAGLIS;
02398028;
lidocaine 7 % , tetracaine 7 %;
2015-09-28;
Topical;
Cream;
72:00.00 – LOCAL ANESTHETICS;
Prescription;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88297
INSTILLAGEL;
02294990;
lidocaine hydrochloride (lidocaine hydrochloride monohydrate) 2 % / w/w , chlorhexidine gluconate 0.05 % / w/w;
2007-12-06;
Urethral;
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78032
XYLOCAINE 1% W EPINEPHRINE 1:100000;
00001791;
lidocaine hydrochloride 10 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
1954-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=589
XYLOCAINE 1% W EPINEPHRINE 1:200000;
00001805;
lidocaine hydrochloride 10 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
1954-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=590
BACTINE FIRST AID SPRAY;
02150379;
lidocaine hydrochloride 2.5 % / w/w , benzalkonium chloride 0.13 % / w/w;
1995-12-31;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
WELLSPRING PHARMACEUTICAL CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19488
XYLOCAINE 2% WITH EPINEPHRINE 1:200000;
02373130;
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
2012-04-25;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85829
OCTOCAINE HCL 2% EPINEPHRINE 1:100000;
00151866;
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
1964-12-31;
Subcutaneous;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=636
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP;
02436221;
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
2016-01-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92056
OCTOCAINE HCL 2% EPINEPHRINE 1:50000;
00151874;
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.02 mg / ml;
1964-12-31;
Subcutaneous;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=635
XYLOCAINE DENTAL LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:50,000;
02345072;
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.02 mg / ml;
2010-07-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83052
XYLOCAINE 2% W EPINEPHRINE 1:200000;
00284106;
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
1965-12-31;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1830
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP;
01901915;
lidocaine hydrochloride 20 mg / ml , epinephrine 0.01 mg / ml;
1989-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12648
XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000;
02331640;
lidocaine hydrochloride 20.00 mg / ml , epinephrine 0.01 mg / ml;
2009-10-19;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81732
LIGNOSPAN FORTE;
00375799;
lidocaine hydrochloride 36 mg / 1.8 ml , epinephrine (epinephrine bitartrate) 36 mcg / 1.8 ml;
1976-12-31;
Block/Infiltration;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2506
LIGNOSPAN STANDARD;
00375780;
lidocaine hydrochloride 36 mg / 1.8 ml , epinephrine 18 mcg / 1.8 ml;
1976-12-31;
Block/Infiltration;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2541
LIDOCAINE PLUS MENTHOL;
02485338;
lidocaine hydrochloride 4 % / w/w , menthol 1 % / w/w;
2019-05-21;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
THE MENTHOLATUM COMPANY OF CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97558
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION;
00828602;
lidocaine hydrochloride 4 mg / ml , dextrose 50 mg / ml;
1990-12-31;
Intravenous;
Solution;
24:04.04.08 – CLASS IB ANTIARRYTHMICS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10519
TPR20;
02309076;
lidocaine hydrochloride 5 % / w/w , menthol 1 % / w/w;
2009-05-05;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
HUMN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79467
JENTADUETO;
02403277;
linagliptin 2.5 mg , metformin hydrochloride 1000 mg;
2013-04-17;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88809
JENTADUETO;
02403250;
linagliptin 2.5 mg , metformin hydrochloride 500 mg;
2013-04-17;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88807
COTAZYM;
00263818;
lipase 10000 unit , amylase 40000 unit , protease 35000 unit;
1973-12-31;
Oral;
Capsule (Immediate Release);
56:16.00 – DIGESTANTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1649
COTAZYM ECS 8;
00502790;
lipase 10800 unit , amylase 42000 unit , protease 45000 unit;
1980-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3891
PANCREASE MT 16;
00789429;
lipase 16800 unit , amylase 70000 unit , protease 40000 unit;
1988-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
VIVUS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9512
VIOKACE;
02241933;
lipase 20880 unit , protease 112500 unit , amylase 113400 unit;
2000-06-02;
Oral;
Tablet;
56:16.00 – DIGESTANTS;
Prescription;
NESTLE ENTERPRISES S.A.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65603
PANCREASE MT 20;
02503441;
lipase 21000 unit , amylase 61000 unit , protease 37000 unit;
2020-12-21;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription , Schedule D;
VIVUS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99292
COTAZYM ECS 20;
00821373;
lipase 25000 unit , amylase 100000 unit , protease 100000 unit;
1989-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9892
CREON MINIMICROSPHERES 25;
01985205;
lipase 25000 unit , amylase 25500 unit , protease 1600 unit;
1992-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13302
PANCREASE MT 2;
02503433;
lipase 2600 unit , amylase 10850 unit , protease 6200 unit;
2020-12-21;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription , Schedule D;
VIVUS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99291
CREON MINIMICROSPHERES 35;
02494639;
lipase 35000 unit , amylase 35700 unit , protease 2240 unit;
2021-01-26;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98463
PANCREASE MT 4;
00789445;
lipase 4200 unit , amylase 17500 unit , protease 10000 unit;
1988-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
VIVUS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9514
CREON MINIMICROSPHERES MICRO;
02445158;
lipase 5000 unit / 100 mg , amylase 5100 unit / 100 mg , protease 320 unit / 100 mg;
2015-11-18;
Oral;
Granules For Suspension, Delayed Release;
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93037
TEVA-LISINOPRIL/HCTZ (TYPE Z);
02301768;
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78710
TEVA-LISINOPRIL/HCTZ (TYPE P);
02302136;
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
2007-11-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78744
SANDOZ LISINOPRIL HCT;
02302365;
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78769
LISINOPRIL/HCTZ (TYPE Z);
02362945;
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
2011-06-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84793
TEVA-LISINOPRIL/HCTZ (TYPE Z);
02301776;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78711
TEVA-LISINOPRIL/HCTZ (TYPE P);
02302144;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
2007-11-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78745
SANDOZ LISINOPRIL HCT;
02302373;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78770
LISINOPRIL/HCTZ (TYPE Z);
02362953;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
2011-06-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84794
TEVA-LISINOPRIL/HCTZ (TYPE Z);
02301784;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78712
TEVA-LISINOPRIL/HCTZ (TYPE P);
02302152;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
2007-11-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78746
SANDOZ LISINOPRIL HCT;
02302381;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78771
LISINOPRIL/HCTZ (TYPE Z);
02362961;
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
2011-06-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84795
ZESTORETIC;
02045737;
lisinopril 20 mg , hydrochlorothiazide 12.5 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16903
ZESTORETIC;
02045729;
lisinopril 20 mg , hydrochlorothiazide 25 mg;
1995-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17903
IMODIUM COMPLETE;
02245185;
loperamide hydrochloride 2 mg , simethicone 125 mg;
2002-06-20;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69200
KALETRA;
02312301;
lopinavir 100 mg , ritonavir 25 mg;
2008-08-11;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79781
KALETRA;
02285533;
lopinavir 200 mg , ritonavir 50 mg;
2006-09-08;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77104
KALETRA;
02243644;
lopinavir 400 mg / 5 ml , ritonavir 100 mg / 5 ml;
2001-03-09;
Oral;
Solution;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67570
CLARITIN ALLERGY + SINUS;
01945157;
loratadine 5 mg , pseudoephedrine sulfate 120 mg;
1991-12-31;
Oral;
Tablet (Immediate And Extended Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11974
HYZAAR;
02297841;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2007-09-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78318
SANDOZ LOSARTAN HCT;
02362449;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84745
TEVA-LOSARTAN/HCTZ;
02377144;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86273
LOSARTAN HCT;
02388979;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2012-07-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87450
MINT-LOSARTAN/HCTZ;
02389665;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2012-07-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87516
PMS-LOSARTAN-HCTZ;
02392232;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2012-09-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87751
AURO-LOSARTAN HCT;
02423650;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90836
LOSARTAN/HCTZ;
02427656;
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
2014-07-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91216
HYZAAR DS;
02241007;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2000-01-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64599
SANDOZ LOSARTAN HCT DS;
02313383;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79891
TEVA-LOSARTAN/HCTZ;
02377152;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86274
LOSARTAN HCT;
02388987;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2012-07-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87451
PMS-LOSARTAN-HCTZ;
02392240;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2012-09-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87752
JAMP-LOSARTAN HCTZ;
02408252;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89298
AURO-LOSARTAN HCT;
02423669;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90837
LOSARTAN/HCTZ;
02427664;
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
2014-07-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91217
MINT-LOSARTAN/HCTZ DS;
02389673;
losartan potassium 100.0 mg , hydrochlorothiazide 25.0 mg;
2012-07-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87517
HYZAAR;
02230047;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
1996-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48580
SANDOZ LOSARTAN HCT;
02313375;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79890
LOSARTAN HCT;
02388960;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
2012-07-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87449
MINT-LOSARTAN/HCTZ;
02389657;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
2012-07-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87515
PMS-LOSARTAN-HCTZ;
02392224;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
2012-09-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87750
JAMP-LOSARTAN HCTZ;
02408244;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89297
AURO-LOSARTAN HCT;
02423642;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90835
LOSARTAN/HCTZ;
02427648;
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
2014-07-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91215
TEVA-LOSARTAN/HCTZ;
02358263;
losartan potassium 50.0 mg , hydrochlorothiazide 12.5 mg;
2012-04-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84332
ORKAMBI;
02463040;
lumacaftor 100 mg , ivacaftor 125 mg;
2017-05-03;
Oral;
Tablet;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95094
ORKAMBI;
02483831;
lumacaftor 100 mg / sachet , ivacaftor 125 mg / sachet;
2018-12-14;
Oral;
Granules;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97420
ORKAMBI;
02483858;
lumacaftor 150 mg / sachet , ivacaftor 188 mg / sachet;
2018-12-14;
Oral;
Granules;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97421
LUBRICATING NASAL GEL;
02220806;
macrogol 15 % , propylene glycol 20 %;
1997-01-17;
Nasal;
Gel;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37257
RHINARIS NASAL GEL;
02352699;
macrogol 15 % , propylene glycol 20 %;
2011-11-24;
Nasal;
Gel;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83795
EYE STREAM;
00707937;
magnesium chloride 0.03 % / w/v , sodium chloride 0.64 % / w/v , potassium chloride 0.075 % / w/v , calcium chloride 0.048 % / w/v;
1987-12-31;
Ophthalmic;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7474
PRISM0CAL;
02274876;
magnesium chloride 0.108 g / 1000 ml , sodium chloride 6.449 g / 1000 ml , lactic acid 0.284 g / 1000 ml , sodium bicarbonate 58.8 g / 1000 ml;
2005-12-24;
Intravenous , Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76040
PRISM0CAL B22K0/0;
02441691;
magnesium chloride 3.05 g / l , sodium chloride 7.14 g / l , sodium bicarbonate 2.12 g / l;
2016-06-18;
Intravenous , Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92609
GELUSIL ANTACID AND ANTI-GAS;
02409836;
magnesium hydroxide 200 mg , aluminum hydroxide-sucrose dried gel 200 mg , simethicone 25 mg;
2014-01-14;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
BOYD PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89449
DIOVOL PLUS ALUMINUM FREE;
02157624;
magnesium hydroxide 200 mg , simethicone 25 mg , calcium carbonate 200 mg;
1995-12-31;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19075
STOMAAX PLUS;
00623709;
magnesium hydroxide 200 mg / 5 ml , aluminum hydroxide 200 mg / 5 ml , dimethicone 25 mg / 5 ml;
1989-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10217
ARIDOL;
02489562;
mannitol 5 mg / cap , mannitol 10 mg / cap , mannitol 20 mg / cap , mannitol 40 mg / cap;
2020-06-15;
Inhalation;
Kit , Powder;
36:00.00 – DIAGNOSTIC AGENTS;
Prescription Recommended;
PHARMAXIS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97957
CYSTOSOL W 3% HEXITOLS;
00799963;
mannitol 500 mg / 100 ml , sorbitol 2.5 g / 100 ml;
1989-12-31;
Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9829
PROQUAD;
02399229;
measles virus vaccine live attenuated (edmonston b strain) 3.00 log10 tcid50 / 0.5 ml , mumps virus vaccine live attenuated (jeryl lynn strain) 4.30 log10 tcid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 3.00 log10 tcid50 / 0.5 ml , varicella-zoster virus vaccine live attenuated (oka/merck strain) 3.99 log10 pfu / 0.5 ml;
2014-05-09;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88411
M-M-R II;
00466085;
measles virus vaccine live attenuated 1000 unit / 0.5 ml , mumps virus vaccine live attenuated (jeryl lynn strain) 5000 unit / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 unit / 0.5 ml;
1979-12-31;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3569
TELEBRIX 38 ORAL;
02131684;
meglumine ioxitalamate 513 mg / ml , sodium ioxitalamate 255 mg / ml;
1995-12-31;
Oral;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
LIEBEL-FLARSHEIM CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17800
ALKERAN;
02087286;
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
1995-12-31;
Intra-Arterial , Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18786
MELPHALAN FOR INJECTION;
02468921;
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
2018-11-20;
Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95758
MELPHALAN FOR INJECTION;
02473348;
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
2018-06-18;
Intra-Arterial , Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96274
TARO-MELPHALAN;
02480026;
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
2021-01-25;
Intra-Arterial , Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97057
MENJUGATE LIQUID;
02440709;
meningococcal group c oligosaccharide 10 mcg / 0.5 ml , corynebacterium diphtheriae crm-197 protein 25 mcg / 0.5 ml;
2015-10-07;
Intramuscular;
Suspension;
80:08.00 – TOXOIDS , 80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92507
NEISVAC-C;
02245057;
meningococcal polysaccharide vaccine grp c 10 mcg / 0.5 ml , tetanus toxoid 20 mcg / 0.5 ml;
2002-01-21;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69061
MENACTRA;
02279924;
meningococcal polysaccharide-diphtheria toxoid conjugate – group a 4.0 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group c 4.0 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group y 4.0 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group w 135 4.0 mcg / 0.5 ml;
2006-10-20;
Intramuscular;
Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76550
GOLD BOND ANTI-ITCH LOTION;
02318482;
menthol 0.5 % / w/w , pramoxine hydrochloride 1 % / w/w , dimethicone 5 % / w/w;
2009-03-05;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80397
GOLD BOND MEDICATED ANTI-ITCH CREAM;
02236991;
menthol 1 % / w/w , pramoxine hydrochloride 1 % / w/w;
1999-01-11;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60289
ABSORBINE JR LINIMENT;
01942301;
menthol 1.25 % , chloroxylenol 0.5 %;
1993-12-31;
Topical;
Liquid;
84:24.04 – BASIC LOTIONS AND LINIMENTS;
Otc;
CLARION BRANDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42113
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM;
02320940;
menthol 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
2009-07-21;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80636
BUCKLEY’S NIGHTTIME COUGH & CONGESTION;
02230939;
menthol 22 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml;
1997-06-23;
Oral;
Syrup;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50217
ABSORBINE JR EXTRA STRENGTH LINIMENT;
01942271;
menthol 4.0 % , chloroxylenol 0.5 %;
1992-12-31;
Topical;
Liquid;
84:24.04 – BASIC LOTIONS AND LINIMENTS;
Otc;
CLARION BRANDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41939
ISOCAINE HCL INJ 2%;
00393711;
mepivacaine hydrochloride 20 mg / ml , corbadrine 0.05 mg / ml;
1977-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2744
CARBOCAINE 2% WITH NEO-COBEFRIN;
02474182;
mepivacaine hydrochloride 20 mg / ml , corbadrine 0.05 mg / ml;
2019-07-30;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96421
MARCELLE/ OIL FREE MULTI-DÉFENSE LOTION SPF 15 FPS/ FLUIDE MULTI-DÉFENSE SANS HUILE;
02093006;
meradimate 4.0 % , ensulizole 2.0 % , octinoxate 7.5 %;
1994-12-31;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42376
JENTADUETO;
02403269;
metformin hydrochloride 850 mg , linagliptin 2.5 mg;
2013-04-17;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88808
MUSCLE & BACK PAIN RELIEF CAPLETS;
02230790;
methocarbamol 400 mg , acetaminophen 325 mg;
1997-04-08;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50062
MUSCLE AND BACK PAIN RELIEF REGULAR STRENGTH TABLETS;
02251876;
methocarbamol 400 mg , acetaminophen 325 mg;
2005-11-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73677
ROBAXACET-8;
01934767;
methocarbamol 400 mg , acetaminophen 325 mg , codeine phosphate 8 mg;
1992-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12942
ROBAXACET EXTRA STRENGTH;
02231176;
methocarbamol 400 mg , acetaminophen 500 mg;
1997-07-07;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50484
EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF;
02239141;
methocarbamol 400 mg , acetaminophen 500 mg;
1999-06-04;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62597
EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF;
02251884;
methocarbamol 400 mg , acetaminophen 500 mg;
2005-09-19;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73678
EXTRA STRENGTH TYLENOL BODY PAIN NIGHT;
02357356;
methocarbamol 400 mg , acetaminophen 500 mg;
2011-03-30;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84247
MUSCLE AND BACK PAIN RELIEF;
02451298;
methocarbamol 400 mg , acetaminophen 500 mg;
2018-04-03;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93755
ROBAXISAL C 1/2;
01934791;
methocarbamol 400 mg , acetylsalicylic acid 325 mg , codeine phosphate 32.4 mg;
1992-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12946
ROBAXISAL EXTRA STRENGTH;
02230949;
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
1997-07-07;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50227
MUSCLE RELAXANT AND BACK PAIN RELIEF EXTRA STRENGTH TABLETS;
02251906;
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
2009-02-23;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73680
EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG;
02252228;
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
2005-05-01;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73710
EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA;
02426625;
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
2014-09-04;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91119
ROBAXISAL C 1/4;
01934783;
methocarbamol 400 mg , codeine phosphate 16.2 mg , acetylsalicylic acid 325 mg;
1992-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12944
MUSCLE AND BACK PAIN PLATINUM RELIEF;
02422042;
methocarbamol 500 mg , ibuprofen 200 mg;
2014-06-17;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90673
ANALGESIC AND MUSCLE RELAXANT;
02377462;
methocarbamol 500 mg , ibuprofen 400 mg;
2012-03-20;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86317
DEPO-MEDROL WITH LIDOCAINE;
00260428;
methylprednisolone acetate 40 mg / ml , lidocaine hydrochloride 10 mg / ml;
1973-12-31;
Intra-Articular , Intrabursal;
Suspension;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1619
FLAGYSTATIN;
01926829;
metronidazole 500 mg , nystatin 100000 unit;
1979-12-31;
Vaginal;
Suppository;
84:04.04 – ANTIBIOTICS , 84:04.08.28 – POLYENES;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12654
MONISTAT 7 DUAL-PAK;
02126257;
miconazole nitrate 100 mg / sup , miconazole nitrate 2 %;
1994-12-31;
Topical , Vaginal;
Suppository , Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16611
MONISTAT 1 COMBINATION PACK;
02239600;
miconazole nitrate 1200 mg / sup , miconazole nitrate 2 %;
1999-02-26;
Topical , Vaginal;
Suppository , Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63070
MONISTAT 3 DUAL-PAK;
02126249;
miconazole nitrate 400 mg / sup , miconazole nitrate 2 %;
1986-12-31;
Topical , Vaginal;
Ovule , Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16610
MIFEGYMISO;
02444038;
mifepristone 200 mg , misoprostol 200 mcg;
2017-01-10;
Buccal , Oral;
Kit , Tablet;
76:00.00 – OXYTOCICS , 56:28.28 – PROSTAGLANDINS;
Prescription;
LINEPHARMA INTERNATIONAL LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92881
MAGNOLAX;
00202045;
mineral oil 0.25 ml / ml , magnesium hydroxide 60 mg / ml;
1972-12-31;
Oral;
Emulsion;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1281
SYSTANE OINTMENT;
02444062;
mineral oil 3 % , lanolin 3 % , white petrolatum 94 %;
2016-03-01;
Ophthalmic;
Ointment;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92885
SOOTHE RESTORE;
02465302;
mineral oil 4.5 % , mineral oil light 1 %;
2018-05-03;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95350
REFRESH LACRI-LUBE;
00210889;
mineral oil 42.5 % , white petrolatum 57.3 %;
1989-12-31;
Ophthalmic;
Ointment;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9820
HUILE DE BAIN THERAPEUTIQUE;
01939068;
mineral oil 91.7 % , lanolin 3 %;
1992-12-31;
Topical;
Solution;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12947
POLLINEX R;
00464988;
modified ragweed tyrosine adsorbate 210 unit / ml , modified ragweed tyrosine adsorbate 500 unit / ml , modified ragweed tyrosine adsorbate 1400 unit / ml , modified ragweed tyrosine adsorbate 4300 unit / ml;
1979-12-31;
Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALLERGY THERAPEUTICS (UK) LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3409
ZENHALE;
02361752;
mometasone furoate 100 mcg / act , formoterol fumarate dihydrate 5 mcg / act;
2011-03-10;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84680
ZENHALE;
02361760;
mometasone furoate 200 mcg / act , formoterol fumarate dihydrate 5 mcg / act;
2011-06-17;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84681
PRIORIX;
02239208;
mumps virus vaccine live attenuated (jeryl lynn strain) 10000 ccid50 / 0.5 ml , measles virus vaccine live attenuated 1000 ccid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 ccid50 / 0.5 ml , water 0.5 ml;
1998-12-04;
Intramuscular , Subcutaneous;
Kit , Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62666
PRIORIX-TETRA;
02297884;
mumps virus vaccine live attenuated (jeryl lynn strain) 25118.9 ccid50 / 0.5 ml , measles virus vaccine live attenuated 1000 ccid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 ccid50 / 0.5 ml , varicella-zoster virus vaccine live attenuated (oka/merck strain) 1995.2623 ccid50 / 0.5 ml;
2008-06-04;
Intramuscular , Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78322
TEVA-BUPRENORPHINE/NALOXONE;
02453908;
naloxone (naloxone hydrochloride dihydrate) 0.5 mg , buprenorphine (buprenorphine hydrochloride) 2 mg;
2017-09-28;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94043
CONTRAVE;
02472945;
naltrexone hydrochloride 8 mg , bupropion hydrochloride 90 mg;
2018-03-16;
Oral;
Tablet (Extended-Release);
28:20.08.92 – Anorexigenic Agents, Miscellaneous;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96230
CLEAR EYES ALLERGY;
02248059;
naphazoline hydrochloride 0.012 % , glycerine 0.26 % , zinc sulfate 0.25 %;
2004-03-24;
Ophthalmic;
Liquid;
52:32.00 – VASOCONSTRICTORS;
Otc;
PRESTIGE BRANDS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72379
NAPHCON A;
00481408;
naphazoline hydrochloride 0.025 % , pheniramine maleate 0.3 %;
1980-12-31;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3743
OPTI-TEARS ALLERGY;
02445573;
naphazoline hydrochloride 0.025 % , pheniramine maleate 0.3 %;
2017-04-04;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93086
SOOTHE ALLERGY;
00750794;
naphazoline hydrochloride 0.02675 % / w/v , pheniramine maleate 0.315 % / w/v;
1987-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8155
CLEAR EYES EXTRA STRENGTH REDNESS RELIEF;
02360837;
naphazoline hydrochloride 0.03 % / w/v , glycerine 0.50 % / w/v;
2011-04-27;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
PRESTIGE BRANDS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84583
VIMOVO;
02361701;
naproxen 375 mg , esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
2011-02-04;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84676
MYLAN-NAPROXEN/ESOMEPRAZOLE MR;
02458608;
naproxen 375 mg , esomeprazole (esomeprazole magnesium) 20 mg;
2017-02-27;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94575
VIMOVO;
02361728;
naproxen 500 mg , esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
2011-02-04;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84677
MYLAN-NAPROXEN/ESOMEPRAZOLE MR;
02443449;
naproxen 500 mg , esomeprazole (esomeprazole magnesium) 20 mg;
2017-02-10;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92813
ALEVE NIGHTTIME;
02444593;
naproxen sodium 220 mg , diphenhydramine hydrochloride 25 mg;
2016-02-24;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92965
TRUMENBA;
02468751;
neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a 60 mcg / 0.5 ml , neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b 60 mcg / 0.5 ml;
2018-01-31;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95723
OXYGEN USP, NITROGEN NF, MEDICAL GAS MIXTURE;
02014378;
nitrogen 50 % , oxygen 50 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13894
NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML;
02145308;
nitroglycerin 20 mg / 100 ml , dextrose 5 g / 100 ml;
1995-12-31;
Intravenous;
Solution;
24:12.08 – NITRATES AND NITRITES;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18086
NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML;
02145316;
nitroglycerin 40 mg / 100 ml , dextrose 5 g / 100 ml;
1995-12-31;
Intravenous;
Solution;
24:12.08 – NITRATES AND NITRITES;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18085
LIQUI-MED ANALGESIC GAS;
00693596;
nitrous oxide 50 % , oxygen 50 %;
1983-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6850
ALNOX GAS;
02071010;
nitrous oxide 50 % , oxygen 50 %;
1995-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
AIR LIQUIDE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18513
EVRA;
02248297;
norelgestromin 200 mcg / 24 hour , ethinyl estradiol 35 mcg / 24 hour;
2003-12-24;
Transdermal;
Patch (Extended Release);
68:12.00 – CONTRACEPTIVES;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72637
SYNPHASIC 21 TABLETS;
02187108;
norethindrone 0.5 mg , ethinyl estradiol 0.035 mg , norethindrone 1.0 mg , ethinyl estradiol 0.035 mg;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42889
BREVICON 1/35 TABLETS (21-DAY PACK);
02189054;
norethindrone 1 mg , ethinyl estradiol 0.035 mg;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42921
BREVICON 1/35 TABLETS (28-DAY PACK);
02189062;
norethindrone 1 mg , ethinyl estradiol 0.035 mg;
1996-09-16;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42922
SELECT 1/35 (21-DAY);
02197502;
norethindrone 1.0 mg , ethinyl estradiol 0.035 mg;
1997-05-08;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42952
LOLO;
02417456;
norethindrone acetate 1 mg , ethinyl estradiol 10 mcg , ethinyl estradiol 10 mcg;
2014-03-24;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90215
MINESTRIN 1/20;
00343838;
norethindrone acetate 1 mg , ethinyl estradiol 20 mcg;
1975-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2254
MINESTRIN 1/20;
00315966;
norethindrone acetate 1 mg , ethinyl estradiol 20 mcg;
1975-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2255
LOESTRIN 1.5/30;
00297143;
norethindrone acetate 1.5 mg , ethinyl estradiol 30 mcg;
1974-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1922
LOESTRIN 1.5/30;
00353027;
norethindrone acetate 1.5 mg , ethinyl estradiol 30 mcg;
1976-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2386
COPHYLAC;
02224577;
normethadone hydrochloride 10 mg / ml , p-hydroxyephedrine hydrochloride 20 mg / ml;
1997-01-23;
Oral;
Drops;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37358
THERADERM CREAM;
02022818;
nystatin 100000 unit / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g , triamcinolone acetonide 1 mg / g;
1993-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BIMEDA-MTC ANIMAL HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15598
BANANA BOAT SUNSCREEN OIL SPRAY HUILE ÉCRAN SOLAIRE EN VAPORISATEUR SPF FPS 4;
02242583;
octinoxate 2 % / w/w , padimate o 1.4 % / w/w;
2001-03-15;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66357
ALMOST POWDER MAKEUP TEINT POUDRE NATUREL SPF 18 / FPS 18;
02482991;
octinoxate 2 % / w/w , titanium dioxide 1.2 % / w/w;
2019-06-01;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97339
AGE RENEWAL SPF 25;
02393093;
octinoxate 2.5 % / w/w , avobenzone 2.5 % / w/w;
2013-05-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87834
CC CREAM BROAD SPECTRUM SPF 30;
02426145;
octinoxate 2.5 % / w/w , homosalate 7.0 % / w/w , oxybenzone 2.0 % / w/w , titanium dioxide 4.1 % / w/w;
2014-09-02;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91075
M.A.C STUDIO FIX FLUID SPF 15;
02328259;
octinoxate 2.5 % / w/w , titanium dioxide 1.0 % / w/w;
2010-03-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81378
RADIANT DEFENSE;
02475014;
octinoxate 3.49 % / w/w , titanium dioxide 3.2 % / w/w , zinc oxide 3.74 % / w/w;
2018-09-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96529
LE FOND DE TEINT;
02458284;
octinoxate 3.9 % / w/w , titanium dioxide 3.3 % / w/w;
2017-09-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94538
ELIZABETH ARDEN NOURISHING LIP BALM SPF 20;
02392895;
octinoxate 4 % / w/w , avobenzone 3 % / w/w;
2013-02-11;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87816
ARTISTRY HYDRA-V SHEER WEIGHTLESS FOUNDATION;
02463490;
octinoxate 4 % / w/w , zinc oxide 2.74 % / w/w;
2018-05-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95157
EXPERT FINISH MAKEUP BROAD SPECTRUM SPF 25;
02409798;
octinoxate 4.0 % / w/w , titanium dioxide 5.2 % / w/w;
2014-01-22;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89446
CERAMIDE LIFT AND FIRM EYE CREAM SPF 15;
02354470;
octinoxate 4.09 % / w/w , oxybenzone 1.40 % / w/w;
2011-03-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83964
PREVAGE ANTI-AGING EYE CREAM SPF 15;
02355302;
octinoxate 4.09 % / w/w , oxybenzone 1.40 % / w/w;
2010-10-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84055
CLÉ DE PEAU BEAUTÉ RADIANT CREAM FOUNDATION;
02446952;
octinoxate 4.4 % / w/w , titanium dioxide 1.2 % / w/w;
2016-07-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93252
UV LIP COLOR SPLASH;
02463989;
octinoxate 4.9 % / w/w , octocrylene 3 % / w/w , avobenzone 2.5 % / w/w , oxybenzone 2 % / w/w;
2018-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95208
FUTURE SOLUTION LX UNIVERSAL DEFENSE;
02436248;
octinoxate 4.9 % / w/w , octocrylene 3 % / w/w , zinc oxide 15.4 % / w/w , oxybenzone 1 % / w/w;
2016-04-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92057
BENEFIANCE WRINKLERESIST24 DAY EMULSION;
02356007;
octinoxate 4.9 % / w/w , octocrylene 5.0 % / w/w , avobenzone 0.8 % / w/w;
2011-02-01;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84118
BENEFIANCE WRINKLERESIST24 DAY CREAM;
02356015;
octinoxate 4.9 % / w/w , octocrylene 5.0 % / w/w , avobenzone 0.8 % / w/w;
2011-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84119
PHELITYL DAY LOTION SPF 15;
02383314;
octinoxate 5 % , avobenzone 2 %;
2012-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ERNO LASZLO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86907
MAC STUDIO FINISH CONCEALER SPF 35;
02248338;
octinoxate 5 % , titanium dioxide 2 %;
2004-01-05;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72680
TEINT LUMIÈRE;
02434016;
octinoxate 5 % / w/w , titanium dioxide 1.52 % / w/w;
2015-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91835
M.A.C. STUDIO WATERWEIGHT SPF 30 FOUNDATION;
02437376;
octinoxate 5 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 2.1 % / w/w;
2015-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92171
ESTEE LAUDER DOUBLE WEAR NUDE WATER FRESH MAKEUP SPF 30;
02459868;
octinoxate 5 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 2.2 % / w/w;
2017-07-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94717
SUPERDEFENSE CITY BLOCK DAILY ENERGY + FACE PROTECTOR SPF 50;
02492970;
octinoxate 5 % / w/w , zinc oxide 3.6 % / w/w , titanium dioxide 3.2 % / w/w;
2020-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98295
CLINIQUE EVEN BETTER MAKEUP SPF 15;
02367998;
octinoxate 5.9 % / w/w , titanium dioxide 3.5 % / w/w , zinc oxide 2.8 % / w/w;
2012-03-01;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85281
CLINIQUE REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY;
02370425;
octinoxate 5.90 % / w/w , titanium dioxide 3.70 % / w/w , zinc oxide 2.90 % / w/w;
2012-03-01;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85558
BRONZ REPAIR SEA AND TROPICS FACE;
02455250;
octinoxate 6 % , avobenzone 2.6 %;
2016-09-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94207
BRIGHT SKIN MOISTURIZER SPF 30;
02392704;
octinoxate 6 % , zinc oxide 4.5 %;
2012-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87795
RED CURRANT PROTECTIVE MOISTURIZER SPF 30;
02410281;
octinoxate 6 % , zinc oxide 4.5 %;
2013-09-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89494
BUTTERSTICK;
02466716;
octinoxate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
2019-06-05;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95506
OLAY AGE DEFYING ADVANCED WITH HYALURONIC ACID HYDRATING MOISTURIZER LOTION WITH SUNSCREEN;
02460874;
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
2018-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94836
OLAY AGE DEFYING CLASSIC DAILY RENEWAL LOTION WITH SUNSCREEN;
02460882;
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
2017-09-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94837
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 SENSITIVE;
02461242;
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
2018-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94873
OLAY COMPLETE UV365* DAILY MOISTURIZING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 15 SENSITIVE;
02461250;
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94875
OLAY SENSITIVE;
02492792;
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
2020-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98279
TROPICAL VANILLA BODY SPF 32;
02330679;
octinoxate 6.00 % , zinc oxide 5.00 %;
2009-08-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81642
TROPICAL VANILLA SUN CREAM;
02330687;
octinoxate 6.00 % , zinc oxide 5.00 %;
2009-08-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81643
SOOTHING CARE;
02416611;
octinoxate 6.00 % / w/w , avobenzone 2.50 % / w/w , octocrylene 1.85 % / w/w;
2014-06-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90120
SPF 50 CLASSIC FACE SPORT COOLA CLASSIC SUNSCREEN WHITE TEA MOISTURIZER;
02464543;
octinoxate 6.25 % / w/w , avobenzone 3 % / w/w;
2018-05-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95268
EXTRA LASTING CREAM-TO-POWDER FOUNDATION;
02358387;
octinoxate 6.34 % / w/w , titanium dioxide 3.00 % / w/w;
2011-06-22;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84344
MARY KAY CC CREAM;
02414430;
octinoxate 6.5 % / w/w , homosalate 5.0 % / w/w , oxybenzone 1.2 % / w/w;
2014-02-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MARY KAY COSMETICS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89908
COMPLETE MOISTURE;
02475189;
octinoxate 6.6 % , octisalate 4.4 %;
2020-04-24;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96549
SUPERFRUIT SOOTHER;
02487160;
octinoxate 6.6 % , octisalate 4.4 %;
2019-05-28;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97729
ULTRA-RICH HYDRATION;
02487926;
octinoxate 6.6 % / w/w , octisalate 4.4 % / w/w;
2019-11-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97804
SHADE AND ILLUMINATE SOFT RADIANCE FOUNDATION SPF 50;
02491494;
octinoxate 6.7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 3.8 % / w/w , ensulizole 2.7 % / w/w;
2020-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TOM FORD BEAUTY DIST.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98149
FUTURIST HYDRA RESCUE MOISTURIZING MAKEUP FOND DE TEINT HYDRATANT SPF/FPS 45;
02494604;
octinoxate 6.7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 3.8 % / w/w , ensulizole 2.7 % / w/w;
2020-02-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98460
HEALTHY GLOW ALL-IN-ONE TINTED MOISTURIZER BROAD SPECTRUM SPF 25;
02496909;
octinoxate 6.7 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 1.3 % / w/w;
2020-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SMASHBOX COSMETICS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98678
CC CREAM CORRECTION COMPLETE COMPLETE CORRECTION FPS 50 / SPF 50;
02486849;
octinoxate 6.8 % , titanium dioxide 4 % , zinc oxide 15.2 %;
2019-07-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CHANEL CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97701
RENEWED HOPE IN A JAR SPF 30;
02461676;
octinoxate 7 % / w/w , avobenzone 2.7 % / w/w , octocrylene 2 % / w/w;
2017-10-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
HFC PRESTIGE INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94933
AMOREPACIFIC COLOR CONTROL CUSHION COMPACT;
02462621;
octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
2018-02-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95041
IOPE AIR CUSHION;
02488299;
octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
2019-08-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97839
SULWHASOO PERFECTING CUSHION;
02491117;
octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
2019-10-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98113
ANEW VITALE DAY CREAM;
02419181;
octinoxate 7.0 % / w/w , octisalate 4.5 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.8 % / w/w;
2014-09-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90373
MAC STUDIO SCULPT SPF 15 FOUNDATION;
02311143;
octinoxate 7.0 % / w/w , titanium dioxide 2.0 % / w/w;
2009-02-06;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79674
FLAWLESS FUTURE;
02417928;
octinoxate 7.14 % / w/w , octisalate 4.75 % / w/w , oxybenzone 4.00 % / w/w , avobenzone 3.00 % / w/w;
2014-07-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90252
FUTURE SOLUTION LX TOTAL PROTECTIVE EMULSION E;
02461951;
octinoxate 7.4 % , octocrylene 2 % , avobenzone 1.5 % , oxybenzone 1 %;
2017-09-08;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94971
FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E;
02461943;
octinoxate 7.4 % , octocrylene 3 % , avobenzone 2 % , oxybenzone 1.5 %;
2017-09-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94970
COLOR-SMART DAY MOISTURIZER HYDRATANT JOUR CORRECTEUR DE TEINT BROAD SPECTRUM SPF 30 FPS 30 A LARGE SPECTRE;
02480565;
octinoxate 7.4 % , titanium dioxide 4.5 %;
2019-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97111
COLOR-SMART DAY MOISTURIZER OIL-FREE HYDRATANT JOUR CORRECTEUR DE TEINT SANS CORPS GRAS BROAD SPECTRUM SPF 30 FPS;
02480573;
octinoxate 7.4 % , titanium dioxide 5.3 %;
2019-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97112
SHISEIDO IBUKI PROTECTIVE MOISTURIZER;
02404850;
octinoxate 7.4 % / w/w , avobenzone 2.5 % / w/w , octocrylene 2 % / w/w , oxybenzone 1 % / w/w;
2013-09-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88968
CLÉ DE PEAU BEAUTÉ CRÈME POUR LES MAINS;
02420910;
octinoxate 7.4 % / w/w , avobenzone 2.5 % / w/w , octocrylene 2.0 % / w/w;
2014-11-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90550
CLINIQUE FOR MEN SPF 21 MOISTURIZER;
02271508;
octinoxate 7.4 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , oxybenzone 2.0 % / w/w;
2006-11-28;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75697
ULTRA SUN PROTECTION CREAM;
02429306;
octinoxate 7.4 % / w/w , octocrylene 3.0 % / w/w , zinc oxide 16.4 % / w/w , titanium dioxide 1.4 % / w/w;
2015-03-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91373
ULTRA SUN PROTECTION LOTION;
02429314;
octinoxate 7.4 % / w/w , octocrylene 3.0 % / w/w , zinc oxide 16.4 % / w/w , titanium dioxide 1.4 % / w/w;
2015-03-16;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91374
UV PROTECTIVE COMPACT FOUNDATION (REFILL);
02424002;
octinoxate 7.4 % / w/w , octocrylene 5 % / w/w , titanium dioxide 11.8 % / w/w;
2016-03-14;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90873
ANTI-AGING COMPLEX EYE TREATMENT BROAD SPECTRUM SPF 15;
02404842;
octinoxate 7.4 % / w/w , zinc oxide 6.5 % / w/w;
2013-08-28;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88967
BEAUTY BOOSTER LIP GLOSS SPF 15;
02461838;
octinoxate 7.5 % , avobenzone 2 %;
2017-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TRISH MCEVOY LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94957
DORMER 211 FACE CREAM SPF 15;
02035472;
octinoxate 7.5 % , avobenzone 2 % , oxybenzone 3 %;
1995-12-31;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DORMER LABORATORIES INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18554
SUNSCREEN LOTION SPF 30;
02473844;
octinoxate 7.5 % , avobenzone 2.5 % , ensulizole 2 %;
2018-08-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VIVIER CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96351
DYNAMIC SKIN RECOVERY SPF 50;
02466007;
octinoxate 7.5 % , avobenzone 3 %;
2018-05-31;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMALOGICA, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95427
ULTRA CALMING DAILY MOISTURIZER SPF 15;
02260255;
octinoxate 7.5 % , avobenzone 3 % , octisalate 2 %;
2005-08-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74548
MARCELLE/MULTI-DEFENSE CREAM/CRÈME MULTI-DÉFENSE/SPF 15 FPS;
02093014;
octinoxate 7.5 % , ensulizole 2.0 % , meradimate 4.0 %;
1994-12-31;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42377
ADAPTASUN SUN CARE LOTION SEA AND TROPICS BODY / LAIT DE SOIN SOLAIRE MER ET TROPIQUES CORPS SPF/FPS 35;
02452642;
octinoxate 7.5 % , homosalate 3 % , avobenzone 2.5 %;
2016-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93901
DRY OIL SUNSCREEN;
02431041;
octinoxate 7.5 % , homosalate 5.0 % , octisalate 5.0 % , oxybenzone 3.0 %;
2015-03-09;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91549
SOFTLIPS SLIMS;
02240701;
octinoxate 7.5 % , octisalate 3 % , oxybenzone 3 %;
2001-02-01;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE MENTHOLATUM COMPANY OF CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64289
MEDICATED LIP BALM;
02481847;
octinoxate 7.5 % , octisalate 5 %;
2018-12-31;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE MENTHOLATUM COMPANY OF CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97233
HYDRATANT DÉFENSE FPS 30;
02468808;
octinoxate 7.5 % , octocrylene 5 % , octisalate 5 % , avobenzone 3 %;
2018-04-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95734
AVON SUN LIP BALM SPF 15;
02240745;
octinoxate 7.5 % , oxybenzone 2 %;
2000-04-06;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64334
DEEP MOISTURE RENEWAL WITH SPF 15;
02308576;
octinoxate 7.5 % , oxybenzone 2.5 %;
2008-09-11;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79420
SUN-SHADES LIP BALM SPF 15 – PINA COLADA STK;
02045613;
octinoxate 7.5 % , oxybenzone 3 %;
1994-12-31;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MELALEUCA OF CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42332
AVON MOISTURE SHIELD-TINTED SPF 15 CRM;
02050773;
octinoxate 7.5 % , oxybenzone 3.5 %;
1996-09-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=32792
REPLENISHING MOISTURE LOTION SPF 15;
02300605;
octinoxate 7.5 % , oxybenzone 5 % , octisalate 5 %;
2007-11-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
H.J. SUTTON INDUSTRIES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78589
LIP BALM SPF 30;
02305283;
octinoxate 7.5 % , oxybenzone 5.5 % , octisalate 3.0 %;
2008-06-09;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CROC BLOC PRODUCTS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79082
HYDRAPHASE UV;
02256940;
octinoxate 7.5 % , terephthalylidene dicamphor sulfonic acid 4.0 % , titanium dioxide 2.5 %;
2004-09-23;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74217
THE RADIANT SKINTINT SPF 30;
02430746;
octinoxate 7.5 % , titanium dioxide 5.3 % , octisalate 2 %;
2015-05-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAX HUBER RESEARCH LABS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91518
PERFECTING MAKEUP BROAD SPECTRUM SPF 25;
02410869;
octinoxate 7.5 % , titanium dioxide 7.1 %;
2013-10-29;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89550
REVERSA CRÈME ANTI-RIDES CONTOUR DES YEUX FPS 15;
02241273;
octinoxate 7.5 % / w/w , avobenzone 2 % / w/w , octisalate 5 % / w/w;
2002-04-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64883
CRÈME DE JOUR;
02232205;
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w;
1998-01-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51733
MATRIX SUPPORT WITH SUNSCREEN BROAD SPECTRUM SPF 30;
02470527;
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
2018-09-24;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NEOSTRATA COMPANY, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95951
SHEER HYDRATION SUNSCREEN BROAD SPECTRUM SPF 40;
02482010;
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
2019-12-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NEOSTRATA COMPANY, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97249
ARTISTRY YOUTH XTEND PROTECTING CREAM;
02391023;
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , oxybenzone 1 % / w/w;
2013-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87640
ARTISTRY YOUTH XTEND PROTECTING LOTION;
02391031;
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , oxybenzone 1 % / w/w;
2013-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87641
LIFT SPF 15;
02355795;
octinoxate 7.5 % / w/w , ensulizole 1.7 % / w/w;
2010-10-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84099
BOBBI BROWN EXTRA REPAIR MOISTURIZING BALM SPF 25;
02368714;
octinoxate 7.5 % / w/w , homosalate 5.0 % / w/w , oxybenzone 3.0 % / w/w , avobenzone 2.0 % / w/w;
2012-01-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85370
SUN ULTIMATE SPRAY SPF/FPS 30;
02450585;
octinoxate 7.5 % / w/w , homosalate 7 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
2016-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93674
CLINIQUE FIT WORKOUT MAKEUP SPF 40;
02462613;
octinoxate 7.5 % / w/w , octisalate 2 % / w/w , titanium dioxide 1.6 % / w/w;
2018-02-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95039
OLAY COMPLETE ALL DAY MOISTURE WITH SUNSCREEN BROAD SPECTRUM SPF 30 SENSITIVE;
02422379;
octinoxate 7.5 % / w/w , octisalate 2.5 % / w/w , octocrylene 2.5 % / w/w , zinc oxide 7.0 % / w/w;
2015-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90706
BABY LIPS;
02369486;
octinoxate 7.5 % / w/w , octisalate 3.0 % / w/w;
2011-12-06;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAYBELLINE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85441
BOBBI BROWN LIP BALM SPF 15;
02397579;
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , avobenzone 3.0 % / w/w;
2013-06-03;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88251
CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 VERY DRY TO DRY;
02384825;
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
2012-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87051
CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 DRY COMBINATION TO COMBINATION OILY;
02384833;
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
2012-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87052
CLINIQUE REPAIRWEAR LASER FOCUS LINE SMOOTHING CREAM SPF 15 VERY DRY TO DRY COMBINATION;
02440547;
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
2015-11-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92492
MAGIX FACE PERFECTOR;
02309068;
octinoxate 7.5 % / w/w , octisalate 4.0 % / w/w;
2008-07-24;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79466
MATTE MOISTURIZER SPF 15;
02274345;
octinoxate 7.5 % / w/w , octisalate 4.0 % / w/w , avobenzone 2.5 % / w/w;
2006-02-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KAMINS DERMATOLOGICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75980
MOISTURE SURGE SHEERTINT HYDRATOR SPF 25;
02492059;
octinoxate 7.5 % / w/w , octisalate 4.5 % / w/w , titanium dioxide 3.8 % / w/w , zinc oxide 3.6 % / w/w;
2020-02-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98206
ANEW PLATINUM DAY CREAM;
02353873;
octinoxate 7.5 % / w/w , octisalate 4.75 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.85 % / w/w;
2011-01-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83908
FOUNDATION PRIMER PLUS SPF 15;
02368455;
octinoxate 7.5 % / w/w , octisalate 5 % / w/w;
2011-07-26;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85341
LIP CONDITIONER SPF 15;
02368463;
octinoxate 7.5 % / w/w , octisalate 5 % / w/w;
2011-06-30;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85343
ESTEE LAUDER DAYWEAR MULTI-PROTECTION SHEER TINT RELEASE MOISTURIZER SPF 15 ALL SKINTYPES;
02246876;
octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 2.0 % / w/w;
2003-08-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71101
ESTEE LAUDER ADVANCED TIME ZONE AGE REVERSING LINE/WRINKLE CREME OIL-FREE SPF 15 FOR NORMAL/COMBINATION SKIN;
02392887;
octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87815
CORRECTION CODE (A.M.) DAILY MOISTURIZER BROAD SPECTRUM SPF 25;
02399288;
octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 3.0 % / w/w , avobenzone 3.0 % / w/w;
2013-09-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ALOETTE COSMETICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88418
VITAMIN C GLOW-PROTECT LOTION SPF 30;
02351498;
octinoxate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
2011-02-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83677
MARCELLE CITY HIGH PROTECTION URBAN DAY CREAM SOIN JOUR HAUTE PROTECTION URBAINE SPF 30 FPS;
02464721;
octinoxate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2017-12-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95286
SPF/FPS 30 ECO-LUX SIZE/FORMAT ÉCOLUX BODY / CORPS;
02482169;
octinoxate 7.5 % / w/w , octocrylene 7 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w;
2020-07-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97263
SPF/FPS 30 BODY/CORPS;
02483955;
octinoxate 7.5 % / w/w , octocrylene 7 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w;
2019-07-26;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97425
ARTISTRY YOUTH XTEND LIFTING SMOOTHING FOUNDATION;
02435829;
octinoxate 7.5 % / w/w , oxybenzone 0.5 % / w/w;
2015-12-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92017
TIMELESS ILLUMINATING MAKEUP BROAD SPECTRUM SPF 30;
02460327;
octinoxate 7.5 % / w/w , oxybenzone 2 % / w/w;
2017-03-28;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94764
FLAWLESS EFFECT LIQUID FOUNDATION BROAD SPECTRUM SPF 15;
02306441;
octinoxate 7.5 % / w/w , oxybenzone 3 % / w/w;
2008-06-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79215
MARCELLE SHEER TINT MOISTURIZER HYDRATANT TEINTÉ TRANSLUCIDE SPF 30 FPS;
02464748;
octinoxate 7.5 % / w/w , oxybenzone 3 % / w/w;
2019-02-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95288
CHAPSTICK MOISTURIZER;
02229613;
octinoxate 7.5 % / w/w , oxybenzone 3.5 % / w/w;
1997-08-22;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47540
SUN AND SNOW SPORT SPF 15;
02363909;
octinoxate 7.5 % / w/w , oxybenzone 3.5 % / w/w;
2011-07-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DAVID ASTLEY AND COMPANY INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84886
MARCELLE REVIVAL+ SKIN RENEWAL ANTI-AGING DAY CREAM SPF 15;
02462079;
octinoxate 7.5 % / w/w , oxybenzone 4 % / w/w , ensulizole 2.5 % / w/w;
2017-06-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94981
REVERSA CREME FPS30;
02435101;
octinoxate 7.5 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
2015-05-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91939
MEANINGFUL BEAUTY CINDY CRAWFORD SKIN BRIGHTENING DÉCOLLETÉ AND NECK TREATMENT SPF 15;
02367505;
octinoxate 7.5 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2014-11-26;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUTHY-RENKER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85235
MOISTURIZING ANTIOXIDANT DAY CRÈME SPF 20;
02361639;
octinoxate 7.5 % / w/w , oxybenzone 5.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w;
2013-12-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUTHY-RENKER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84670
BOBBI BROWN SKIN FOUNDATION SPF 15;
02310430;
octinoxate 7.5 % / w/w , titanium dioxide 1.0 % / w/w;
2009-02-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79607
CLINIQUE REPAIRWEAR LASER FOCUS LINE SMOOTHING CREAM SPF 15 COMBINATION OILY TO OILY;
02440539;
octinoxate 7.5 % / w/w , titanium dioxide 1.5 % / w/w;
2015-11-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92491
ESTEE LAUDER PERFECTIONIST YOUTH-INFUSING MAKEUP SPF 25;
02405113;
octinoxate 7.5 % / w/w , titanium dioxide 1.9 % / w/w;
2014-07-15;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88994
LA MER THE SOFT FLUID LONG WEAR FOUNDATION SPF 20;
02447622;
octinoxate 7.5 % / w/w , titanium dioxide 1.9 % / w/w;
2016-10-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAX HUBER RESEARCH LABS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93320
RÉNERGIE LIFT;
02438615;
octinoxate 7.5 % / w/w , titanium dioxide 3.1 % / w/w;
2017-07-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92299
RÉNERGIE LIFT MAKEUP;
02495546;
octinoxate 7.5 % / w/w , titanium dioxide 3.2 % / w/w;
2020-09-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98544
SHEER DEFENSE TINTED MOISTURIZER BROAD SPECTRUM SPF 15 M50;
02317591;
octinoxate 7.5 % / w/w , titanium dioxide 4.19 % / w/w;
2009-05-13;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80309
SHEER DEFENSE TINTED MOISTURIZER BROAD SPECTRUM SPF 15 ML40;
02317605;
octinoxate 7.5 % / w/w , titanium dioxide 4.37 % / w/w;
2009-04-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80312
SHEER DEFENSE TINTED MOISTURIZER BROAD SPECTRUM SPF 15 ML30;
02317613;
octinoxate 7.5 % / w/w , titanium dioxide 4.79 % / w/w;
2009-04-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80313
SHEER DEFENSE TINTED MOISTURIZER BROAD SPECTRUM SPF 15 L20;
02317621;
octinoxate 7.5 % / w/w , titanium dioxide 5.02 % / w/w;
2009-04-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80314
SHEER DEFENSE TINTED MOISTURIZER BROAD SPECTRUM SPF 15 L10;
02317648;
octinoxate 7.5 % / w/w , titanium dioxide 5.12 % / w/w;
2009-04-13;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80315
CLINIQUE MOISTURE SURGE CC CREAM HYDRATING COLOUR CORRECTOR SPF 30;
02402114;
octinoxate 7.5 % / w/w , titanium dioxide 5.2 % / w/w , octisalate 5.0 % / w/w , zinc oxide 3.2 % / w/w;
2013-05-20;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88698
SUPER SHEER SUNSCREEN LOTION SPF 50;
02337576;
octinoxate 7.5 % / w/w , zinc oxide 10.5 % / w/w;
2011-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMATOLOGIC COSMETIC LABORATORIES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82315
CLINIQUE SPF 30 WITH SOLARSMART+ OIL-FREE FACE CREAM;
02455587;
octinoxate 7.5 % / w/w , zinc oxide 5 % / w/w , titanium dioxide 4.6 % / w/w , octisalate 4.5 % / w/w;
2017-05-14;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94240
CLINIQUE SUPER CITY BLOCK OIL-FREE DAILY FACE PROTECTOR SPF 40;
02404265;
octinoxate 7.5 % / w/w , zinc oxide 6.0 % / w/w , titanium dioxide 5.2 % / w/w , octisalate 2.0 % / w/w;
2015-02-06;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88905
ELTAMD SKINCARE UV FACIAL SPF 30;
02322277;
octinoxate 7.5 % / w/w , zinc oxide 7 % / w/w;
2010-01-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80773
INDEFENSE30;
02461161;
octinoxate 7.5 % / w/w , zinc oxide 7 % / w/w;
2017-04-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INDEED LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94866
ELTAMD SKINCARE UV CLEAR;
02496291;
octinoxate 7.5 % / w/w , zinc oxide 9 % / w/w;
2020-06-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98618
PREVENTION + DAILY MATTE MOISTURIZER OIL-FREE;
02437554;
octinoxate 7.5 % / w/w , zinc oxide 9.0 % / w/w;
2015-02-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
IMAGE INTERNATIONAL MANUFACTURING LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92188
PREVENTION + DAILY ULTIMATE PROTECTION MOISTURIZER;
02437597;
octinoxate 7.5 % / w/w , zinc oxide 9.0 % / w/w , octisalate 5.0 % / w/w;
2015-02-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
IMAGE INTERNATIONAL MANUFACTURING LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92192
DAILY MOISTURIZING CREAM SPF 15;
02246994;
octinoxate 7.5 g / 100 g , oxybenzone 3 g / 100 g , octisalate 3 g / 100 g;
2005-09-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VIVIER CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71227
REVERSA UV FLUIDE HYDRATANT NON GRAS FPS 15;
02245318;
octinoxate 8.5 % , oxybenzone 4.0 % , avobenzone 2 %;
2002-03-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69344
PROTECTIVE PROTECTRICE SUNSCREEN SPRAY LOTION LOTION ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 8;
02406209;
octisalate 1.4 % / w/w , octocrylene 1.4 % / w/w , avobenzone 1.2 % / w/w;
2014-06-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89093
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 30 SENSITIVE;
02461188;
octisalate 2.5 % , octinoxate 7.5 % , octocrylene 2.5 % , zinc oxide 6.9 %;
2018-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94867
OLAY TOTAL EFFECTS 7 IN ONE TONE CORRECTING MOISTURIZER WITH SUNSCREEN;
02306972;
octisalate 3 % , avobenzone 2 % , octocrylene 3 %;
2009-01-22;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79265
PROTECTIVE PROTECTRICE SUNSCREEN SPRAY LOTION LOTION ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 15;
02406217;
octisalate 3 % / w/w , octocrylene 2 % / w/w , avobenzone 1.5 % / w/w;
2014-06-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89094
MAKEUP SETTING SPRAY PULVÉRISATION POUR FIXER LE MAQUILLAGE;
02482444;
octisalate 3.94 % / w/w , avobenzone 3 % / w/w , homosalate 3.6 % / w/w;
2020-07-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97289
BEAUTY BALM INSTANT SOLUTIONS BROAD SPECTRUM SPF 35;
02461846;
octisalate 4 % , octinoxate 7.5 % , oxybenzone 2.5 %;
2017-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TRISH MCEVOY LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94958
SUN AND SNOW SPORT SPRAY SPF 30;
02247403;
octisalate 4 % , octocrylene 8 % , octinoxate 6 % , oxybenzone 5 %;
2004-04-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DAVID ASTLEY AND COMPANY INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71649
OLAY REGENERIST WHIP;
02463938;
octisalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w , homosalate 8 % / w/w;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95202
OLAY TOTAL EFFECTS WHIP;
02463946;
octisalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w , homosalate 8 % / w/w;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95203
SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF/FPS 15;
02440105;
octisalate 4.5 % , homosalate 3 % , octocrylene 3 % , avobenzone 1.5 %;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92449
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 COMBINATION/OILY;
02461269;
octisalate 4.5 % , homosalate 4 % , avobenzone 3 % , octocrylene 2.6 %;
2017-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94877
OLAY TOTAL EFFECTS 7IN1 ANTI-AGING MOISTURIZER WITH SUNSCREEN BROAD SPECTRUM SPF 15;
02424665;
octisalate 4.5 % , homosalate 4.0 % , avobenzone 3.0 % , octocrylene 2.6 %;
2014-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90934
SHEER TOUCH TOUCHER SOYEUX OIL-FREE SUNSCREEN ÉCRAN SOLAIRE SANS HUILE SPF/FPS 50+;
02454572;
octisalate 4.5 % , homosalate 9 % , octocrylene 6 % , avobenzone 3 %;
2016-10-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94128
ESTÉE LAUDER RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME CRÈME TRI-PEPTIDE VISAGE ET COU SPF/FPS 15;
02482614;
octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
2019-03-26;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97304
ESTEE LAUDER RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME CRÈME TRI-PEPTIDE VISAGE ET COU SPF/FPS 15 DRY SKIN PEAUX SÈCHES;
02488566;
octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
2020-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97865
SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 15;
02409461;
octisalate 4.5 % / w/w , homosalate 3 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89417
OLAY TOTAL EFFECTS 7IN1 FEATHERWEIGHT MOISTURIZER WITH SUNSCREEN;
02424517;
octisalate 4.5 % / w/w , homosalate 4.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.6 % / w/w;
2015-01-12;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90920
HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF 30;
02440113;
octisalate 4.5 % / w/w , homosalate 5.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92450
HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF 50;
02440121;
octisalate 4.5 % / w/w , homosalate 8 % / w/w , octocrylene 5 % / w/w , avobenzone 2.7 % / w/w;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92451
COPPERTONE MOUSSE SUNSCREEN SPF 50 WATERBABIES;
02479702;
octisalate 4.5 % / w/w , homosalate 9 % / w/w , octocrylene 9 % / w/w , avobenzone 3 % / w/w;
2020-02-07;
Topical;
Aerosol, Foam;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97035
PHOTO REGUL CREAM / CRÈME;
02470799;
octisalate 5 % , octinoxate 4.9 % , homosalate 4 % , avobenzone 3 %;
2018-04-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95984
ELTAMD SKINCARE UV SPORT SPF 50;
02314924;
octisalate 5 % , octinoxate 7.5 % , zinc oxide 9 %;
2010-03-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80045
SUN AND SNOW SPORT LOTION SPF 30;
02247404;
octisalate 5 % , octocrylene 2 % , octinoxate 7.5 % , oxybenzone 6 %;
2004-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DAVID ASTLEY AND COMPANY INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71650
SUNSCREEN CONTINUOUS SPRAY SPF 30 SPORT;
02493772;
octisalate 5 % , octocrylene 5 % , avobenzone 3 % , homosalate 7.5 %;
2020-02-27;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98377
BABY MINERAL SUNSCREEN LOTION;
02466805;
octisalate 5 % , titanium dioxide 3 % , zinc oxide 6 %;
2018-03-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95516
ESTEE LAUDER DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME SPF 15 FOR NORMAL/ COMBINATION SKIN;
02352605;
octisalate 5 % / w/w , avobenzone 3 % / w/w;
2011-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83786
ÉMULSION HYDRATANTE ANTIRIDES;
02425556;
octisalate 5 % / w/w , avobenzone 3 % / w/w;
2014-07-01;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91019
CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER VERY DRY TO DRY;
02440067;
octisalate 5 % / w/w , avobenzone 3 % / w/w;
2016-01-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92445
CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER DRY COMBINATION;
02440075;
octisalate 5 % / w/w , avobenzone 3 % / w/w;
2016-01-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92446
CLINIQUE PEP-START HYDRORUSH MOISTURIZER SPF 20;
02453673;
octisalate 5 % / w/w , avobenzone 3 % / w/w;
2017-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94023
CLINIQUE FOR MEN SUPER ENERGIZER SPF 25 ANTI-FATIGUE HYDRATING CONCENTRATE;
02473836;
octisalate 5 % / w/w , avobenzone 3 % / w/w;
2019-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96352
SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L’ÂGE COMBINATION OILY TO OILY / MIXTE À GRASSE SPF 25 FPS;
02492024;
octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98203
SPORT FOR KIDS SUNSCREEN LOTION SPRAY SPF 50+;
02456044;
octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 6 % / w/w;
2017-01-03;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94289
ESTEE LAUDER DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME SPF 15 FOR DRY SKIN;
02352613;
octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 2 % / w/w;
2011-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83787
ALOE SOOTHING MOISTURE LOTION SPF 15;
02450739;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 2.9 % / w/w , octocrylene 2.2 % / w/w;
2016-12-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93688
SEAWEED OIL-CONTROL LOTION SPF 15;
02450747;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 2.9 % / w/w , octocrylene 2.2 % / w/w;
2017-02-24;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93689
DAILY MOISTURIZING LOTION SPF 15;
02317508;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 1.7 % / w/w , oxybenzone 3 % / w/w;
2010-02-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80302
ESTEE LAUDER DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME OIL-FREE SPF 25;
02371316;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
2011-12-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85647
ESTEE LAUDER RESILIENCE LIFT FIRMING/SCULPTING FACE AND NECK CREME SPF 15 FOR NORMAL/COMBINATION SKIN;
02380633;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
2013-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86642
ESTEE LAUDER RESILIENCE LIFT FIRMING/SCULPTING FACE AND NECK CREME SPF 15 FOR DRY SKIN;
02380641;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
2013-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86643
ESTEE LAUDER RESILIENCE LIFT FIRMING/SCULPTING FACE AND NECK CREME OIL-FREE SPF 15 FOR NORMAL/COMBINATION SKIN;
02392879;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87814
ULTRA LIFT ANTI-WRINKLE FIRMING MOISTURIZING CREAM;
02419076;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 3 % / w/w;
2014-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90361
MOISTURE RESCUE SPF 15;
02448351;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w;
2016-06-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93405
CETAPHIL PRO DERMACONTROL OIL CONTROL MOISTURIZER;
02374536;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 7 % / w/w;
2012-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85986
NO7 PROTECT & PERFECT INTENSE ADVANCED DAY CREAM;
02453541;
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 7.5 % / w/w;
2017-01-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94010
SUN EXPERT;
02455471;
octisalate 5 % / w/w , homosalate 4 % / w/w , octinoxate 7.5 % / w/w , avobenzone 2.5 % / w/w;
2016-06-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94228
BLUE THERAPY MOISTURIZING CREAM DRY SKIN SPF 15;
02387565;
octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , terephthalylidene dicamphor sulfonic acid 1 % / w/w;
2012-09-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BIOTHERM CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87317
BLUE THERAPY MOISTURIZING CREAM NORMAL/COMBINATION SKIN SPF 15;
02387573;
octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , terephthalylidene dicamphor sulfonic acid 1 % / w/w;
2012-09-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BIOTHERM CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87318
NEUTROGENA MOISTURE OIL-FREE SPF 15;
02416905;
octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
2015-08-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90151
NEUTROGENA HEALTHY SKIN ANTI-WRINKLE CREAM SPF 15;
02416913;
octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
2015-04-23;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90152
CLINIQUE SUPERDEFENSE DAILY DEFENSE MOISTURIZER SPF 20 COMBINATION OILY TO OILY;
02409208;
octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89392
CLINIQUE SUPERDEFENSE DAILY DEFENSE MOISTURIZER SPF 20 VERY DRY TO DRY COMBINATION;
02409216;
octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89393
ESTEE LAUDER ADVANCED TIME ZONE AGE REVERSING LINE/WRINKLE CREME SPF 15 FOR NORMAL/COMBINATION SKIN;
02380870;
octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , octinoxate 7.5 % / w/w;
2012-11-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86663
CLINIQUE EVEN BETTER SKIN TONE CORRECTING MOISTURIZER SPF 20;
02322072;
octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.7 % / w/w;
2009-08-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80748
CLINIQUE EVEN BETTER LOTION SPF 20;
02375354;
octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.7 % / w/w;
2012-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86076
CLINIQUE EVEN BETTER HAND CREAM SPF 15;
02375281;
octisalate 5.0 % / w/w , homosalate 3.0 % / w/w , avobenzone 3.0 % / w/w;
2012-03-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86068
FIRMARINE DAY CREAM SPF 30 CRÈME DE JOUR SPF 30;
02389681;
octisalate 5.0 % / w/w , octinoxate 7.5 % / w/w , avobenzone 3.0 % / w/w;
2012-09-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ERNO LASZLO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87518
HYDRAPHASE UV INTENSE;
02362058;
octisalate 5.0 % / w/w , octocrylene 7.0 % / w/w , avobenzone 3.0 % / w/w , homosalate 4.7 % / w/w;
2011-08-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84707
NEUTROGENA HEALTHY SKIN FACE LOTION SPF 15;
02404753;
octisalate 5.0 % / w/w , oxybenzone 4.0 % / w/w , octocrylene 3.0 % / w/w , avobenzone 1.5 % / w/w;
2015-04-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88954
HAWAIIAN TROPIC SUNSCREEN LOTION ÉCRAN SOLAIRE 4;
02329212;
octocrylene 1 % / w/w , oxybenzone 0.5 % / w/w;
2010-01-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81490
SUNLOTION LOTIONSOLAIRE SPF/FPS 4;
02447355;
octocrylene 1 g / 100 g , oxybenzone 0.5 g / 100 g;
2016-02-22;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93293
OMBRELLE – LOTION EXTREME SPF 30;
02241277;
octocrylene 10 % , avobenzone 3.0 % , titanium dioxide 2.2 % , terephthalylidene dicamphor sulfonic acid 1.0 %;
2000-02-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64887
DRY-TOUCH SUNSCREEN SPF 45;
02487780;
octocrylene 10 % , homosalate 10 % , octisalate 5 % , avobenzone 3 %;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97794
REVERSA URBAN PROTECTION HYDRATING CARE SPF 30 SOIN HYDRATANT PROTECTION URBAINE FPS 30;
02473178;
octocrylene 10 % , octinoxate 7.5 % , octisalate 5 % , avobenzone 2 %;
2018-04-21;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96253
OMBRELLE SPORT SPRAY;
02290472;
octocrylene 10 % , oxybenzone 6 % , octisalate 5 % , avobenzone 3 %;
2007-03-27;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77578
OMBRELLE STICK SPF 60;
02285738;
octocrylene 10 % , titanium dioxide 6.25 % , avobenzone 3 % , drometrizole trisiloxane 2 %;
2007-03-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77122
ULTRA PROTECTION SUNSCREEN STICK SPF 60;
02285746;
octocrylene 10 % , titanium dioxide 6.25 % , avobenzone 3 % , drometrizole trisiloxane 2 %;
2007-04-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77123
GLOWSCREEN;
02503107;
octocrylene 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
2021-01-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99261
FACE SUNSCREEN SPF 45;
02487764;
octocrylene 10 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97790
COOLZONE INSTANTLY COOLS & REFRESHES RAFRAÎCHIT INSTANTANÉMENT SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 50;
02387050;
octocrylene 10 % / w/w , oxybenzone 5 % / w/w , avobenzone 3 % / w/w;
2013-01-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87262
SPORT PERFORMANCE SUNSCREEN STICK ECRAN SOLAIRE EN BÂTONNET SPF FPS 50;
02317036;
octocrylene 10 % / w/w , oxybenzone 6 % / w/w , avobenzone 2 % / w/w;
2009-05-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80254
KIDS SUNSCREEN STICK ÉCRAN SOLAIRE EN BÂTONNET POUR ENFANTS SPF FPS 50;
02317745;
octocrylene 10 % / w/w , oxybenzone 6 % / w/w , avobenzone 2 % / w/w;
2009-05-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80328
SUNSCREEN STICK ÉCRAN SOLAIRE EN BÂTONNET WITH ALOE VERA/AVEC ALOÈS;
02317990;
octocrylene 10 % / w/w , oxybenzone 6 % / w/w , avobenzone 2 % / w/w;
2009-05-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80350
COPPERTONE SUNSCREEN STICK WATERBABIES;
02467100;
octocrylene 10 % / w/w , zinc oxide 15 % / w/w , octinoxate 7.5 % / w/w;
2018-01-22;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95550
REVERSA CRÈME RADIANCE FPS 30;
02435802;
octocrylene 10.0 % / w/w , octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 2.0 % / w/w;
2015-07-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92015
NOURISHING DAY CREAM;
02466570;
octocrylene 2 % / w/w , ensulizole 2 % / w/w , avobenzone 1.5 % / w/w;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95491
UV LIP COLOR SPLASH TOUCHE COULEUR LÈVRES PROTECTION UV TAHITI BLUE;
02466201;
octocrylene 3 % , avobenzone 2.5 % , oxybenzone 2 % , octinoxate 4.9 %;
2018-02-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95451
SHISEIDO BENEFIANCE NUTRIPERFECT DAY CREAM SPF 15;
02306468;
octocrylene 3 % , octinoxate 5 % , ensulizole 2 %;
2009-02-02;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79216
MATTIFYING DAY CREAM;
02466597;
octocrylene 3 % / w/w , ensulizole 2 % / w/w , avobenzone 2 % / w/w;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95493
URBAN ENVIRONMENT UV PROTECTION CREAM;
02423901;
octocrylene 3.0 % / w/w , octinoxate 2.9 % / w/w , zinc oxide 10.6 % / w/w;
2014-12-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90864
URBAN ENVIRONMENT OIL-FREE UV PROTECTOR;
02423928;
octocrylene 3.0 % / w/w , octinoxate 4.9 % / w/w , zinc oxide 12.5 % / w/w;
2014-12-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90865
HIGH PERFORMANCE SUNSCREEN SPRAY SPF 15;
02454564;
octocrylene 3.5 % / w/w , homosalate 5 % / w/w , avobenzone 1.5 % / w/w;
2017-01-03;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94127
NO 7 MEN PROTECT & PERFECT INTENSE MOISTURISER SPF 15;
02443341;
octocrylene 4 % / w/w , avobenzone 3 % / w/w , octisalate 3 % / w/w;
2016-04-07;
Topical;
Suspension;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92799
ROSALIAC UV LEGERE;
02330792;
octocrylene 4.6 % / w/w , octisalate 3.3 % / w/w , avobenzone 2.0 % / w/w , drometrizole trisiloxane 1.0 % / w/w;
2010-06-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81654
ROSALIAC UV RICHE;
02330857;
octocrylene 4.6 % / w/w , octisalate 3.3 % / w/w , avobenzone 2.0 % / w/w , drometrizole trisiloxane 1.0 % / w/w;
2009-11-02;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81660
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN LOTION SPF 30;
02423545;
octocrylene 5 % / w/w , avobenzone 1.8 % / w/w , homosalate 7 % / w/w;
2014-12-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90826
HAWAIIAN TROPIC PROTECTIVE DRY OIL SUNSCREEN SPRAY SPF/FPS 10;
02421844;
octocrylene 5 % / w/w , avobenzone 3 % / w/w;
2015-03-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90652
DRY BALANCE SUNSCREEN LOTION SPF 50+;
02456028;
octocrylene 5 % / w/w , homosalate 9 % / w/w , octisalate 4 % / w/w , avobenzone 3 % / w/w;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94287
ULTRA SUN PROTECTION LOTION TI;
02463660;
octocrylene 5 % / w/w , octinoxate 4.9 % / w/w , oxybenzone 3 % / w/w , avobenzone 2.5 % / w/w;
2017-11-28;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95176
ESTEE LAUDER REVITALIZING SUPREME+ GLOBAL ANTI-AGING CREME SPF 15;
02473828;
octocrylene 5 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2018-10-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96345
HAWAIIAN TROPIC SILK HYDRATION FACE OIL-FREE SUNSCREEN;
02424681;
octocrylene 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w;
2015-02-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90936
ISLAND SPORT SUNSCREEN LOTION SPF 30;
02449269;
octocrylene 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w;
2017-07-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93509
VITA LIFT SPF 15 DAILY MOISTURIZER;
02419068;
octocrylene 5.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , homosalate 2.0 % / w/w;
2014-06-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90360
FACIAL FUEL;
02483777;
octocrylene 5.9 % / w/w , homosalate 8.8 % / w/w , octisalate 4.9 % / w/w , avobenzone 3 % / w/w;
2019-03-19;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97412
HAWAIIAN TROPIC DUO DEFENCE REFRESH SUNSCREEN MIST SPF 30;
02477866;
octocrylene 6 % / w/w , avobenzone 2.7 % / w/w , homosalate 6 % / w/w;
2019-02-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96871
BRIGHT BOOST MOISTURIZER SPF 30;
02488116;
octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
2020-01-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97821
CLEAR COMPLEXION SHEER DAILY MOISTURIZER;
02491842;
octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
2020-03-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98184
PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 30;
02496798;
octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98664
HYDRO BOOST WATER GEL LOTION SUNSCREEN SPF 30;
02463172;
octocrylene 6 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w , homosalate 5 % / w/w;
2019-01-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95108
HAWAIIAN TROPIC KIDS SUNSCREEN LOTION SPF/FPS 50+;
02423219;
octocrylene 6 % / w/w , oxybenzone 4 % / w/w , avobenzone 3 % / w/w;
2015-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90795
LIP PROTECTOR SPF 15 SUNSCREEN;
02375419;
octocrylene 6.0 % / w/w , avobenzone 2.5 % / w/w , octinoxate 2.0 % / w/w;
2014-03-24;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MARY KAY COSMETICS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86083
BIENFAIT MULTI-VITAL SPF 30;
02270161;
octocrylene 7 % , octisalate 5 % , avobenzone 3 %;
2005-12-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75557
REDERMIC [C] UV – SPF 25;
02431882;
octocrylene 7 % , octisalate 5 % , avobenzone 3 %;
2015-04-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91635
CRÈME RAJEUNISSANTE HAUTE FERMETÉ JOUR;
02418088;
octocrylene 7 % , oxybenzone 3 % , avobenzone 3 %;
2014-04-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90267
OMBRELLE SPORT LOTION SPF 30;
02269902;
octocrylene 7 % , titanium dioxide 2.5 % , avobenzone 1.5 % , terephthalylidene dicamphor sulfonic acid 0.5 %;
2006-04-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75527
OMBRELLE SPORT LOTION SPF 45;
02269910;
octocrylene 7 % , titanium dioxide 3.3 % , avobenzone 1.5 % , terephthalylidene dicamphor sulfonic acid 0.5 %;
2006-04-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75528
FUTUR E SPF 15 MOISTURIZING LOTION;
02390671;
octocrylene 7 % / w/w , ensulizole 2 % / w/w;
2013-06-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87609
TOLERIANE SENSITIVE CRÈME UV;
02492458;
octocrylene 7 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-06-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98246
ABSOLUE VELVET CREAM WITH BROAD SPECTRUM SPF 15;
02495252;
octocrylene 7 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2020-09-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98518
CHAPSTICK ACTIVE SPF 30;
02245381;
octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , oxybenzone 5 % / w/w;
2003-03-14;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69420
LIFTACTIV UV;
02374528;
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2012-05-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85985
RENERGIE LIFT MULTI-ACTION SPF 15 FIRMING MOISTURIZING CREAM ALL SKIN TYPES;
02438232;
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2015-06-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92260
REVITALIFT ANTI-WRINKLE + FIRMING DAY CREAM;
02466724;
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2018-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95508
RÉNERGIE LIFT MULTI-ACTION ULTRA SPF30;
02492962;
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2019-12-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98294
AGE PERFECT ROSY TONE DAY CREAM;
02490501;
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 2.7 % / w/w;
2020-03-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98055
MULTI-ACTION CREAM SPF 30;
02446979;
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 5 % / w/w;
2016-10-24;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93254
RÉNERGIE LIFT MULTI-ACTION ULTRA;
02484005;
octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
2019-08-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97434
REVITALIFT TRIPLE POWER LZR DAY LOTION;
02491141;
octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
2020-02-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98116
AQUALIA THERMAL UV DEFENSE MOISTURIZING CREAM SPF30;
02491265;
octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
2021-01-05;
Topical;
Cream;
-;
Otc;
VICHY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98127
BIENFAIT MULTI-VITAL (SPF 30);
02283379;
octocrylene 7.0 % , octisalate 5.0 % , avobenzone 3.0 %;
2007-01-22;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76898
SPF 30 IDEAL SOLEIL LIP PROTECTION STICK;
02393956;
octocrylene 7.0 % / w/w , avobenzone 2.5 % / w/w , drometrizole trisiloxane 4.0 % / w/w;
2013-06-18;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87913
SPF 30 WRINKLE REDUCING CREAM;
02404214;
octocrylene 7.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , homosalate 2.7 % / w/w;
2013-07-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88900
AQUALIA THERMAL UV;
02393948;
octocrylene 7.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , homosalate 6.0 % / w/w;
2013-06-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87912
WRINKLE EXPERT AGE DEFENSE UV LOTION;
02498324;
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-03-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’OREAL CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98810
HYALU-MELON WITH CONDITIONING (HYALURONIC ACID + WATERMELON);
02507048;
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99645
PINEA-C;
02507056;
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99646
NIACINA-B;
02508982;
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2021-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99830
COOLZONE INSTANTLY COOLS & REFRESHES RAFRAÎCHIT INSTANTANÉMENT SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 30;
02387042;
octocrylene 7.4 % / w/w , oxybenzone 3 % / w/w , avobenzone 1 % / w/w;
2013-01-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87261
SPF/FPS 30 BROAD SPECTRUM ALCOHOL FREE SUNSCREEN;
02462184;
octocrylene 7.5 % , octinoxate 7.5 % , octisalate 5 % , avobenzone 2.5 %;
2018-06-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BU BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94991
NO7 EARLY DEFENCE GLOW ACTIVATING DAY CREAM;
02444429;
octocrylene 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2016-09-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92947
SPF 50+ FPS ULTRA LOTION;
02449617;
octocrylene 7.5 % / w/w , octisalate 5 % / w/w , octinoxate 4.5 % / w/w , avobenzone 3 % / w/w;
2016-07-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93545
HYDRANCE OPTIMALE SPF 25;
02270269;
octocrylene 8 % , octinoxate 7.5 % , titanium dioxide 3.2 %;
2005-09-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES DERMATOLOGIQUES AVÈNE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75565
COPPERTONE LOTION SUNSCREEN SPF 50 DEFEND & CARE FACE;
02467070;
octocrylene 8 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2019-01-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95547
COPPERTONE LOTION SUNSCREEN SPF 50 SPORT;
02475413;
octocrylene 8 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , oxybenzone 3 % / w/w;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96580
ULTRA SHEER DRY-TOUCH SUNSCREEN SPF 30;
02486407;
octocrylene 8 % / w/w , homosalate 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.5 % / w/w;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97662
CLEAR FACE SUNSCREEN LOTION;
02487845;
octocrylene 8 % / w/w , homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97800
FACE & NECK MULTI ACTION VISAGE ET COU MULTI ACTION DAY CREAM / CRÈME DE JOUR SPF 30 / FPS 30;
02476118;
octocrylene 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
2019-05-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96704
COPPERTONE CLEAR SUNSCREEN SPF 30 SPORT;
02488345;
octocrylene 9 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
2020-02-07;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97844
URBAN SKIN DEFENCE;
02478471;
octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.75 % / w/w;
2019-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96925
CLINOLEIC 20%;
02344327;
olive oil 16 % / w/w , soybean oil 4 % / w/w;
2012-03-28;
Intravenous;
Emulsion;
40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82981
OLMETEC PLUS;
02319616;
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80508
ACT OLMESARTAN HCT;
02443112;
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92768
APO-OLMESARTAN/HCTZ;
02453606;
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
2017-06-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94016
GLN-OLMESARTAN HCTZ;
02475707;
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
2020-02-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96608
AURO-OLMESARTAN HCTZ;
02476487;
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
2019-01-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96741
OLMETEC PLUS;
02319624;
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80509
ACT OLMESARTAN HCT;
02443120;
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92771
APO-OLMESARTAN/HCTZ;
02453614;
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
2017-05-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94017
GLN-OLMESARTAN HCTZ;
02475715;
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
2020-02-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96609
AURO-OLMESARTAN HCTZ;
02476495;
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
2019-01-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96742
OLMETEC PLUS;
02319632;
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80510
ACT OLMESARTAN HCT;
02443139;
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92772
APO-OLMESARTAN/HCTZ;
02453622;
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
2017-05-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94018
GLN-OLMESARTAN HCTZ;
02475723;
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
2020-02-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96610
AURO-OLMESARTAN HCTZ;
02476509;
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
2019-01-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96743
SANDOZ OPIUM & BELLADONNA;
01901869;
opium 65 mg , belladonna 15 mg;
1991-12-31;
Rectal;
Suppository;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11257
CHOLEDYL EXPECTORANT ELIXIR;
00476374;
oxtriphylline 100 mg / 5 ml , guaifenesin 50 mg / 5 ml;
1981-12-31;
Oral;
Elixir;
48:16.00 – EXPECTORANTS , 86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4258
COPPERTONE SUNSCREEN LOTION SPF 8 DEFEND & GLOW;
01931199;
oxybenzone 2 % / w/w , octinoxate 7 % / w/w;
1970-12-31;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41935
HIGH PERFORMANCE SUNSCREEN LOTION SPF 15;
02454289;
oxybenzone 2 % / w/w , octocrylene 3 % / w/w , avobenzone 2 % / w/w;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94080
SUN-SHADES LIP BALM SPF 15 – VANILLA STK;
02045672;
oxybenzone 3 % , octinoxate 7.5 %;
1994-12-31;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MELALEUCA OF CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42329
MARCELLE FLAWLESS AIR SERUM FOUNDATION SÉRUM DE TEINT PEAU PARFAITE SPF 15 FPS;
02461080;
oxybenzone 3 % / w/w , octinoxate 7.5 % / w/w;
2017-06-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94858
DAY CREAM SPF 15;
02246708;
oxybenzone 5 % , octinoxate 7 % , avobenzone 2 %;
2003-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KAMINS DERMATOLOGICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70903
TARGIN;
02339609;
oxycodone hydrochloride 10 mg , naloxone hydrochloride 5 mg;
2010-10-05;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82520
TARGIN;
02339617;
oxycodone hydrochloride 20 mg , naloxone hydrochloride 10 mg;
2010-10-05;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82521
TARGIN;
02339625;
oxycodone hydrochloride 40 mg , naloxone hydrochloride 20 mg;
2010-10-05;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82522
TEVA-OXYCOCET;
00608165;
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5778
RIVACOCET;
02242468;
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
2001-12-12;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66193
SANDOZ OXYCODONE/ACETAMINOPHEN;
02307898;
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
2008-05-01;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79356
APO-OXYCODONE/ACET;
02324628;
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
2009-04-15;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81005
TARGIN;
02387425;
oxycodone hydrochloride 5.00 mg , naloxone hydrochloride 2.50 mg;
2012-10-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87301
AIR USP;
02014483;
oxygen 19.5 % , nitrogen 80.5 %;
1993-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13885
HELIUM OXYGEN MIXTURE;
00572896;
oxygen 20 % , helium 80 %;
1911-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5689
MEDICAL AIR U.S.P.;
02154781;
oxygen 23.5 % / v/v , nitrogen 76.5 % / v/v;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19291
OXYGEN USP, HELIUM USP, MEDICAL GAS MIXTURE;
02014440;
oxygen 24 % , helium 76 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13890
HELIOX;
02154846;
oxygen 50 % , helium 50 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
LINDE CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19290
HELIUM-OXYGEN MIX GAS;
01906801;
oxygen 50 % , helium 50 %;
1997-05-02;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46353
ENTONOX;
02154757;
oxygen 50 % , nitrous oxide 50 %;
1995-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
LINDE CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19102
OXYGEN CARBON DIOXIDE MIXTURE;
00572853;
oxygen 95 % , carbon dioxide 5 %;
1911-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5686
ZEPOSIA;
02506009;
ozanimod (ozanimod hydrochloride) 0.23 mg , ozanimod (ozanimod hydrochloride) 0.46 mg;
2020-11-12;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99536
BLISTEX LIP BALM;
02013878;
padimate o 6.6 % , oxybenzone 2.5 % , dimethicone 2 %;
1993-12-31;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42159
ELIZABETH ARDEN LIP PROTECTANT STICK SPF 15;
02250071;
padimate o 8 % , oxybenzone 3 %;
2005-05-15;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73489
AKYNZEO;
02468735;
palonosetron (palonosetron hydrochloride) 0.5 mg , netupitant 300 mg;
2017-11-20;
Oral;
Capsule;
56:22.00 – ANTIEMETICS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95721
PLEGRIDY;
02444402;
peginterferon beta-1a 63 mcg / 0.5 ml , peginterferon beta-1a 94 mcg / 0.5 ml;
2015-09-25;
Subcutaneous;
Kit , Liquid;
08:18.20 – INTERFERONS;
Prescription , Schedule D;
BIOGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92944
VIACORAM;
02451557;
perindopril arginine 14 mg , amlodipine (amlodipine besylate) 10 mg;
2016-04-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93784
APO-PERINDOPRIL/AMLODIPINE;
02468581;
perindopril arginine 14 mg , amlodipine (amlodipine besylate) 10 mg;
2019-06-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95701
VIACORAM;
02451530;
perindopril arginine 3.5 mg , amlodipine (amlodipine besylate) 2.5 mg;
2016-04-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93782
APO-PERINDOPRIL/AMLODIPINE;
02468573;
perindopril arginine 7 mg , amlodipine (amlodipine besylate) 5 mg;
2019-06-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95700
COVERSYL PLUS LD;
02246568;
perindopril erbumine 2 mg , indapamide 0.625 mg;
2003-05-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70751
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD;
02470411;
perindopril erbumine 2 mg , indapamide 0.625 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95939
COVERSYL PLUS;
02246569;
perindopril erbumine 4 mg , indapamide 1.25 mg;
2002-12-19;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70752
APO-PERINDOPRIL-INDAPAMIDE;
02297574;
perindopril erbumine 4 mg , indapamide 1.25 mg;
2021-02-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78291
TEVA-PERINDOPRIL/INDAPAMIDE;
02464020;
perindopril erbumine 4 mg , indapamide 1.25 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95216
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE;
02470438;
perindopril erbumine 4 mg , indapamide 1.25 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95940
COVERSYL PLUS HD;
02321653;
perindopril erbumine 8 mg , indapamide 2.5 mg;
2009-05-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80705
TEVA-PERINDOPRIL/INDAPAMIDE;
02464039;
perindopril erbumine 8 mg , indapamide 2.5 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95215
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD;
02470446;
perindopril erbumine 8 mg , indapamide 2.5 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95941
PERJETA-HERCEPTIN;
02405024;
pertuzumab 420 mg / 14 ml , trastuzumab 440 mg / vial;
2013-05-09;
Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88985
SEBAMED DIAPER RASH CREAM;
02240541;
petrolatum 10.00 % , mineral oil 7.00 %;
2000-04-17;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LOFCO CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64111
SOOTHE NIGHT TIME;
02125706;
petrolatum 80 % , mineral oil 20 %;
1994-12-31;
Ophthalmic;
Ointment;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16777
VISINE FOR ALLERGY WITH ANTIHISTAMINE;
02242764;
pheniramine maleate 0.3 % / w/v , naphazoline hydrochloride 0.025 % / w/v;
2003-12-29;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66582
ROBITUSSIN AC;
01934740;
pheniramine maleate 7.5 mg / 5 ml , guaifenesin 100 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
1993-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13494
PREPARATION H-PE GEL;
02209594;
phenylephrine hydrochloride 0.25 % / w/w , hamamelis virginiana 50 % / w/w;
1997-05-05;
Rectal , Topical;
Gel;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36788
DRISTAN NASAL MIST;
01929313;
phenylephrine hydrochloride 0.5 % / w/v , pheniramine maleate 0.2 % / w/v;
1992-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41952
DIMETAPP-C;
02244078;
phenylephrine hydrochloride 1 mg / ml , brompheniramine maleate 0.4 mg / ml , codeine phosphate 2 mg / ml;
2001-09-05;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Narcotic (Cdsa I);
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68031
DIMETANE EXPECTORANT C;
02244079;
phenylephrine hydrochloride 1 mg / ml , brompheniramine maleate 0.4 mg / ml , codeine phosphate 2 mg / ml , guaifenesin 20 mg / ml;
2001-09-28;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68034
NEOCITRAN COLD & SORE THROAT NIGHT;
02246602;
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 325 mg / sachet , pheniramine maleate 20 mg / sachet;
2003-06-18;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70790
NEOCITRAN EXTRA STRENGTH COLD & CONGESTION;
00843792;
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet;
1989-12-31;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10188
DAYTIME COLD;
02487276;
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
2020-01-14;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97743
NIGHTTIME COLD;
02487233;
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet;
2020-01-14;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97739
NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT;
02215403;
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet;
1996-09-04;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37051
NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT – APPLE CINNAMON;
02456982;
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet;
2017-08-01;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94410
DIMETAPP EXTRA STRENGTH;
02245075;
phenylephrine hydrochloride 10 mg / 5 ml , brompheniramine maleate 4 mg / 5 ml;
2002-08-01;
Oral;
Syrup;
04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69079
EXTRA STRENGTH TYLENOL COLD DAYTIME;
02276186;
phenylephrine hydrochloride 5 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 10 mg;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76185
EXTRA STRENGTH TYLENOL SINUS NIGHTTIME;
02276038;
phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg , acetaminophen 500 mg;
2006-07-24;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76170
DIMETAPP;
02243980;
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml;
2001-07-23;
Oral;
Syrup;
04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67924
ROBITUSSIN CHILDREN’S COLD;
02394693;
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml;
2013-07-17;
Oral;
Syrup;
04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87984
DIMETAPP DM COUGH & COLD;
02243969;
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml , dextromethorphan hydrobromide 10 mg / 5 ml;
2001-07-25;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67912
DIMETANE EXPECTORANT DC;
02244080;
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml , guaifenesin 100 mg / 5 ml , hydrocodone bitartrate 1.8 mg / 5 ml;
2001-09-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68035
BLES;
02245464;
phospholipid 27 mg / ml , surfactant-associated proteins sp-b and sp-c 500 mcg / ml;
2002-02-05;
Intratracheal;
Suspension;
48:36.00 – PULMONARY SURFACTANTS;
Ethical;
BLES BIOCHEMICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69524
MAVIRET;
02467550;
pibrentasvir 40 mg , glecaprevir 100 mg;
2017-09-13;
Oral;
Tablet;
08:18.40.20 – HCV Protease Inhibitors , 08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95591
VISKAZIDE;
00568627;
pindolol 10 mg , hydrochlorothiazide 25 mg;
1983-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5156
VISKAZIDE;
00568635;
pindolol 10 mg , hydrochlorothiazide 50 mg;
1983-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5157
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
02330547;
piperacillin (piperacillin sodium) 12 g / vial , tazobactam (tazobactam sodium) 1.5 g / vial;
2010-03-10;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81627
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02377748;
piperacillin (piperacillin sodium) 12 g / vial , tazobactam (tazobactam sodium) 1.5 g / vial;
2012-03-13;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86356
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
02299623;
piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
2007-11-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78500
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02401312;
piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
2015-03-11;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88623
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02362619;
piperacillin (piperacillin sodium) 2.00 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
2011-08-29;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84762
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
02299631;
piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
2007-11-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78501
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION;
02370166;
piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
2013-06-17;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85518
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02401320;
piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
2015-03-11;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88624
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02362627;
piperacillin (piperacillin sodium) 3.000 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
2011-08-29;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84763
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02439131;
piperacillin (piperacillin sodium) 36 g / vial , tazobactam (tazobactam sodium) 4.5 g / vial;
2015-09-11;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92352
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
02299658;
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
2007-11-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78502
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION;
02370174;
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
2013-06-17;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85519
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02401339;
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
2015-03-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88625
PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
02362635;
piperacillin (piperacillin sodium) 4.0 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
2011-08-29;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84764
SYSTANE LUBRICANT EYE DROPS;
02248967;
polyethylene glycol 400 0.4 % / w/v , propylene glycol 0.3 % / w/v;
2004-04-08;
Ophthalmic;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73342
TRIPLE ANTIBIOTIC OINTMENT;
02088339;
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin (bacitracin zinc) 500 unit / g , gramicidin .25 mg / g;
1994-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
MELALEUCA OF CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16171
BIODERM OINTMENT;
00621366;
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin 500 unit / g;
1987-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8398
POLYSPORIN ANTIBIOTIC OINTMENT;
02237227;
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g;
1998-08-13;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60546
POLYSPORIN TRIPLE ANTIBIOTIC OINTMENT;
02237226;
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g;
1998-08-13;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60545
TRIPLE ANTIBIOTIC OINTMENT;
02246693;
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g;
2003-01-20;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70888
POLYSPORIN COMPLETE;
02240568;
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g , lidocaine 50 mg / g;
2005-05-24;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64139
POLYSPORIN ANTIBIOTIC CREAM;
02230844;
polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g;
1997-08-07;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50105
POLYSPORIN PLUS PAIN RELIEF;
02239201;
polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
1999-06-18;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62658
POLYSPORIN FOR KIDS;
02248189;
polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
2004-04-05;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72525
POLYSPORIN EYE AND EAR DROPS STERILE;
02239156;
polymyxin b (polymyxin b sulfate) 10000 unit / ml , gramicidin 0.025 mg / ml;
2000-02-12;
Ophthalmic , Otic;
Drops;
52:04.04 – ANTIBACTERIALS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62612
POLYSPORIN PLUS PAIN RELIEF EAR DROPS;
02239155;
polymyxin b (polymyxin b sulfate) 10000 unit / ml , lidocaine hydrochloride 50 mg / ml;
1999-12-29;
Otic;
Drops;
52:04.04 – ANTIBACTERIALS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62611
POLYTRIM OPHTHALMIC SOLUTION;
02011956;
polymyxin b (polymyxin b sulfate) 10000 unit / ml , trimethoprim (trimethoprim sulfate) 1 mg / ml;
1993-12-31;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13628
BAND-AID BRAND ADHESIVE BANDAGES PLUS ANTIBIOTIC;
02236954;
polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
1998-04-06;
Topical;
Ointment , Pad;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60248
ANTIBIOTIC OINTMENT;
02372037;
polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
2012-05-16;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85716
POLYSPORIN SINGLES;
02481618;
polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
2019-10-28;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97207
ORIGINAL ANTIBIOTIC CREAM;
02317656;
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g;
2010-10-26;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80317
COMPLETE ANTIBIOTIC OINTMENT;
02304465;
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine 50 mg / g , bacitracin zinc 500 unit / g;
2009-01-23;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78975
ANTIBIOTIC CREAM PLUS PAIN RELIEF;
02372045;
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 40 mg / g;
2012-04-09;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85717
ANTIBIOTIC CREAM PLUS PAIN RELIEF FOR KIDS;
02377187;
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 40 mg / g;
2012-07-11;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86278
ANTIBIOTIC PLUS PAIN RELIEF CREAM;
02304457;
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
2009-07-30;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78974
ANTIBIOTIC CREAM FOR KIDS;
02315033;
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
2009-07-30;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80057
SANDOZ POLYTRIMETHOPRIM;
02239234;
polymyxin b sulfate 10000 unit / ml , trimethoprim (trimethoprim sulfate) 1 mg / ml;
2012-08-02;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62695
CLEAR EYES TRIPLE ACTION RELIEF;
02301687;
polyvinyl alcohol 0.5 % , povidone 0.6 % , tetrahydrozoline hydrochloride 0.05 %;
2008-03-26;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
PRESTIGE BRANDS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78699
MURINE;
02247538;
polyvinyl alcohol 5 mg / ml , povidone 6 mg / ml;
2004-03-24;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
PRESTIGE BRANDS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71788
POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE;
02299100;
potassium chloride 0.15 g / 100 ml , sodium chloride 0.9 g / 100 ml;
2008-04-07;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78450
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE;
00603244;
potassium chloride 0.3 g / 100 ml , sodium chloride 0.45 g / 100 ml , dextrose 5 g / 100 ml;
1983-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6228
POTASSIUM PHOSPHATES;
00804789;
potassium phosphate monobasic 224 mg / ml , potassium phosphate dibasic 236 mg / ml;
1989-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10509
POTASSIUM PHOSPHATES INJECTION, USP;
02139545;
potassium phosphate monobasic 224 mg / ml , potassium phosphate dibasic 236 mg / ml;
1984-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19442
POLYSPORIN POLY TO GO;
02318946;
pramoxine hydrochloride 1 % , benzalkonium chloride 0.13 %;
2009-03-12;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80442
PROCTODAN-HC OINTMENT;
02234466;
pramoxine hydrochloride 1 % , hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
1998-01-23;
Rectal , Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55837
ANUSOL PLUS OINTMENT;
01945912;
pramoxine hydrochloride 1 % , zinc sulfate 0.5 %;
1992-12-31;
Rectal , Topical;
Ointment;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12764
POLYSPORIN ITCH RELIEF;
02246156;
pramoxine hydrochloride 1.0 % , zinc acetate 0.1 %;
2003-04-02;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70300
ITCH RELIEF LOTION;
02318423;
pramoxine hydrochloride 1.0 % / w/w , zinc acetate 0.1 % / w/w;
2009-09-09;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80391
PROCTODAN-HC SUPPOSITORIES;
02240851;
pramoxine hydrochloride 20 mg , hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
2000-03-23;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64442
ANUSOL PLUS SUPPOSITORIES;
01945904;
pramoxine hydrochloride 20 mg , zinc sulfate 10 mg;
1992-12-31;
Rectal;
Suppository;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12763
EMLA CREAM;
00886858;
prilocaine 2.5 % , lidocaine 2.5 %;
1991-12-31;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11440
ORAQIX;
02325993;
prilocaine 2.5 % , lidocaine 2.5 %;
2010-02-11;
Topical;
Gel;
52:16.00 – LOCAL ANESTHETICS;
Otc;
DENTSPLY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81134
PRILOCAINE HCL 4% EPINEPH 1:200000INJ;
00393746;
prilocaine hydrochloride 40 mg / ml , epinephrine 0.005 mg / ml;
1977-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2828
4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000;
02347695;
prilocaine hydrochloride 40 mg / ml , epinephrine 0.005 mg / ml;
2011-01-18;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83307
SECARIS;
00551805;
propylene glycol 20 % / w/w , macrogol 15 % / w/w;
1982-12-31;
Nasal;
Gel;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4885
RHINARIS NASAL MIST;
02354551;
propylene glycol 5 % / w/w , macrogol 15 % / w/w;
2012-01-11;
Nasal;
Spray, Metered Dose;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83972
VIOKACE;
02230019;
protease 57100 unit , lipase 10440 unit , amylase 56400 unit;
1997-01-23;
Oral;
Tablet;
56:16.00 – DIGESTANTS;
Prescription;
NESTLE ENTERPRISES S.A.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48551
ENTEX LA;
02246971;
pseudoephedrine hydrochloride 120 mg , guaifenesin 600 mg;
2004-02-02;
Oral;
Tablet (Extended-Release);
48:16.00 – EXPECTORANTS;
Otc;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71201
ROBITUSSIN CHILDREN’S COUGH AND COLD;
02044013;
pseudoephedrine hydrochloride 15 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml;
1993-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14551
BUCKLEY’S COMPLETE + MUCUS RELIEF;
02335948;
pseudoephedrine hydrochloride 30 mg , acetaminophen 250 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
2010-08-02;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82152
COMPLETE DAYTIME LIQUID CAPSULES;
02428113;
pseudoephedrine hydrochloride 30 mg , acetaminophen 250 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
2015-05-01;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91260
BUCKLEYS COLD & SINUS;
02307111;
pseudoephedrine hydrochloride 30 mg , acetaminophen 325 mg , dextromethorphan hydrobromide 15 mg;
2008-07-21;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79278
EXTRA STRENGTH SINUS RELIEF DAYTIME;
02050242;
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
1996-10-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27225
COLD AND FLU-IN-ONE EXTRA STRENGTH;
02281147;
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg;
2007-04-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76681
TOTAL COLD AND FLU;
02286394;
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg;
2007-01-29;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77185
EXTRA STRENGTH SINUTAB SINUS NIGHTTIME;
02215241;
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , diphenhydramine hydrochloride 25 mg;
1998-03-05;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37037
BUCKLEY’S NIGHTTIME COLD AND SINUS;
02307014;
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , doxylamine succinate 6.25 mg;
2008-07-21;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79269
BUCKLEY’S COMPLETE NIGHTTIME SOFTGELS;
02335239;
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , doxylamine succinate 6.25 mg;
2010-08-02;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82084
EXTRA STRENGTH COLD MEDICATION DAYTIME RELIEF;
02083736;
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
1995-12-31;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17880
BUCKLEY’S COMPLETE EXTRA STRENGTH COUGH, COLD & FLU DAY;
02241593;
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
2000-08-08;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65250
EXTRA STRENGTH FLU RELIEF DAYTIME;
02248580;
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
2004-03-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72935
NIGHTTIME COLD & FLU LIQUID CAPSULES;
02258927;
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg;
2005-01-10;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74415
SUDAFED SINUS ADVANCE;
02242217;
pseudoephedrine hydrochloride 30 mg , ibuprofen 200 mg;
2000-08-01;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65897
COLD + SINUS NIGHTTIME;
02369559;
pseudoephedrine hydrochloride 30 mg , ibuprofen 200 mg , chlorpheniramine maleate 2 mg;
2015-01-01;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85448
DM-DECONGESTANT-EXPECTORANT SYRUP;
02241490;
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
2000-03-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65130
COUGH & COLD RELIEF;
02405873;
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
2013-08-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89064
DM-DECONGESTANT-EXPECTORANT (EXTRA STRENGTH) SYRUP;
02241489;
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
2000-02-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65129
COUGH & COLD RELIEF EXTRA STRENGTH;
02405881;
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
2013-07-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89065
COLD + SINUS PLUS;
02359243;
pseudoephedrine hydrochloride 30.0 mg , ibuprofen 200.0 mg , chlorpheniramine maleate 2.0 mg;
2011-04-19;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84427
EXTRA STRENGTH SUDAFED HEAD COLD & SINUS;
02239159;
pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
2000-08-15;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62615
EXTRA STRENGTH HEAD COLD AND SINUS;
02248646;
pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
2004-04-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73003
EXTRA STRENGTH TYLENOL SINUS PRESSURE & PAIN;
02478110;
pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
2019-06-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96884
CLARITIN ALLERGY + SINUS EXTRA STRENGTH;
02260557;
pseudoephedrine sulfate 240 mg , loratadine 10 mg;
2005-03-01;
Oral;
Tablet (Immediate And Extended Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74601
R & C SHAMPOO WITH CONDITIONER;
02125447;
pyrethrins 0.33 % , piperonyl butoxide 3 %;
1995-12-31;
Topical;
Shampoo;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18634
LICE KILLING SHAMPOO;
02298015;
pyrethrins 0.33 % , piperonyl butoxide 4 %;
2008-03-05;
Topical;
Shampoo;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78333
LICE SHAMPOO;
02409321;
pyrethrins 0.33 % / w/w , piperonyl butoxide 4 % / w/w;
2014-04-24;
Topical;
Shampoo;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89404
Z-PLUS SHAMPOO;
00800686;
pyrithione zinc 2 % , menthol 0.3 %;
1990-12-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
DORMER LABORATORIES INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10999
ACCURETIC;
02237367;
quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
1998-10-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60690
APO-QUINAPRIL/HCTZ;
02408767;
quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
2013-08-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89352
AURO-QUINAPRIL HCTZ;
02473291;
quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
2019-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96270
ACCURETIC;
02237368;
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
1998-10-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60691
APO-QUINAPRIL/HCTZ;
02408775;
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
2013-08-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89353
AURO-QUINAPRIL HCTZ;
02473305;
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
2019-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96271
ACCURETIC;
02237369;
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
2003-06-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60692
APO-QUINAPRIL/HCTZ;
02408783;
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
2013-08-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89354
AURO-QUINAPRIL HCTZ;
02473321;
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
2019-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96273
ALTACE HCT;
02283166;
ramipril 10 mg , hydrochlorothiazide 12.5 mg;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76878
TARO-RAMIPRIL HCTZ;
02449455;
ramipril 10 mg , hydrochlorothiazide 12.5 mg;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93529
ALTACE HCT;
02283182;
ramipril 10 mg , hydrochlorothiazide 25 mg;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76880
TARO-RAMIPRIL HCTZ;
02449471;
ramipril 10 mg , hydrochlorothiazide 25 mg;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93531
PMS-RAMIPRIL-HCTZ;
02342154;
ramipril 10.0 mg , hydrochlorothiazide 12.5 mg;
2010-02-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82765
PMS-RAMIPRIL-HCTZ;
02342170;
ramipril 10.0 mg , hydrochlorothiazide 25.0 mg;
2010-02-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82767
ALTACE HCT;
02283131;
ramipril 2.5 mg , hydrochlorothiazide 12.5 mg;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76876
TARO-RAMIPRIL HCTZ;
02449439;
ramipril 2.5 mg , hydrochlorothiazide 12.5 mg;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93527
ALTACE HCT;
02283158;
ramipril 5 mg , hydrochlorothiazide 12.5 mg;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76877
TARO-RAMIPRIL HCTZ;
02449447;
ramipril 5 mg , hydrochlorothiazide 12.5 mg;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93528
ALTACE HCT;
02283174;
ramipril 5 mg , hydrochlorothiazide 25 mg;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76879
TARO-RAMIPRIL HCTZ;
02449463;
ramipril 5 mg , hydrochlorothiazide 25 mg;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93530
CERVARIX;
02342227;
recombinant human papillomavirus type 16 l1 protein 20 mcg / 0.5 ml , recombinant human papillomavirus type 18 l1 protein 20 mcg / 0.5 ml;
2010-02-10;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82773
BEXSERO;
02417030;
recombinant neisseria meningitidis group b nhba fusion protein 50 mcg / 0.5 ml , recombinant neisseria meningitidis group b nada protein 50 mcg / 0.5 ml , recombinant neisseria meningitidis group b fhbp fusion protein 50 mcg / 0.5 ml , outer membrane vesicles (neisseria meningitidis group b nz98/254 strain) 25 mcg / 0.5 ml;
2014-02-26;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90167
CABENUVA;
02497247;
rilpivirine 300 mg / ml , cabotegravir 200 mg / ml;
2020-09-21;
Intramuscular;
Suspension (Extended-Release) , Kit;
08:18.08 – ANTIRETROVIRALS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98709
TEVA-COMBO STERINEBS;
02272695;
salbutamol (salbutamol sulfate) 2.5 mg / 2.5 ml , ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg / 2.5 ml;
2005-11-18;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75820
TARDAN SHP;
00266493;
salicylic acid 2 % , triclosan 0.3 % , coal tar 5 %;
1973-12-31;
Topical;
Shampoo;
84:28.00 – KERATOLYTIC AGENTS , 84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1667
CANTHARONE PLUS;
00772011;
salicylic acid 30 % , podophyllin 2 % , cantharidin 1 %;
1984-12-31;
Topical;
Liquid;
84:28.00 – KERATOLYTIC AGENTS;
Prescription;
DORMER LABORATORIES INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9361
SEBCUR-T;
00666114;
salicylic acid 4 % , coal tar 10 %;
1986-12-31;
Topical;
Shampoo;
84:28.00 – KERATOLYTIC AGENTS , 84:32.00 – KERATOPLASTIC AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6848
ADVAIR 125;
02245126;
salmeterol (salmeterol xinafoate) 25 mcg / act , fluticasone propionate 125 mcg / act;
2001-12-21;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69136
ADVAIR 250;
02245127;
salmeterol (salmeterol xinafoate) 25 mcg / act , fluticasone propionate 250 mcg / act;
2001-12-21;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69137
ADVAIR 100 DISKUS;
02240835;
salmeterol (salmeterol xinafoate) 50 mcg / act , fluticasone propionate 100 mcg / act;
1999-09-24;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64426
ADVAIR 250 DISKUS;
02240836;
salmeterol (salmeterol xinafoate) 50 mcg / act , fluticasone propionate 250 mcg / act;
1999-09-24;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64427
ADVAIR 500 DISKUS;
02240837;
salmeterol (salmeterol xinafoate) 50 mcg / act , fluticasone propionate 500 mcg / act;
1999-09-24;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64428
VIVAXIM;
02248361;
salmonella typhi vi capsular polysaccharide vaccine 25 mcg / 0.5 ml , hepatitis a vaccine – inactivated 160 unit / 0.5 ml;
2005-11-09;
Intramuscular;
Solution , Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72706
KOMBOGLYZE;
02389185;
saxagliptin (saxagliptin hydrochloride) 2.5 mg , metformin hydrochloride 1000 mg;
2013-04-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87469
KOMBOGLYZE;
02389169;
saxagliptin (saxagliptin hydrochloride) 2.5 mg , metformin hydrochloride 500 mg;
2013-04-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87467
KOMBOGLYZE;
02389177;
saxagliptin (saxagliptin hydrochloride) 2.5 mg , metformin hydrochloride 850 mg;
2013-04-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87468
ARTISS;
02326167;
sealer protein (human) 125 mg / ml , aprotinin (synthetic) 3000 kiu / ml , thrombin (human) 4 unit / ml , calcium chloride 40 mcmol / ml;
2011-12-18;
Topical;
Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81150
TISSEEL;
02326132;
sealer protein (human) 125 mg / ml , aprotinin (synthetic) 3000 kiu / ml , thrombin (human) 500 unit / ml , calcium chloride 40 mcmol / ml;
2011-12-14;
Topical;
Kit;
20:28.16 – HEMOSTATICS;
Schedule D;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81147
SENOKOT S;
00026123;
sennosides 8.6 mg , docusate sodium 50 mg;
1975-12-31;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2133
SENNA S. TABLETS;
02246951;
sennosides 8.6 mg , docusate sodium 50 mg;
2003-10-29;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71178
SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS;
02247134;
sennosides 8.6 mg , docusate sodium 50 mg;
2003-03-07;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71374
SANDOZ SENNA S;
02247390;
sennosides 8.6 mg , docusate sodium 50 mg;
2004-12-10;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71635
NUWIQ;
02474050;
simoctocog alfa 3000 unit / vial , water 2.5 ml / syr;
2018-07-25;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96406
NUWIQ;
02474069;
simoctocog alfa 4000 unit / vial , water 2.5 ml / syr;
2018-07-25;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96407
JANUMET XR;
02416808;
sitagliptin (sitagliptin phosphate monohydrate) 100 mg , metformin hydrochloride 1000 mg;
2015-01-13;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90141
JANUMET;
02333872;
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 1000 mg;
2009-10-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81956
JANUMET XR;
02416794;
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 1000 mg;
2014-01-15;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90140
JANUMET;
02333856;
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 500 mg;
2009-10-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81954
JANUMET XR;
02416786;
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 500 mg;
2015-01-13;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90139
JANUMET;
02333864;
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 850 mg;
2009-10-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81955
H.E.L.P. ACETATE BUFFER PH 4.85;
02373807;
sodium acetate 27.22 g / l , acetic acid 6.82 g / l;
2012-03-09;
Dialysis;
Solution;
40:04.00 – ACIDIFYING AGENTS;
Ethical;
B. BRAUN AVITUM AG
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85902
BICART SELECT COMBI-PAK;
02425246;
sodium bicarbonate 720 g / cartridge , sodium chloride 1200 g / cartridge;
2016-02-22;
Dialysis;
Kit , Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90988
SAG-M;
02386925;
sodium chloride 0.877 % / w/v , adenine 0.0169 % / w/v , dextrose 0.9 % / w/v , mannitol 0.525 % / w/v;
2013-01-20;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
HAEMONETICS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87250
PHENOL SALINE INJ;
00298409;
sodium chloride 0.9 % , phenol 0.4 %;
1963-12-31;
Intradermal , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1911
GLYCERINATED PHENOL SALINE;
00298417;
sodium chloride 0.9 % , phenol 0.4 % , glycerine 50 %;
1963-12-31;
Intradermal , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1912
ACID CONCENTRATE D12203;
00860468;
sodium chloride 263 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
1989-12-31;
Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9848
POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP;
02269414;
sodium chloride 450 mg / 100 ml , potassium chloride 150 mg / 100 ml;
2008-03-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75479
REGIOCIT;
02496755;
sodium chloride 5.03 g / l , sodium citrate 5.29 g / l;
2020-07-27;
Extracorporeal;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98660
LACTATED RINGER’S INJECTION;
00039470;
sodium chloride 6 mg / ml , potassium chloride 0.3 mg / ml , calcium chloride 0.2 mg / ml , sodium lactate 3.1 mg / ml;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1745
LACTATED RINGER’S IRRIGATION;
00758566;
sodium chloride 600 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml , sodium lactate 310 mg / 100 ml;
1988-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8601
POTASSIUM CHLORIDE IN LACTATED RINGER’S INJECTION;
02243421;
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 179 mg / 100 ml , calcium chloride 20 mg / 100 ml;
2001-05-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67329
LACTATED RINGER’S INJECTION, USP;
00061085;
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml;
1957-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1628
LACTATED RINGER’S IRRIGATION SOL;
00799971;
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml;
1989-12-31;
Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9830
LACTATED RINGER’S INJECTION USP;
01931636;
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12186
ADDITIVE SOLUTION SODIUM ADENINE GLUCOSE MANNITOL (SAGM);
02444097;
sodium chloride 8.77 g / l , adenine 0.169 g / l , dextrose 9 g / l , mannitol 5.25 g / l;
2016-08-22;
0-Unassigned;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MACO PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92892
RINGER’S INJECTION USP;
01936034;
sodium chloride 860 mg / 100 ml , calcium chloride 33 mg / 100 ml , potassium chloride 30 mg / 100 ml;
1996-09-10;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=21999
(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP;
00786209;
sodium chloride 900 mg / 100 ml , potassium chloride 150 mg / 100 ml;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9826
(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP;
00786217;
sodium chloride 900 mg / 100 ml , potassium chloride 300 mg / 100 ml;
1989-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9827
SODIUM PHOSPHATES INJECTION USP;
00896187;
sodium phosphate monobasic 276 mg / ml , sodium phosphate dibasic 268 mg / ml;
1991-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11258
HARVONI;
02432226;
sofosbuvir 400 mg , ledipasvir 90 mg;
2014-10-16;
Oral;
Tablet;
08:18.40.16 – HCV Polymerase Inhibitors , 08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91668
EPCLUSA;
02456370;
sofosbuvir 400 mg , velpatasvir 100 mg;
2016-08-02;
Oral;
Tablet;
08:18.40.16 – HCV Polymerase Inhibitors , 08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94324
VOSEVI;
02467542;
sofosbuvir 400 mg , velpatasvir 100 mg , voxilaprevir 100 mg;
2017-09-18;
Oral;
Tablet;
08:18.40.16 – HCV Polymerase Inhibitors;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95590
SEROSTIM;
02239046;
somatropin 5 mg / kit , water 1 ml / kit;
1999-07-28;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62499
SORBITOL MANNITOL IRRIGATION;
00498807;
sorbitol 27 mg / ml , mannitol 5.4 mg / ml;
1980-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3823
SMOFLIPID 20%;
02396963;
soybean oil 6 % / w/v , medium chain triglycerides (mct) 6 % / w/v , olive oil 5 % / w/v , fish oil 3 % / w/v;
2013-05-08;
Intravenous;
Emulsion;
40:20.00 – CALORIC AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88197
TEVA-SPIRONOLACTONE/HCTZ;
00613231;
spironolactone 25 mg , hydrochlorothiazide 25 mg;
1984-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5858
TEVA-SPIRONOLACTONE/HCTZ;
00657182;
spironolactone 50 mg , hydrochlorothiazide 50 mg;
1986-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6892
ALLERGENIC EXTRACTS, K-O-R-T GRASS MIXTURE;
02447304;
standardized kentucky blue/june grass pollen 100000 unit / ml , standardized orchard grass pollen 100000 unit / ml , standardized redtop grass pollen 100000 unit / ml , standardized timothy grass pollen 100000 unit / ml;
2015-11-10;
Intracutaneous , Subcutaneous;
Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93285
ALLERGENIC EXTRACT – MIXTURE OF 4 STANDARDIZED GRASS POLLEN;
02325535;
standardized timothy grass pollen 25000 unit / ml , standardized orchard grass pollen 25000 unit / ml , standardized kentucky blue/june grass pollen 25000 unit / ml , standardized redtop grass pollen 25000 unit / ml;
2011-03-22;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81091
BLEPHAMIDE;
00807788;
sulfacetamide sodium 10 % , prednisolone acetate 0.2 %;
1989-12-31;
Ophthalmic;
Drops;
52:04.08 – SULFONAMIDES , 52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10169
SULFATRIM PEDIATRIC;
00445266;
sulfamethoxazole 100 mg , trimethoprim 20 mg;
1979-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3677
TEVA-TRIMEL;
00726540;
sulfamethoxazole 40 mg / ml , trimethoprim 8 mg / ml;
1987-12-31;
Oral;
Suspension;
08:12.20 – SULFONAMIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7313
SULFATRIM;
00445274;
sulfamethoxazole 400 mg , trimethoprim 80 mg;
1979-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3678
SULFATRIM DS;
00445282;
sulfamethoxazole 800 mg , trimethoprim 160 mg;
1979-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3679
NEO-MEDROL ACNE LOTION;
00195057;
sulfur 50 mg / ml , methylprednisolone acetate 2.5 mg / ml , neomycin sulfate 2.5 mg / ml , aluminum chlorohydrate 100 mg / ml;
1965-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1394
SUVEXX;
02496305;
sumatriptan (sumatriptan succinate) 85 mg , naproxen sodium 500 mg;
2020-07-24;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98619
TEVA-TELMISARTAN HCTZ;
02330288;
telmisartan (telmisartan sodium) 80 mg , hydrochlorothiazide 12.5 mg;
2012-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81603
TELMISARTAN HCTZ;
02390302;
telmisartan (telmisartan sodium) 80 mg , hydrochlorothiazide 12.5 mg;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87575
TELMISARTAN HCTZ;
02390310;
telmisartan (telmisartan sodium) 80 mg , hydrochlorothiazide 25 mg;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87576
TEVA-TELMISARTAN HCTZ;
02379252;
telmisartan (telmisartan sodium) 80.0 mg , hydrochlorothiazide 25.0 mg;
2012-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86513
TWYNSTA;
02371030;
telmisartan 40 mg , amlodipine (amlodipine besylate) 10 mg;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85623
TWYNSTA;
02371022;
telmisartan 40 mg , amlodipine (amlodipine besylate) 5 mg;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85622
TWYNSTA;
02371057;
telmisartan 80 mg , amlodipine (amlodipine besylate) 10 mg;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85625
TWYNSTA;
02371049;
telmisartan 80 mg , amlodipine (amlodipine besylate) 5 mg;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85624
MICARDIS PLUS;
02244344;
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
2001-08-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68312
JAMP TELMISARTAN-HCT;
02389940;
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87541
SANDOZ TELMISARTAN HCT;
02393557;
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
2012-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87877
TELMISARTAN/HCTZ;
02395355;
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
2012-11-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88046
TELMISARTAN-HCTZ;
02395525;
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88061
ACH-TELMISARTAN HCTZ;
02419114;
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
2014-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90365
AURO-TELMISARTAN HCTZ;
02456389;
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
2016-08-23;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94325
MICARDIS PLUS;
02318709;
telmisartan 80 mg , hydrochlorothiazide 25 mg;
2008-12-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80418
JAMP TELMISARTAN-HCT;
02389959;
telmisartan 80 mg , hydrochlorothiazide 25 mg;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87542
SANDOZ TELMISARTAN HCT;
02393565;
telmisartan 80 mg , hydrochlorothiazide 25 mg;
2012-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87878
TELMISARTAN/HCTZ;
02395363;
telmisartan 80 mg , hydrochlorothiazide 25 mg;
2012-11-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88047
TELMISARTAN-HCTZ;
02395533;
telmisartan 80 mg , hydrochlorothiazide 25 mg;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88062
ACH-TELMISARTAN HCTZ;
02419122;
telmisartan 80 mg , hydrochlorothiazide 25 mg;
2014-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90366
AURO-TELMISARTAN HCTZ;
02456397;
telmisartan 80 mg , hydrochlorothiazide 25 mg;
2016-08-23;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94326
TRUVADA;
02274906;
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
2006-04-06;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76043
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL;
02443902;
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
2017-07-31;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92868
APO-EMTRICITABINE-TENOFOVIR;
02452006;
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93840
PMS-EMTRICITABINE-TENOFOVIR;
02461110;
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
2019-09-12;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94861
JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE;
02487012;
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
2019-07-23;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97716
AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE;
02496356;
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
2020-11-09;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98623
ALLERGY EYE DROPS;
02290596;
tetrahydrozoline hydrochloride 0.05 % / w/v , zinc sulfate 0.25 % / w/v;
2007-05-23;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77592
VISINE MULTI-SYMPTOM;
02338602;
tetrahydrozoline hydrochloride 0.05 % / w/v , zinc sulfate 0.25 % / w/v;
2012-03-21;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82425
8-SYMPTOM RELIEF;
02448955;
tetrahydrozoline hydrochloride 0.05 % / w/v , zinc sulfate 0.25 % / w/v;
2016-07-22;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93478
SYMDEKO;
02478080;
tezacaftor 100 mg , ivacaftor 150 mg , ivacaftor 150 mg;
2018-06-28;
Oral;
Tablet;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96881
AZARGA;
02331624;
timolol (timolol maleate) 0.5 % / w/v , brinzolamide 1 % / w/v;
2009-08-25;
Ophthalmic;
Suspension;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81730
COSOPT;
02240113;
timolol (timolol maleate) 5 mg / ml , dorzolamide (dorzolamide hydrochloride) 20 mg / ml;
1999-05-27;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63627
XALACOM;
02246619;
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
2002-10-24;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70807
GD-LATANOPROST/TIMOLOL;
02373068;
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
2013-05-01;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85818
SANDOZ LATANOPROST/TIMOLOL;
02394685;
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
2013-03-04;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87982
JAMP-LATANOPROST/TIMOLOL;
02453770;
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
2020-02-07;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94031
INSPIOLTO RESPIMAT;
02441888;
tiotropium (tiotropium bromide monohydrate) 2.5 mcg / act , olodaterol (olodaterol hydrochloride) 2.5 mcg / act;
2015-05-29;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92626
CLÉ DE PEAU BEAUTÉ 50+ ÉMULSION TRÈS HAUTE PROTECTION UV POUR LE CORPS;
02450046;
titanium dioxide 1.5 % / w/w , zinc oxide 19.3 % / w/w , octocrylene 3 % / w/w , octinoxate 7.4 % / w/w;
2017-01-03;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93602
BOBBI BROWN SKIN WEIGHTLESS LONG-WEAR FOUNDATION SPF15 FULL COVER OIL-FREE SHINE CONTROL;
02462605;
titanium dioxide 1.6 % / w/w , octinoxate 3 % / w/w;
2017-10-30;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95040
UV 50 ECRAN MULTI-PROTECTION SPF 50;
02446529;
titanium dioxide 10.9 g / 100 g , homosalate 4 g / 100 g , octocrylene 4 g / 100 g , oxybenzone 1.5 g / 100 g;
2016-02-15;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93187
SPORTS BB;
02453681;
titanium dioxide 15 % / w/w , octinoxate 4.9 % / w/w;
2016-12-15;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94024
GLOW TINTED MOISTURIZER SPF 15;
02491435;
titanium dioxide 2.9 % / w/w , octinoxate 7.5 % / w/w;
2020-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TOM FORD BEAUTY DIST.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98144
SKIN LONG-WEAR FLUID POWDER FOUNDATION SPF 20;
02490374;
titanium dioxide 3.7 % / w/w , ensulizole 2 % / w/w , zinc oxide 1.8 % / w/w;
2020-03-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98042
CLE DE PEAU BEAUTE 50+ CREME TEINTEE PROTECTRICE UV;
02450208;
titanium dioxide 4.6 % / w/w , octocrylene 3 % / w/w , octinoxate 7.4 % / w/w;
2017-01-20;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93623
THE SOFT MOISTURE POWDER FOUNDATION SPF 30;
02486415;
titanium dioxide 6 % / w/w , octinoxate 5.1 % / w/w;
2021-01-01;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAX HUBER RESEARCH LABS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97661
BOBBI BROWN INTENSIVE SKIN SERUM FOUNDATION SPF 40 LYCHEE, BAMBOO GRASS & CORDYCEPS EXTRACTS;
02431459;
titanium dioxide 6.1 % , octinoxate 3.9 % , zinc oxide 3.8 %;
2015-04-08;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91578
ROSALIAC CC CREME;
02427400;
titanium dioxide 6.2 % / w/w , octocrylene 4.5 % / w/w , octisalate 3.5 % / w/w , octinoxate 3 % / w/w;
2014-09-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91193
FIX+ SPF 30 SUN SPRAY;
02288400;
titanium dioxide 6.25 % , octocrylene 10.00 % , avobenzone 3.00 % , drometrizole trisiloxane 2.00 %;
2007-04-12;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77383
UV PROTECTIVE STICK FOUNDATION;
02423995;
titanium dioxide 7.2 % / w/w , octinoxate 2.9 % / w/w;
2016-02-22;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90872
URBAN ENVIRONMENT TINTED UV PROTECTOR;
02423936;
titanium dioxide 7.2 % / w/w , octinoxate 7.4 % / w/w , ensulizole 2.0 % / w/w;
2014-12-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90866
CLINIQUE SUPERBALANCED SILK MAKEUP SPF 15;
02446219;
titanium dioxide 7.8 % / w/w , octinoxate 7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 1.9 % / w/w;
2016-10-05;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93149
MARCELLE/CC/CREAM/CRÈME COMPLETE CORRECTION/CORRECTION COMPLÈTE/SPF 35 FPS;
02406926;
titanium dioxide 8.35 % / w/w , octinoxate 7.5 % / w/w;
2013-07-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89158
UV 50 ECRAN TEINTÉ MULTI-PROTECTION SPF 50;
02456273;
titanium dioxide 8.4 % , homosalate 4 % , octocrylene 4 % , oxybenzone 1.5 %;
2017-02-15;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94316
FACE IT POWER PERFECTION BB CREAM SPF 37/PA++;
02412519;
titanium dioxide 9.70 % / w/w , octinoxate 5.00 % / w/w , zinc oxide 2.94 % / w/w;
2017-09-12;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE FACE SHOP CO., LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89719
TOBRADEX;
00778907;
tobramycin 0.3 % / w/v , dexamethasone 0.1 % / w/v;
1990-12-31;
Ophthalmic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11068
TOBRADEX;
00778915;
tobramycin 0.3 % / w/w , dexamethasone 0.1 % / w/w;
1990-12-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10971
JINARC;
02491575;
tolvaptan 15 mg , tolvaptan 15 mg;
2020-03-26;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98156
JINARC;
02491583;
tolvaptan 30 mg , tolvaptan 15 mg;
2020-03-26;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98157
JINARC;
02437503;
tolvaptan 45 mg , tolvaptan 15 mg;
2015-06-01;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92184
JINARC;
02437511;
tolvaptan 60 mg , tolvaptan 30 mg;
2015-06-01;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92185
JINARC;
02437538;
tolvaptan 90 mg , tolvaptan 30 mg;
2015-06-01;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92186
PHESGO;
02512912;
trastuzumab 40 mg / ml , pertuzumab 80 mg / ml;
2021-04-08;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100216
OGIVRI;
02474433;
trastuzumab 440 mg / vial , water 20 ml / vial;
2019-06-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96454
PHESGO;
02512920;
trastuzumab 60 mg / ml , pertuzumab 60 mg / ml;
2021-04-09;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100217
DUOTRAV PQ;
02278251;
travoprost 0.004 % / w/v , timolol (timolol maleate) 0.5 % / w/v;
2006-04-11;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76384
APO-TRAVOPROST-TIMOP PQ;
02415305;
travoprost 0.004 % / w/v , timolol (timolol maleate) 0.5 % / w/v;
2018-12-06;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89992
VIADERM KC CRM;
00717002;
triamcinolone acetonide 1 mg / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g , nystatin 100000 unit / g;
1983-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9448
TEVA-TRIACOMB;
00550507;
triamcinolone acetonide 1 mg / g , nystatin 100000 unit / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g;
1992-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12862
TEVA-TRIAMTERENE/HCTZ;
00532657;
triamterene 50 mg , hydrochlorothiazide 25 mg;
1981-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4523
APO TRIAZIDE;
00441775;
triamterene 50 mg , hydrochlorothiazide 25 mg;
1984-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5672
ANTISEPTIC HAND SOAP;
00564311;
triclosan 0.6 % , bronopol 0.1 %;
1983-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
DUSTBANE PRODUCTS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5480
LONSURF;
02472104;
trifluridine 15 mg , tipiracil (tipiracil hydrochloride) 6.14 mg;
2018-03-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAIHO PHARMA CANADA, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96138
LONSURF;
02472112;
trifluridine 20 mg , tipiracil (tipiracil hydrochloride) 8.19 mg;
2018-03-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAIHO PHARMA CANADA, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96139
SEPTRA INJECTION;
00550086;
trimethoprim 16 mg / ml , sulfamethoxazole 80 mg / ml;
1982-12-31;
Intravenous;
Solution;
08:12.20 – SULFONAMIDES;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4703
TEVA-TRIMEL DS;
00510645;
trimethoprim 160 mg , sulfamethoxazole 800 mg;
1981-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4610
TEVA-TRIMEL;
00510637;
trimethoprim 80 mg , sulfamethoxazole 400 mg;
1981-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4611
TEVA-COTRIDIN;
02169126;
triprolidine hydrochloride 2 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
1996-07-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20329
TEVA-COTRIDIN EXPECTORANT;
02053403;
triprolidine hydrochloride 2 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
1994-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15618
ARTHRITIS PAIN RELIEF;
02486725;
trolamine salicylate 10 % / w/w , menthol 1.25 % / w/w , capsaicin 0.035 % / w/w;
2019-10-28;
Topical;
Lotion;
28:08.04.24 – SALICYLATES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97690
ANORO ELLIPTA;
02418401;
umeclidinium (umeclidinium bromide) 62.5 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
2014-03-14;
Inhalation;
Powder;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90298
ENTRESTO;
02446944;
valsartan (sacubitril valsartan sodium hydrate complex) 103 mg , sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg;
2015-11-13;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:32.92 – RENIN-ANGIOTENSINE-ALDOSTERONE SYSTEM INHIBITORS, MISC.;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93251
ENTRESTO;
02446928;
valsartan (sacubitril valsartan sodium hydrate complex) 26 mg , sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg;
2015-11-13;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:32.92 – RENIN-ANGIOTENSINE-ALDOSTERONE SYSTEM INHIBITORS, MISC.;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93249
ENTRESTO;
02446936;
valsartan (sacubitril valsartan sodium hydrate complex) 51 mg , sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg;
2015-11-13;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:32.92 – RENIN-ANGIOTENSINE-ALDOSTERONE SYSTEM INHIBITORS, MISC.;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93250
DIOVAN-HCT;
02241901;
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
2000-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65571
SANDOZ VALSARTAN HCT;
02356708;
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84183
TEVA-VALSARTAN/HCTZ;
02357003;
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84211
VALSARTAN HCT;
02367017;
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85183
VALSARTAN-HCTZ;
02367777;
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85261
VALSARTAN HCT;
02384744;
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87043
AURO-VALSARTAN HCT;
02408120;
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89287
DIOVAN-HCT;
02246955;
valsartan 160 mg , hydrochlorothiazide 25 mg;
2003-01-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71182
SANDOZ VALSARTAN HCT;
02356716;
valsartan 160 mg , hydrochlorothiazide 25 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84184
TEVA-VALSARTAN/HCTZ;
02357011;
valsartan 160 mg , hydrochlorothiazide 25 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84212
VALSARTAN HCT;
02367025;
valsartan 160 mg , hydrochlorothiazide 25 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85184
VALSARTAN-HCTZ;
02367785;
valsartan 160 mg , hydrochlorothiazide 25 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85262
VALSARTAN HCT;
02384752;
valsartan 160 mg , hydrochlorothiazide 25 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87044
AURO-VALSARTAN HCT;
02408139;
valsartan 160 mg , hydrochlorothiazide 25 mg;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89288
DIOVAN-HCT;
02308908;
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
2008-05-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79451
SANDOZ VALSARTAN HCT;
02356724;
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84185
TEVA-VALSARTAN/HCTZ;
02357038;
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84213
VALSARTAN HCT;
02367033;
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85185
VALSARTAN HCT;
02384760;
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87045
AURO-VALSARTAN HCT;
02408147;
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89289
DIOVAN-HCT;
02308916;
valsartan 320 mg , hydrochlorothiazide 25 mg;
2008-05-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79452
SANDOZ VALSARTAN HCT;
02356732;
valsartan 320 mg , hydrochlorothiazide 25 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84186
TEVA-VALSARTAN/HCTZ;
02357046;
valsartan 320 mg , hydrochlorothiazide 25 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84214
VALSARTAN HCT;
02367041;
valsartan 320 mg , hydrochlorothiazide 25 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85186
AURO-VALSARTAN HCT;
02408155;
valsartan 320 mg , hydrochlorothiazide 25 mg;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89290
DIOVAN-HCT;
02241900;
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
2000-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65570
SANDOZ VALSARTAN HCT;
02356694;
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84182
TEVA-VALSARTAN/HCTZ;
02356996;
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84210
VALSARTAN HCT;
02367009;
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85182
VALSARTAN-HCTZ;
02367769;
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85260
VALSARTAN HCT;
02384736;
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87042
AURO-VALSARTAN HCT;
02408112;
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89280
CHAMPIX;
02298309;
varenicline (varenicline tartrate) 0.5 mg , varenicline (varenicline tartrate) 1 mg;
2007-10-02;
Oral;
Kit , Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78360
TEVA-VARENICLINE;
02426781;
varenicline (varenicline tartrate) 0.5 mg , varenicline (varenicline tartrate) 1 mg;
2019-04-23;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91135
APO-VARENICLINE;
02435675;
varenicline (varenicline tartrate) 0.5 mg , varenicline (varenicline tartrate) 1 mg;
2018-06-12;
Oral;
Kit , Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92001
VARILRIX;
02241047;
varicella-zoster virus vaccine live attenuated (oka-strain) 2000 unit / 0.5 ml , water 0.5 ml;
2003-04-09;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64641
VENCLEXTA;
02458063;
venetoclax 10 mg , venetoclax 50 mg , venetoclax 100 mg;
2016-10-31;
Oral;
Kit , Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94512
BREO ELLIPTA;
02408872;
vilanterol (vilanterol trifenatate) 25 mcg / act , fluticasone furoate 100 mcg / act;
2013-11-29;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89362
VIIBRYD;
02443759;
vilazodone hydrochloride 10 mg , vilazodone hydrochloride 20 mg;
2018-07-06;
Oral;
Kit , Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92850
HUMATE-P;
02261227;
von willebrand factor (human) 1680 unit / 10 ml , antihemophilic factor (human) 600 unit / 10 ml;
2004-12-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74662
NUWIQ;
02432986;
water 2.5 ml / syr , simoctocog alfa 1000 unit / vial;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91742
NUWIQ;
02432994;
water 2.5 ml / syr , simoctocog alfa 2000 unit / vial;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91743
NUWIQ;
02432951;
water 2.5 ml / syr , simoctocog alfa 250 unit / vial;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91740
NUWIQ;
02432978;
water 2.5 ml / syr , simoctocog alfa 500 unit / vial;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91741
EXTRA STRENGTH DIAPER RASH OINTMENT;
02352702;
white petrolatum 38 % / w/w , zinc oxide 40 % / w/w;
2010-08-29;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83796
CAVILON MOISTURE BARRIER OINTMENT;
02443333;
white petrolatum 68.4 % / w/w , dimethicone 10.0 % / w/w;
2016-01-08;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92798
MEDLINE REMEDY ESSENTIALS PROTECTANT PASTE;
02455463;
white petrolatum 75 % , zinc oxide 20 %;
2019-07-22;
Topical;
Paste;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
MEDLINE INDUSTRIES INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94227
ALEXANDER’S RASH EASE FOR ADULTS;
02390361;
white petrolatum 88.7 % , zinc oxide 5.0 %;
2012-10-08;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ALTACOMP ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87581
HYMENOPTERA VENOM PRODUCT-MIXED VESPID VENOM PROTEIN (1650 MCG);
02221314;
yellow jacket venom protein 550 mcg / vial , white faced hornet venom protein 550 mcg / vial , yellow hornet venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43302
CHILDREN’S BENADRYL BUG BITE RELIEF;
02478072;
zinc acetate 0.1 % , diphenhydramine hydrochloride 2 %;
2019-03-04;
Topical;
Solution;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96880
TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 50+ SUNSCREEN;
02439891;
zinc oxide 10 % / w/w , octinoxate 7.5 % / w/w , homosalate 6 % / w/w , octisalate 5 % / w/w;
2017-05-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SKINMEDICA, AN ALLERGAN COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92429
SKIN RENEWING DAY CREAM;
02473852;
zinc oxide 10.5 % , octinoxate 7.5 %;
2018-09-07;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CERAVE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96358
ZINCOFAX;
02239162;
zinc oxide 15 % , white petrolatum 69 %;
1999-12-15;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62617
DIAPER RASH OINTMENT;
02302241;
zinc oxide 15 % , white petrolatum 72 %;
2014-03-14;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78758
DIAPER RASH CREAM;
02337452;
zinc oxide 15 % / w/w , white petrolatum 80.3 % / w/w;
2010-04-19;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
H.J. SUTTON INDUSTRIES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82304
UNIVERSAL DEFENSE E;
02488531;
zinc oxide 15.4 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w;
2019-12-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97863
CLÉ DE PEAU BEAUTÉ 50+ CRÈME PROTECTRICE UV;
02450216;
zinc oxide 16.4 % / w/w , octocrylene 3 % / w/w , octinoxate 7.4 % / w/w;
2017-02-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93625
UV ESSENTIAL MULTI PROTECTION;
02495791;
zinc oxide 17.1 % / w/w , octinoxate 7.5 % / w/w , titanium dioxide 3.8 % / w/w;
2020-06-26;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CHANEL CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98569
ULTRA SUN PROTECTOR CREAM CRÈME SOLAIRE ULTRA PROTECTION 50+;
02496879;
zinc oxide 19.4 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , titanium dioxide 3.8 % / w/w;
2020-12-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98672
CLINIQUE EVEN BETTER GLOW LIGHT REFLECTING MAKEUP SPF 15;
02456540;
zinc oxide 3 % / w/w , octinoxate 6 % / w/w , titanium dioxide 3.8 % / w/w;
2017-09-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94351
ZINCOFAX EXTRA STRENGTH;
02239160;
zinc oxide 40 % , white petrolatum 47 %;
1999-11-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62616
ALEXANDER’S RASH EASE – FOR BABIES;
02342421;
zinc oxide 5 % , white petrolatum 88.7 %;
2010-05-29;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ALTACOMP ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82792
ALEXANDER’S RASH EASE – SPORT CREAM;
02462540;
zinc oxide 5 % / w/w , white petrolatum 88.7 % / w/w;
2017-09-17;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ALTACOMP ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95030
VANILLA LATTE TINTED MOISTURIZER;
02371928;
zinc oxide 6 % / w/w , octinoxate 6 % / w/w;
2012-06-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85703
CARAMEL LATTE TINTED MOISTURIZER;
02363550;
zinc oxide 6.00 % / w/w , octinoxate 6.00 % / w/w;
2011-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84853
TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN;
02439875;
zinc oxide 8 % / w/w , octinoxate 7.5 % / w/w , octisalate 3 % / w/w;
2017-05-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SKINMEDICA, AN ALLERGAN COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92426
TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN TINTED;
02439867;
zinc oxide 8 % / w/w , octinoxate 7.5 % / w/w , titanium dioxide 3.5 % / w/w , octisalate 3 % / w/w;
2017-05-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SKINMEDICA, AN ALLERGAN COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92417
ELTAMD SKINCARE UV DEFENSE SPF 45;
02322293;
zinc oxide 9 % / w/w , octinoxate 7.5 % / w/w;
2009-10-21;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80775
ELTAMD SKINCARE UV DAILY SPF 40;
02322307;
zinc oxide 9 % / w/w , octinoxate 7.5 % / w/w;
2010-01-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80776
UV DAILY TINTED;
02431343;
zinc oxide 9 % / w/w , octinoxate 7.5 % / w/w;
2015-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91576
ESSENTIALS BY ARTISTRY MULTI-PROTECT LOTION;
02470136;
zinc oxide 9.19 % / w/w , octinoxate 7.49 % / w/w , ensulizole 3 % / w/w;
2018-05-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95908
LANEIGE BB CUSHION;
02462273;
zinc oxide 9.8 % / w/w , octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w;
2018-02-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95002
SHEER BROAD SPECTRUM SPF 45;
02437775;
zinc oxide 9.9 % / v/v , octinoxate 7.5 % / v/v , octisalate 5.0 % / v/v , octocrylene 8.0 % / w/w;
2016-02-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VIVIER CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92215
VISINE FOR ALLERGY 3 SYMPTOM RELIEF;
02144093;
zinc sulfate 0.25 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
1996-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42685

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut